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Abstract
This thesis describes the development of the [RuCl2(P^N^N)L] catalytic system for asymmetric
hydrogenation. It has been demonstrated that the current system is efficient in preparing a range
of bulky chiral alcohols in good enantioselectivity, many of which are likely to be inaccessible
using the more classic [RuCl2(P^P)N^N)] system developed by Noyori and coworkers. It has
been shown that the current system is tolerant of a range of substrate electronic effects as well
as the presence of heteroaromatic functionality, thus showing its applicability in synthesis. This
has been extended to prepare a number of bulky derivatives of synthetically important
molecules. The demonstration of this is significant as in drug design, for example, studies that
aim to extend lipophilicity or steric bulk make the ability to prepare alcohols across the full
range of steric properties important. We have shown that chiral alcohols with adjacent gem-
dimethyl groups can be prepared in high enantioselectivity and their conversion into other
valuable molecules, such as chiral lactones has been demonstrated.
Detailed mechanistic studies have been undertaken for the present system in order to aid rational
design of new, more active and selective catalysts. A number of achiral variants of the original
system have been prepared and the key features of ligand structure for efficient catalysis have
been identified. This was accomplished by rigorous kinetic analysis of each complex, using
specialist gas-uptake monitoring equipment. The key features of catalyst structure and optimal
reaction conditions for efficient asymmetric hydrogenation have been identified.
Our greater understanding of the present system allowed us to rationally design new catalysts of
for enantioselective hydrogenation. Our aim was to be able to tune the catalyst structure to
carry out hydrogenation of a greater variety of ketone substrate with high activity and
selectivity. We have successfully prepared second generation catalysts that show enhanced
enantioselectivity for a variety of substrates, many of which were problematic with the Noyori
system.
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Chapter I
Introduction
1.1 Catalytic Asymmetric Hydrogenation
The chirality, or “handedness”, of molecules is of fundamental importance in both science and
technology. In particular, the biological activity of many pharmaceuticals and agrochemicals is
often specific to a single enantiomer.1 The demand for enantiopure compounds has escalated in
recent times and has motivated intensive research to develop improved methods for the
synthesis of optically pure compounds. Catalytic asymmetric hydrogenation, using molecular
hydrogen to reduce prochiral olefins, ketones and imines, has become one of the most efficient,
practical and atom-economical methods for the construction of homochiral compounds2 and as
such, much work is focused on designing original catalysts with enhanced activity and
selectivity.
Catalytic asymmetric hydrogenation has its origins in the 1960s when William Knowles and his
colleagues at Monsanto demonstrated that rhodium complexes containing enantioenriched
phosphine ligands could catalyse the enantioselective addition of hydrogen to a prochiral
olefinic substrate (Scheme I-1).3 Knowles’ work integrated the newly established methods to
prepare chiral phosphines of Mislow4 and Horner5 with Wilkinson’s groundbreaking discovery
of [RhCl(PPh3)3] as a hydrogenation catalyst.6 Knowles demonstrated that hydrogenation of -
phenylacrylic acid 1 could be accomplished using [RhL3Cl] (L = (R)-(-)-methyl-n-
propylphenylphosphine 3 of 69% optical purity) with a 15 % enantiomeric excess observed in
the acid product.
Scheme I-1 The hydrogenation of -phenylacrylic acid with a
ruthenium complex of the optically active phosphine (-)-
methylpropylphenylphosphine 3. Reaction conditions: -phenylacrylic
acid 1 (1 eq.), [RhClL3] (0.15 mol%), NEt3 (0.53 mol%), H2 (20-30
bar), benzene/ethanol (1:1), 60C.
Although not comparable with enantioselectivities obtained in asymmetric catalysis today, this
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initial result, together with work by Horner,7 provided the clue that catalytic asymmetric
hydrogenation could be an efficient tool for the preparation of enantioenriched compounds. An
important breakthrough, in terms of levels of enantioselectivity, came later when Kagan found
that a rhodium complex containing the enantiopure diphosphine (((4R,5R)-2,2-dimethyl-1,3-
dioxolane-4,5-diyl)bis(methylene))bis(diphenylphosphine)), (-)-DIOP 6, prepared in two steps
from (+)-ethyl tartrate, catalyses the enantioselective reduction of unsaturated prochiral acids in
up to 72 % e.e. (Scheme I-2).8 Kagan proposed that two factors were necessary in order to
obtain such stereoselectivity in catalysis: the ligand conformations must have maximum rigidity
with the ligands staying firmly bound to the metal, and that the acid function of the substrates
was important.†
Extensive mechanistic studies by Halpern suggested that the substrate binds to the metal centre
through the olefinic bond and the carbonyl oxygen, producing ring-stabilised diasteromeric
intermediates (TS1, Scheme I-2),9 supporting Kagan’s claim that a remote functionality such as
the acid function is salient. A more detailed discussion of the complex chemistry discovered on
this mechanism can be found elsewhere.10
Scheme I-2 The hydrogenation of -functionalised olefins with a ruthenium complex of the diphosphine (R,R)-6,
showing the transition state proposed by Halpern. Reaction conditions: 1 or 4 (1 eq.), [RhClL(solvent)] (0.02-3
mol%), NEt3 (0.06 mol%), H2 (1 bar), benzene/ethanol (1:2), rt.
Knowles noted the importance of the diphosphine to enantioselectivity and developed a new
breed of chiral diphosphines. It was found that employing a cationic rhodium complex of the
diphosphine (R,R)-DiPAMP 10, enantioselectivity of up to 95% could be obtained in the
hydrogenation of -acylaminoacrylic acids (Scheme I-3). This led to the development of the
first industrial application of catalytic asymmetric hydrogenation, in the synthesis of L-DOPA
9,11 a compound found to be useful in the treatment of Parkinson’s disease.12
† Kagan’s work was also insightful in that he showed that the chirality did not have to be at the phosphorus centre and
could be incorporated in the ligand backbone, further from the metal centre.
RhI
P
P
O
NH
COOH
Ph
H
*
TS1
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The success of this process - operated on an industrial scale since 1974 - opened the door to a
new era in asymmetric catalysis. In subsequent years, the discovery of a variety of ligands, in
combination with various metals, has led to several processes for alkene hydrogenation running
on a commercial scale13,14 and a number of recently launched drugs, such as Tipranavir,15
Rozerem,16 Sitagliptin17 and Aliskiren18 are reported to use asymmetric hydrogenation in their
synthesis. The asymmetric hydrogenation of ketones, however, is a newer field and its origins
lie in the 1980s, in particular in the work of Ryoji Noyori.
Scheme I-3 The hydrogenation of -acylaminoacrylic acids with the ruthenium complex of the
diphosphine (R,R)-DiPAMP 9. Deprotection of the aryl substituents and the amide component of
compound 8 (steps (i) and (ii)) yields L-DOPA, produced on an industrial scale via this route. Reaction
conditions: 4 or 7 (1 eq.), [Rh(R,R-10)1,5-COD]+BF4- (0.001 mol%), H2 (3 bar), MeOH, 50C. (i) 9, HCl
(aq); (ii) HBr (5 eq.), H2O, reflux, 3 h.
1.2 Asymmetric Hydrogenation of Functionalised Ketones
Despite the tremendous success in the hydrogenation of prochiral olefins, until the 1980s
attempts at catalytic asymmetric ketone hydrogenation had been generally fruitless. The
breakthrough came about with the discovery of a new ligand, the atropisomeric chiral
diphosphine ligand 2,2’-bis(diphenylphosphino)-1,1'-binapthyl (BINAP) 11, which when
employed with ruthenium, was found to be remarkably effective not only in the enantioselective
hydrogenation of a wide variety range of olefinic substrates such as enamides,19,20 α-
(acylamino)acrylic acids, alkyl- and aryl-substituted acrylic acids,21 β,γ-unsaturated carboxylic 
acids, 21 allylic and homoallylic alcohols,22 but also in the hydrogenation of ketones with
proximal functional groups, which act as a tether to the ruthenium centre.23 A number of
functional groups were shown to tether the substrate to the catalyst leading to highly
enantioselective hydrogenation, for example: dialkylamino, hydroxyl, alkoxyl, siloxyl, keto,
alkoxycarbonyl, alkylthiocarbonyl, dialkylaminocarbonyl, and carboxyl groups - a number of
which are represented in Table I-1.
Noyori proposed that the hydrogenation of such substrates is possible due to an alternative
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mechanism operating compared to hydrogenation using rhodium complexes. It was proposed
that the reaction proceeds via a Ru monohydride intermediate formed by heterolysis of
molecular hydrogen by the Ru complex (Scheme I-4). The ruthenium centre remains in the +II
oxidation state throughout the catalytic cycle; rhodium on the other hand oxidatively adds H2
and the catalytic cycle thus involves a +I/+III redox process. Heteroatoms in the functional
groups are needed to tether the substrate to the catalytic ruthenium centre and
enantiodifferentiation is brought about by a combination of the 5 or 6 membered chelate ring
formed between the substrate and the catalyst, and the unique dissymmetric template created by
ruthenium and the C2 symmetric chiral diphosphine (Scheme I-4, TSA and TSB).
Entry Tether Ru Catalyst
Catalyst
Loading
[mol%]
PH2
[bar]
Time
[h]
Conversion
(yield)
[%]
ee [%]
1 CH2NMe2 [Ru((S)-11)(OAc)2] 0.13 50 12 72 96 (S)
2 CH2OH [RuCl2((R)-11)] 0.43 93 32 >99 92 (R)
3 CO2Me [RuCl2((R)-11)] 0.13 96 46 97 83 (R)
4 CH2CH2OH [RuCl2((R)-11)] 0.11 70 42 >99 98 (R)
5 CH2CO2Et [RuBr2((R)-11)] 0.08 86 51 >99 >99 (R)
6 CH2COSPh [RuCl2((R)-11)] 0.19 95 86 (42) 93 (R)
7 o-BrC6H4 [RuBr2((R)-11)] 0.09 100 62 97 92 (R)
Table I-1 Hydrogenation of functionalised ketones using ruthenium complexes of the C2-symmetric
diphosphine BINAP 11. General conditions:functionalised ketone, ruthenium catalyst, MeOH or
EtOH, H2, rt.
This development proved to be extremely efficient for the asymmetric hydrogenation of a wide
variety of functionalised ketones resulting in the industrial production of synthetic intermediates
of antibiotic carbapenems24 and antibacterial Levofloxacin.25 However, simple unfunctionalised
ketones are not hydrogenated using such catalytic systems because the substrates are unable to
stabilise the transition state by forming the chelate structure depicted in Scheme I-4.
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Scheme I-4 Mechanism of BINAP-Ru catalysed hydrogenation of β-keto esters and the 
diastereomeric transition states involved (naphthalene rings omitted for clarity). S = solvent
1.3 Asymmetric Hydrogenation of Simple Ketones
In spite of extensive studies, only a limited number of transition metal catalysts were known to
exhibit any activity in the hydrogenation of simple ketones up until the 1990s, and even fewer
were noted to induce stereoinduction. Until this point, enantioselective reduction of achiral
ketones was affected by chiral stoichiometric reagents including BINAL-H,26,27 DIP chloride28
and Alpine Borane29 or by CBS reduction using borane/catechol borane and a chiral
oxazaborolidine catalyst.30 For technical and economic reasons, particulary in large scale
reactions in industry, homogenous hydrogenation is obviously more desirable than
stoichiometric hydride reduction.
The major breakthrough in the catalytic asymmetric hydrogenation of simple ketones using
transition metals was made by Noyori in the mid-1990s by the development of ruthenium
catalysts bearing both BINAP and a chiral 1,2-diamine on the metal centre.31 Noyori proposed
that employing protic ligands, for example ligands containing an NH2, could improve the
activity and selectivity of the BINAP-Ru(II) catalyst by forming a secondary, hydrogen bonding
interaction with the C=O moiety. Indeed it was shown that the reactivity of [RuCl2(PPh3)3] was
significantly enhanced by the addition of one equivalent of ethylene diamine and an excess of
potassium hydroxide, with TOF increasing from less than 5 to 6700 mol cat-1 mol prod-1 h-1 in
the hydrogenation of acetophenone.31 Turnover frequency was enhanced further using the
anisotropic diphosphine BINAP and its derivatives. It was shown that maximum turnover
frequencies of over 250,000 mol cat-1 mol prod-1 h-1 could be obtained using a preformed
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ruthenium catalyst comprising TolBINAP in combination with DPEN, and 200 equivalents of
KOtBu relative to ruthenium.32
The asymmetric version of this reaction, employing (S)-TolBINAP and (S,S)-DPEN, was found
to give good enantioselectivity in the hydrogenation of acetophenone and 1’acetonaphthone
(Scheme I-5).32 However, this could be significantly increased by employing the more sterically
demanding (S)-XylBINAP and the diamine (S)-DAIPEN - readily obtainable from leucine - and
this combination remains the best system for a many enantioselective hydrogenations.33 High
enantioselectivity is dependent upon using the ‘matched’ diphosphine/diamine combination i.e.
the (S)/(R)-combination of XylBINAP and DPEN gives substantially lower selectivity.
Scheme I-5 Asymmetric hydrogenation of simple ketones using [RuCl2(P^P)(N^N)] catalysts.
A wide range of simple alcohols have subsequently been prepared with high levels of
enantioenrichment and the catalytic system has been shown to be tolerant of a number of
functionalities (Table I-2).31,32,33 Substitution of different electronic groups of the phenyl ring
had little effect on enantioselectivity and hydrogenation of the ketone proceeded while leaving
groups such as NH2, NO2, ester groups, and halogens untouched.
The [RuCl2(P^P)(N^N)] system has also been found to be efficient in the highly enantioselective
hydrogenation of unsymmetrical, sterically differentiated benzophenones,34 some heteroaromatic
ketones,‡35 conjugated33 and unconjugated ketones36 – leaving the olefinic bond intact –
cycloalkyl methyl ketones,33 dialkoxymethyl methyl ketones24 and α-amino aromatic ketones.37
Thus this system has given unprecedented access to a wide variety of synthetically valuable
chiral secondary alcohols (Scheme I-6). Noyori has also demonstrated the synthesis of a number
of biologically relevant molecules using [RuCl2(P^P)(N^N)] catalysts (Scheme I-7). None-the-
less, there were some rather significant gaps in the substrate scope that will be discussed later. It
should also be noted that some of the same principles have been applied in the asymmetric
‡ The hydrogenation of some heteroaromatic ketones is accomplished successfully with the heterocycle
remaining intact. However, borate additives are often required to prevent deactivation of the catalyst.35
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transfer hydrogenation of simple ketones, but the interested reader is directed to other reviews on
this related field of study.38-41
Alcohol R or X
e.e. [%]
(S)-18/
(S)-20
(S)-17/
(S)-20
(S)-11/
(S,S)-19
CH3 99 91 87
C2H5 99 92
n-C3H7 94
n-C4H9 90
CH2Ph 98
CH(CH3)2 99
C(CH3)3 61a
CH3 99 99 95
F 97 82
Cl 98 94
Br 96 98
CF3 99 99
CH3O 92 82
CH3 >99 87
F 98 88
Br >99 77
CF3 99 83
CH3O 99 88 88
CH3 99 99
F 97 77
Cl 96 94
CF3 >99
Alcohol R or X
e.e. [%]
(S)-18/
(S)-20
(S)-17/
(S)-20
(S)-11/
(S,S)-19
CH3 98 84 94
C2H5 97 89
n-C4H9 98 93
CH2CH(CH3)2 96
cyclo-C6H11 95
C(CH3)3 96
Ph 97 87
F 97 73
Br >99 84
I 99 83 71
CF3 >99 78
CH3O >99 86 92
(CH3)2CHOCO 99
(CH3)2NCO 88
NO2 >99 83
NH2 >99
CH3CONH 95
(CH3)2N 94
CH3 95
F 99 92
Cl 99 86 87
CH3O 95
Table I-2 Hydrogenation of an unprecidented range of simple ketones using diphosphine/diamine-ruthenium
complexes. a 6% conversion.
Ar R
O
Ru Cat
KOH, iPrOH
rt, H2
Ar R
OH PAr2
PAr2
(S)-11, Ar = Ph, (S)-BINAP
(S)-17, Ar = Tol, (S)-TolBINAP
(S)-18, Ar = Xyl, (S)-XylBINAP
NH2
NH2
R NH2
NH2
MeO
MeO
(S)-20, R = (CH3)2CH, (S)-DAIPEN(S,S)-19, (S,S)-DPEN
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Scheme I-6 Scope of [RuCl2(P^P)(N^N)] catalysts (references in text).
Scheme I-7 Products obtained by routes involving asymmetric hydrogenation catalysed by
[RuCl2(P^P)(N^N)] complexes.24
1.4 Mechanism of Hydrogenation of Unfunctionalised Ketones
The rational design of efficient homogeneous catalysts is greatly accelerated by an in-depth
knowledge of the mechanism of the desired process, especially of the underlying origin of
activity and selectivity. The mechanism of the hydrogenation of unfunctionalised ketones has
undergone extensive study in an attempt to fully delineate the catalytic process. Such an
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understanding is of huge importance in the design of new asymmetric hydrogenation catalysts,
not only in the optimisation of the original Noyori catalyst scaffold, but in discovering and
developing new breeds of catalysts. Here, the current understanding of the mechanism by which
Noyori’s [(P^P)(N^N)RuCl2] catalytic system is believed to operate, and the proposed origin of
enantioselectivity in the asymmetric process, is discussed.
1.4.1 Noyori’s Proposed Mechanism
The fundamental principle behind the high activity and enantioselectivity of [RuCl2
(P^P)(N^N)] catalysts first presented by Noyori, was the need for a terminal N-H functionality
to facilitate hydride transfer between the Ru-H species and the ketone.31 Noyori realised that the
ketone must somehow interact with the catalyst structure in a way such that it is geometrically
possible for hydride delivery to the carbonyl functionality. It was postulated that since
electrophilic metal centres tend to form σ-complexes rather than π-complexes with carbonyl 
compounds the relative locations of the nucleophile and the carbonyl carbon are inappropriate
for a reaction to occur.24 Thus he accounted for the lack of reactivity of simple ketones with
[RuCl2(P^P)]-type catalysts, which are efficient catalysts for the hydrogenation of
functionalised ketones.31 In the case of functionalised ketones, coordination of an adjacent
heteroatom allowed the positioning of the metal hydride for efficient hydride transfer to the
ketone. Noyori proposed that increased activity in the hydrogenation of simple, or
unfunctionalised ketones, could be achieved by addition of diamine additives, with ligand-
substrate hydrogen bonding interactions holding the substrate in place for efficient hydride
transfer.
As discussed, this conceptually new idea for the hydrogenation of simple ketones was borne out
experimentally allowing for a highly efficient process, and a greater understanding of the
mechanism has developed from the original idea. Noyori has proposed a mechanism for the
hydrogenation of acetophenone using catalyst (S),(S,S)-37, structurally similar to the original
catalyst precursor (S),(S,S)-14 (Scheme I-8)§42 based on detailed experimental observations.
The catalytic cycle is made of two distinct modes: catalyst generation from precatalysts and the
catalytic cycles leading to turnover of substrate.
§ Noyori makes use of this precatalyst in preference to the original precatalyst (S),(S,S)-14 as it is claimed
that the activation of (S),(S,S)-37 is considerably more complex than that of (S),(S,S)-14. However, both
catalyst precursors are believed to generate the same stereo-determining reactive species, and thus operate
by the same mechanism, both giving identical enantioselectivities in the hydrogenation of a variety of
ketonic substrates.
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(i) Catalyst Generation
Noyori proposed that hydrogenation proceeded first by generation of real catalysts from the
precatalyst A, then subsequent dual-operating catalytic cycles 1 and 2 (Scheme I-8).42 The
generation of the real catalytic species from the 18 electron species A can follow two reversible
pathways. A ligand can dissociate to form the cationic species B which can then be
deprotonated to form the 16e Ru amide complex E. Alternatively E can be be formed through
species D via a Dcb mechanism (akin to SN1CB) whereby the ligand elimination is facilitated by
deprotonation of the amine, to give species E. Noyori postulates that the formation of H2, RO-
and B(OR)3 from the destruction of BH4 in alcoholic solvent, or chloride salts when catalyst
precursors such as (S),(S,S)-14 are used, shifts the equilibrium in these reversible steps towards
the formation of species B and E which can be considered ‘true catalysts,’ with their relative
amounts dependent on base concentration.42
Scheme I-8 Mechanism of the hydrogenation of unfunctionalised ketones as proposed by Noyori.
Mechanism described in reference 42 for system where P-P = (S)-TolBINAP, HN-NH = (S,S)-DPEN,
L1 = BH4, L2 = H, with isopropanol as solvent.
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(ii) Catalytic Cycles
Noyori suggests that once the catalytic species B and E are generated, two cycles are in
operation, dependant on the reaction conditions.42 Under standard conditions, i.e. in alcoholic
media and in the presence of base, catalytic cycle 1 is the major pathway and is thought to be
responsible for the exceedingly high catalytic turnover in isopropanol.43 The cationic 16e
complex B first reacts with H2 to form the 18e complex C which can undergo deprotonation to
generate species F.42 Reaction of F with ketone substrate gives the 16e amido Ru species E as
well as the alcoholic product. Protonation of E by the alcohol solvent regenerates B, thus
completing catalytic cycle 1. Alternatively, F can also be regenerated by direct reaction of E
with H2, giving the less significant catalytic cycle 2. However, this cycle becomes important
when hydrogenations are carried out in aprotic solvents or at high base concentration.
It is important to note that the proposed catalytic cyles make assumptions on the relative
basicity and acidity of reaction intermediate such that relative basicity:
:NH (G) > :NH (E) > (RO-)(isopropanol)n
and the relative acidity of
2-H2 (C) > NH2 (B) ≥ isopropanol > NH2 (A) > NH2 (F)
Thus under standard conditions, i.e. catalytic cycle 1, B and C are the resting states, where a
high concentration of C and its easy deprotonation are required for high catalyst efficiency. In
catalytic cycle 2, E is the resting species.
(iii) Origin of Enantioselectivity
Noyori’s proposed mechanism is based on a metal-ligand dual functionality first proposed in
2001. It was postulated that the hydride transfer step, i.e. the stereodirecting step, involves the
two ground state components F and E linked by transition step TS1.42 The NH proton in F plays
a pivotal role in hydrogen delivery to ketones.
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Scheme I-9 The hydride transfer step in the hydrogenation of unfunctionalised ketones.
In the ground state species F (Scheme I-9), the NH moiety has an excellent hydrogen bonding
ability which can activate carbonyl substrates, and this combined with the sufficiently
nucleophilic hydride in a fac relationship sets up a charge-alternating H--Ru+N--
H+arrangement which fits well with the C=O dipole.42 Only the axial N-H protons are involved
in this arrangement due to stereoelectronic reasons. The Ru center can then deliver a hydride to
the electrophilic C=O carbon, while the nitrogen supplies a proton to the oxygen atom
simultaneously to give E.
Scheme I-10 Diastereomeric transition states for TS1 in the metal-ligand bifunctional
catalysis. Reproduced from reference 42.
The origin of enantioselectivity can be seen by consultation of the possible diasteromeric
transition states for TS1 (Scheme I-10). The prochiral ketone approaches 38 so as to minimise
nonbonded repulsion with the substituents upon phosphorus, in this case the tolyl ring, and to
maximise the electronic attraction between the equatorial NH and the ketone phenyl group. This
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allows transfer of the hydride to the Si prochiral face of the ketone resulting in the formation of
the (R) form of the alcohol product using the (S),(S,S) catalyst.
1.5 Evidence for Noyori’s Proposed Mechanism
1.5.1 Role of Diamine Ligand
When Noyori first reported the efficient enantioselective hydrogenation of unfunctionalised
ketones in 1995 by diphosphine-diamine-Ru(II) complexes he noted that at least one primary
amine end is necessary to facilitate reaction after diamine ligand screening experiments31 and
reported that N,N,N’,N’-tetramethylenediamine (TMEDA) is totally ineffective in catalysis.24
This led to the proposal that the NH proton in catalyst such as (S,SS)-14 plays a key role in the
catalytic cycle.
Noyori proposed that diamine-substrate hydrogen bonding was important and this was backed
up by later work which showed remarkable selectivity for the ketone functionality over the
alkene functionality (lacking a hydrogen bond acceptor) in the hydrogenation of alkenyl
ketones.33 This was particularly remarkable as diamine-free BINAP-Ru complexes were shown
to have good catalytic activity for hydrogenation of the C=C unit of allylic alcohols.22
Scheme I-10 shows that as well as forming a hydrogen bond with the ketone substrate, that the
diamine may also be responsible for an electrostatic interation with the phenyl group of the
substrate through the equatorial proton of the ‘other’ NH2 group. Noyori backed up this claim
by showing that in competition experiments, electron poor derivatives of acetophenones were
hydrogenated faster than acetophenone itself, which in turn was hydrogenated faster than
electron rich derivatives, although substituent effects were significantly less pronounced than
simple sodium borohydride reduction44. Noyori also noted that this is consistent with the poor
performance of NH2/pyridine hybrid ligands instead of bis-NH2 ligands such as DPEN, in the
hydrogenation of acetophenone.45
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1.5.2 Role of Base
The base plays a crucial role in the rate of the catalytic reaction. Noyori initially reported that at
least two equivalents of base are needed for sufficient activity, and that the role of base is to
neutralise HCl formed in the catalyst generation step.31 Noyori showed that the addition of base
reduces the incubation period and proposed that this was due to the enhanced acceleration of the
Dcb elimation step in the formation of species B.42 Further work however showed that the base
also facilitates the catalytic cycle itself. It was shown that the reaction rate after the incubation
period is accelerated by increasing the base concentration (Figure I-2).42 Noyori postulated that
the base facilitates the deprotonation of C to F which readily catalyses the reduction of ketone.
However, there is an optimum base concentration and above this, deprotonation of B to E is
also evident, decreasing the effective concentration of C, thus reducing the accelerative effects.
Figure I-2 Dependence of hydrogenation rate on
concentration of base for hydrogenation of
acetopheone with catalyst (S),(S,S)-14.
Conditions: isopropanol, [acetophenone] = 0.89-
0.99 M, [catalyst (S),(S,S)-14] = 0.42-0.47 mM
(S/C = 1800), 4 bar H2, 30C.42
Noyori initially proposed that the nature of the base was not important and showed that
productive hydrogenation could be accomplished using alkaline bases such KOH, KOiPr and
KOtBu as well as strong organic bases such as phosphazenes (sterically hindered neutral
nitrogen bases). However, a subsequent study by Chen showed that an alkali metal cation is in
fact important for high activity, with reactivity in the order K > Na ~ Rb > Li.46 Chen proposed
that such acceleration in activity is a result of rapid hydrogen cleavage as similar trends are not
no H2
KOH
no H2
ED
KOH
H2
No
base
no H2
ED
H2
KOH
H2
ED
KOH
Figure I-1 Reduction of acetophenone
catalysed by [RuCl2(P(C6H5)3)3]. Reaction
conditions: S:C 5000:1, [ketone] = 1.4 M, 28
oC, 20 eq. KOH (where applicable), 1 eq.
ethylene diamine (ED, where applicable), 3
bar H2.
Enantioselective Hydrogenation Using Ruthenium Complexes Chapter I
of Tridentate Ligands Scott Phillips
15
observed in transfer hydrogenation catalysts. Chen’s results led to the suggestion that in
hydrogenation catalysts, the amine nitrogen and two aryl rings create a cation binding site for
potassium in species C/G (Scheme I-11). Binding of potassium increases the acidity of bound
dihydrogen and brings the alkoxide base into close proximity to dihydrogen, thus facilitating
efficient hydrogen cleavage to give the real catalyst F.
Scheme I-11 Importance of metal cation in dihyrogen cleavage in Noyori catalysts.
Despite having such a profound impact on reaction rate, the concentration of base has no effect
upon the level of enantioselectivity.42 This is consistent with the proposal that the
stereodeterming step proceeds via the same Ru reducing species, F.
1.5.3 Effect of Solvent
The solvent was noted to be of particular importance in the original work by Noyori. While the
reaction can be carried out in methanol, ethanol, tert-butanol, toluene or even DMF, isopropanol
is the solvent of choice and gives rise to enhanced reaction rates.42 This led to the proposition
that the solvent was implicit in the reaction mechanism. One proposal for the alcohol
dependency is thought to be the formation of diphosphine/diamine-RuH(OR) or -Ru(OR)2
species that act as a reservoir to the active catalyst.42 Noyori proposed that the stability of such
species and the ease of such to be transformed into active catalysts would depend on the
properties of the RO groups.
Entry Solvent TOF[h-1]
1 isopropanol 2650
2 n-butanol 1170
3 1-phenyethanol 920
4 ethanol 41
5 methanol 8
Table I-3 Solvent Effect on Catalysis
Alcoholic solvent has also been proposed to participate in the hydrogen activation step. Ikariya
first suggested - based on deuterium labelling experiments using the phosphine-free
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[RuCl(NH2CH2CH2NMe2)Cp*] system - that isopropanol was implicit in the splitting of
hydrogen probably via the hydrogen bonding network shown in Scheme I-12, thus leading to
enhanced activity versus hydrogenation in aprotic solvent.47 This was supported by theoretical
studies by Andersson, who showed that there is a significantly lower activation barrier for the
alcohol-mediated splitting of hydrogen compared to the non-alcohol mediated process for the
same system.48 Morris has since presented both experimental and theoretical work showing
similar alcohol effects using [Ru(H)2(BINAP)PICA] derivatives.49
Scheme I-12 Alcohol-assisted hydrogen activation
The nature of the solvent is also of importance to the degree of enantioselectivity. Bergens
showed that isopropanol is by far the more superior solvent when compared to THF in terms of
enantioselectivity with the e.e. of reactions in THF decreasing as the reaction proceeds. The
basis of this is in the reversibility of each step of the catalytic cycle. Bergens postulated that the
huge excess of isopropanol can intercept the ruthenium intermediate 42 which pushes the
reaction in the forward direction and prevents the reverse reaction and thus racemisation
(Scheme I-13). Any small amount of the Ru amide present is therefore converted back to the
dihydride species or ‘stored’ as the Ru isopropoxide species. In the absence of isopropanol, the
reaction of 1-phenylethanol with the Ru-amide species 42 occurs, leading to racemisation of the
alcohol product, is in competition with the regeneration of 41.
Scheme I-13 Reaction equilibria leading to high enantioselctivity for reactions in isopropanol.
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1.5.4 Source of Hydrogen/Effect of Hydrogen Pressure
The transfer hydrogenation of ketones by transition metals with isopropanol as the hydrogen
donor is a well known process and it was conceivable that the [RuCl2(P^P)(N^N)] system
operates without the need for molecular hydrogen. It was found by Noyori however that the
presence of diamine retarded transfer hydrogenation - i.e. when no molecular hydrogen was
present - and accelerated H2-hydrogenation, and is thus a net H2-hydrogenation. This was
confirmed by deuterium labelling experiments using d8-iPrOH as solvent (and potential hydride
source), which yielded no deuterated 1-phenylethanol in the H2-hydrogenation of acetophenone.
Complex E, although potentially reactive towards isopropanol, must preferentially form B
which reacts with molecular hydrogen in a more rapid process with transfer hydrogenation
unable to compete.
The rate of catalysis is particularly sensitive to hydrogen pressure since an increase in hydrogen
concentration in solution facilitates the conversion of B to C thus reducing the incubation
period. The rate is intrinsically linked to the base concentration however as base is need to
convert C into the reducing species F.42 Without base the rate is insensitive to hydrogen
pressure whereas even with small concentrations, the rate rapidly increases.
As is expected from the proposed catalytic cycle, the levels of enantioselectivity in the reaction
are unaffected by hydrogen pressure. 42
1.5.5 Kinetic Evidence
Noyori showed that for the hydrogenation of acetophenone with catalyst precursor (S),(S,S)-14,
consumption of the substrate as a function of time was sigmoidal in nature.42 This is consistent
with the presence of an incubation period, i.e. the generation of the real catalytic species B and
E from precatalyst A. This incubation period is largely diminished by addition of base, due to
the enhanced Dcb elimination.
The consumption of acetophenone by the system was shown to be pseudo-first order, once the
incubation period was taken into account, with pseudo-zero order observed at high
substrate:catalyst ratios where saturation kinetics were in effect.42
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1.5.6 Ligand Structure
The effect of ligand structure upon catalyst activity and enantioselectivity, and the resultant
development of new catalysts, is discussed throughout this review. Experimental results, by in
large, have supported the mechanistic proposal and origin of enantioslectivity proposed by
Noyori. The need for an amine group has already been discussed but modification of the
phosphine components has also supported Noyori’s proposals. The 3,5-dialkyl meta effect has
been demonstrated to give higher enantioselectivity suggesting that the phosphine substituents
are implicit in enantioinduction.33 The configuration of the alcohol products in all cases are
consistent with hydrogen bonding interaction between the diamine and the substrate in such a
way as orientate the bulkier aryl group of the substrate away from the phosphine substituents
allowing facially selective hydride transfer, i.e. (S)-BINAP/(S,S)-DPEN combination always
gives (S)-configured product (unless group priorities are different). This mode of
enantioselection has been backed up by the theoretical work of Harvey who, making use of DFT
calculations, has shown that the approach of acetophenone with the phenyl group oriented away
from the phosphine ligands is favoured both by steric interactions and weak hydrogen bonding
between the phenyl ring and ruthenium bound NH2. Harvey reproduced the magnitude of
enantioselectivity obtained in the experimental findings semiquantatively and has demonstrated
that the much reduced enantioselectivity of the mismatched diphosphine/diamine combination
can also be reproduced.50
1.5.7 Identification, Isolation and Synthesis of Catalytic Intermediates
Since the disclosure of Noyori’s highly active and selective catalytic system in the mid-1990s,
much effort has gone into the identification, isolation and synthesis of intermediates in order to
scrutinise the proposed reaction mechanism. Noyori noted early on however, that a number of
problems existed which prevented the isolation or even observation of key intermediates. The
inherent instability of the ruthenium complexes due to their reactive nature was the principal
problem to be overcome. A second problem was the solvent: despite isopropanol being the
solvent of choice in terms of reactivity and enantioselecivity, H-D exchange between d8-
isopropanol and the hydride/dihydrogen ligands on Ru species prevented detailed NMR
observations.
These problems have been overcome in many cases however by tuning catalyst structure for
maximum stability and it has become possible to prepare both ruthenium monohydride and
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dihydride complexes (examples in Scheme I.14). Analysis of the performance of such
complexes in catalysis has led to the suggestion that the dihydride is more likely to be the active
catalytic species as the preformed dihydride complexes such as 45 do not need base to function
whereas monohydride species, such as 44, do.51 It has also been proposed that the hydride must
have a fac relationship with the diamine ligand in the active species to give the most active
catalysts (eg. 46 and 47) and for highly enantioselective catalysis both the diamine and
phosphine must be meridional (46).24
Scheme I-14 Ruthenium monohydride and dihydride species that have been
studied.
How such hydride species are formed in the catalytic cycle has also received attention although
isolation and even identification of ruthenium complexes of bound dihydrogen, believed to
preceed the hydride species, is very difficult due to the inherent instability of such complexes.
Bergens and coworkers have however observed species 49 (Scheme I-15) at low temperatures,
which could be converted into an active catalyst (presumably the dihydride species) with the
addition of base.52
N
H2
H2
N
Ph2
P
P
Ph2
Ru
H
49
Ph
Ph
H H
Scheme I-15
The ruthenium species that are present after the transfer of the hydride to the ketone substrates
have also been identified although similar problems with stability have been encountered.
Morris has proposed that the amido species 50 is the product after hydride-transfer53 although
Bergens and coworkers have provided evidence for the presence of alkoxide intermediates such
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as 51 that proceed the formation of such species.54 Intermediates similar to 51 have also been
observed in ester hydrogenation55 and computational models have backed up Bergens’
proposal.56
Scheme I-16 Ruthenium intermediates believed to be the result of hydride transfer.
1.6 Extensions of the Noyori System
Noyori’s discovery of an efficient catalytic system for the enantioselective hydrogenation of
simple ketones, and a greater understanding of its mechanism of operation, prompted a huge
research effort in the area. A number of novel catalysts have been designed by modification
of the diphosphine and diphosphine components but few catalysts rival the
[RuCl2(XylBINAP)(DAIPEN)] system in terms of activity and selectivity. However, the
search for more active/highly selective catalysts are still fuelled by the desire for a universal
process, overcoming some significant limitations of the system such as the inability to
hydrogenate bulkier substrates efficiently as well as many heteroaromatic ketones without
the need for additives.57 Ketones with sterically similar substituents have also been shown
to be problematic in hydrogenation, including dialkyl ketones for example. More practically
useful catalysts for adoption into industrially-viable processes are also highly desirable.
(i) Phosphine Modification
Noyori’s original work implied, and mechanistic studies later supported (See section 1.4),
that the aryl substituents upon phosphorus play a crucial role in determing
enantioselectivity. Indeed a significant increase in enantioselectivity of the alcohol product
is seen as the steric bulk upon the phosphorus aryl ring is increasing from -PPh2 to -P(tol)2
to -P(xyl)2 (See Table I-2 for examples). Pregosin has described this as the 3,5-dialkyl meta
effect, and shown that it is common in a number of enantioselective processes catalysed by
phosphine-ligated transition metals.58,59 Research on modification of the diphosphine
component has mainly been focussed upon exploiting this phenomenon by using new
diphosphines with either axial, planar, or backbone chirality, in the hydrogenation of
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ketones with the goal of improved activity/selectivity, or by discovering catalysts which are
more easily prepared and thus more industrially viable.
Due to the unprecedented success of binaphthyl ligands in a wide range of processes that
goes far beyond hydrogenation chemistry, early attempts at improvement of catalyst
structure were based on diphosphines with similar axial chirality. Lin showed that even
subtle changes to the binaphthyl ring could lead to an improvement in enantioselectivity.
Lin demonstrated that the 3,5-dialkyl meta effect can be mimicked by substituents on the
binaphthyl ring in the 4/4’ positions.60 Catalysts containing the 4,4’-disubstituted
diphosphines (S)-60, (S)-61 and (S)-62 gave elevated enantioselectivity comparable with
that obtained using catalaysts made from the xylyl-based phosphine for a range of simple
ketones (Scheme I-17). Lin suggested that unlike xylyl-based phosphines, the 4,4’
substituents are readily tunable for practical asymmetric hydrogenation of different
substrates.
Scheme I-17
Modification of the atropisomeric diphosphine in order to narrow the dihedral angle
between phosphorus atoms when bound to ruthenium has also been shown to increase
enantioselectivity, by apparently maximising interactions between the phosphine
substituents and the substrate. Genêt showed that enantioselectivity increased going from
(R)-BINAP (θ = 80) to the smaller dihedral angle ligand (R)-SYNPHOS 63 (θ = 75) for a
wide range of substrates.57** Enantioselectivity obtained with (R)-SYNPHOS 63 was again
comparable to hydrogenation using (R)-XylBINAP 18 without the need for large phosphorus
substituents, and thus a simplified synthetic route to the desired diphosphine.
** Other smaller bite angle ligands, as determined by computational modelling, were also shown to have a
positive effect upon enantioselecitivity in this study with SYNPHOS being the most active and selective.
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Scheme I-18 Atropisomeric biaryl diphosphine ligands for the enantioselective
hydrogenation of simple ketones
Most of the early attention regarding the diphosphine component centred on the binaphthyl
system due to it conformational rigidity when bound to ruthenium, thus controlling the dihedral
angle between phosphorus donors, which has been shown to be key. Since then, other axial
chiral ligands have been employed with some success based on the biaryl system. Chan paved
the way is this area by employing the ruthenium complex of dipyridylphosphine ligand XylP-
Phos (R)-66 in combination with (R,R)-DPEN in the hydrogenation of simple ketones (Scheme
I-18).61 This ligand, as well as its diphenylphosphino- and ditolylphosphino- derivatives (S)-64
and (S)-65, had been previously used in the highly enantioselective hydrogenation of
functionalised ketones, and the methoxy groups, while being necessary to block the pyridyl
nitrogen from coordinating to the metal centre, could also conceivably act to anchor the
biphosphine in one conformer.62,63 Chan showed that using XylP-Phos (R)-66 in combination
with (R,R)-DPEN, enantioselectivities were obtained on par with that with Xyl-
BINAP/DAIPEN.
This idea opened the way for the development of a range of atropisomeric biaryl diphosphines
for use in ketone hydrogenation on an industrial scale. Researchers at Chirotech (now Dr
Reddys) have developed a highly efficient protocol for enantioselective hydrogenation with
diphosphine ligands based on the BIPHEMP motif (Scheme I-18, 67-70).64 It was observed that
ruthenium complexes of biaryl phosphines (R)-OMeBIPHEP 67 and (R)-HexaPHEMP 68 in
combination with (R,R)-DPEN/(R)-DAIPEN/(R,R)-DACH proved to be active and highly
enantioselective catalysts. (R)-OMeBIPHEP 67 proved to give less active catalysts but it
emerged that making use of the 3,5-dialkyl meta effect, ruthenium complexes of (S)-Xyl-
HexaPHEMP 69 in combination with (S)-DAIPEN gave a catalyst that performed as well as, if
not better than, the corresponding BINAP ligand in the enantioselective hydrogenation of
functionalised ketones. Problematic syntheses of both enantiomers of Xyl-HexaPHEMP 69 have
led to the development of the more accessible Xyl-TetraPHEMP 70, which gives equally
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excellent performance and has the advantage that best results are obtained in combination with
DPEN, a more economically viable alternative to DAIPEN.65
Scheme I-19 TunePhos ligands
Zhang has developed a related system employing the atropisomeric bridged biaryl ligand (S)-C3-
XylTunePHOS 71 (Scheme I-19),66 which has also shown great activity and selectivity in
hydrogenation, rivalling that of the corresponding BINAP system when used in conjunction
with (S)-DAIPEN.67 Zhang reasoned that this ligand is more easily accessible than Chan’s P-
Phos ligands, and its modular nature allows tuning (thus deriving its name) for the
hydrogenation of specific substrate classes.67 This has been extended to (R)-C2-TunePhos 72 68
but this class of ligand has so far failed to deliver the high levels of enantioselectivity
accomplished by C3-TunePHOS.
Scheme I-20 Other axial chiral diphosphine ligands employed
in enantioselective hydrogenation of ketones.
Other structurally different diphosphines containing axial symmetry have also been
demonstrated to be highly efficient catalysts. Zhang showed that diphosphines based on the
dicyclopentane stucture could be used as ligands for ruthenium in combination with DPEN
(Scheme I-20, (R,R)-73), giving enantioselectivities of up to 93%, although this level of
enantioinduction could not be replicated over a large range of substrates. 69 More luck was had
employing the unusual chiral spiro diphosphine (SDP) ligands in the work of Zhou.70 When
combined with (R,R)-DPEN upon ruthenium, the xylyl-derivative (S)-74 gave
enantioselectivity on par with that of the corresponding BINAP-derived diphosphine.
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Scheme I-21 The PhanePhos Ligand Class
While diphosphines base on axial chirality have proved hugely successful in such
enantioselective transformations, synthesis of such structures, especially with xylyl
substituents that appear in the best catalysts, remains tricky. Thus, structurally different
diphosphines are desirable. Researchers at Chirotech have developed an excellent system
based on a diphosphine with planar chirality and this still remains the only efficient
alternative to atropisomeric phosphines for the highly enantioselective hydrogenation of a
diverse range of simple ketones. Screening of a variety of diphosphines showed (S)-
PhanePhos 77 (Scheme I-21) to have both the high catalytic activity and high
enantioselectivity needed for efficient catalysis. Making use of the 3,5-dialkyl meta effect,
the most efficient ligand (S)-XylPhanePhos 78 was discovered. The best results have been
obtained when used in conjuction with (S,S)-DPEN, with results comparable to that
obtained using the XylBINAP/(S)-DAIPEN system, i.e. enantioselectivities generally above
90% for a range of substrates - including simple, some heteroaromatic, and unsaturated
ketones - and catalysis carried out with substrate:catalyst ratios of up to 40,000.
(ii) Diamine Modification
While many diphosphines have been developed for enantioselective hydrogenation with
[RuCl2(P^P)(N^N)] systems, relatively little research has been aimed at modifications of the
diamine component. Most catalysts are based on the vicinal 1,2-diamines DPEN and
DAIPEN, which have allowed for highly active and enantioselective hydrogenation of a
wide range of simple ketones. A limited number of other diamines have been discovered
however with niche applications and others with practical advantages in synthesis.
Work undertaken by researchers at Johnson Matthey looked at the development of the 1,3-
analogue of DPEN. The ruthenium complex of the C3-diamine DPPN in combination with
(R)-XylP-Phos ((R)(S,S)-79) (Scheme I-22), displayed reactivity and selectivity on par of its
C2 derivative DPEN, in the hydrogenation of a range of simple ketones.71 This suggests that
the structural modification associated with the expansion of the diamine-Ru chelate ring
from a five membered ring to six does not impart radical new properties on the system.
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However, it was found – subsequent to the work of the Noyori and coworkers72 and research
in this group73 in this challenging area – that such complexes were more adept at the
enantioselective hydrogenation of tert-butyl alkyl ketones, attaining enantioselectivity up to
74% with catalyst (R)(S,S)-80. Complexes containing 1,2-diamines that are generally poor
in such transformations.74 This is likely due to the more open environment created by the
lengthening of the diamine chain length (the enantioselective hydrogenation of bulky
ketones will be discussed further in section 1.7.2).
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Scheme I-22 Ruthenium catalysts of 1,3-diamines and diphosphines
devloped by Johnson Matthey.
This idea is furthered when using 1,4-diamines, such as IPBAN 84 and IPHAN, derived
from tartaric acid and mannitol, respectively. Ruthenium complexes of IPBAN 84 in
combination with chiral diphosphines have been shown to be more selective for more bulky
secondary alkyl ketones such as isobutyrophenone compared to acetophenone and its
derivatives (Table I-4).74,75 Unlike catalysis with complexes of 1,2-diamines/diphosphines,
the 3,5-dialkyl meta effect of the phosphine is not observed.
Entry Ketone Phosphine Conversion[%] ee [%]
1 81 (S)-P-Phos >99 81 (S)
2 81 (S)-XylP-Phos >99 51 (S)
3 81 (S)-TolBINAP >99 85 (S)
4 81 (S)-XylBINAP >99 64 (S)
5 82 (S)-P-Phos >99 97 (S)
6 82 (S)-XylP-Phos >99 75 (S)
8 82 (S)-TolBINAP >99 97 (S)
Table I-4 Hydrogenation of simple ketones by [RuCl2(diphosphine)((S)-
IPBAN)] catalysts. General conditions: Ketone 81 or 82 (1 eq.), Ru catalyst
(0.1 mol%), KOtBu (4 mol%), iPrOH, H2 (10 bar), rt.
Enantioselective Hydrogenation Using Ruthenium Complexes Chapter I
of Tridentate Ligands Scott Phillips
26
Ruthenium complexes of IPHAN combined with diphosphine ligands have been shown to
be efficient in the hydrogenation of other bulkier substrates, in particular of substituted
tetralones.76 Noyori showed that a whole range of the corresponding chiral alcohols could
be prepared in greater than 90% e.e. using (S)-XylBINAP/(R,R)-IPHAN-ruthenium complex
85 (Scheme I-23). Hems and coworkers at Johnson Matthey have also employed complexes
of the 1,4-diamine DAMDO 96 (Scheme I-25) for such transformations, obtaining good
enantioselectivities of up to 81% in the hydrogenation of tetralone 86, but note that such
complexes are prone to decomposition.74
Scheme I-23 Enantioselective hydrogenation of tetralones using
[RuCl2(diphosphine)(IPHAN)] complexes.
Ruthenium complexes of IPHAN and BINAP have also been used in the hydrogenation
of tricky bicylo [2.2.2] and [2.2.1] ketones. This is particularly worthy of mention as
such sterically congested frameworks require highly active catalytic species and the
ability to discriminate between tertiary and secondary alkyl groups to achieve selectivity
(Scheme I-24).77 Noyori showed that 2-diphenylmethyl-3-quinuclidine could be
hydrogenated giving the cis isomer exclusively in greater than 99% enantioselectivity.77
It was noted that the product is a useful intermediate for the synthesis of a series of
human NK1 antagonists.78
Scheme I-24 Hydrogenation of bicyclic systems with [RuCl2(IPHAN)(BINAP)]
Johnson Matthey have also developed the 1,4-diamine (R,R)-AABPY 97, which it fas felt would
provide rigidity to the ligand compared to the other diamines discussed (Scheme I-25).74 Depite
good activity, it was found that only moderate enantioselectivity could be imparted to alcohol
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products (20-84% e.e. for hydrogenation of a range of simple ketones) when complexes of 97 in
combination with P-Phos or BINAP were used (the matched complexes).
96, (R,R,S,S)-DAMDO
OO
OMe
OMe
H2N
H2N
NBoc
H2N
H2N
97, (R,R)-AABPY
Scheme I-25 1,4-Diamines employed in enantioselective hydrogenation.
Compared to development of the phosphine component, the diamine has received relatively
little attention. The examples described have shown however has shown that the diamine has a
very significant role in the formation of enantiopure secondary alcohols and further
developments are likely to ensue.
(iii) Base-free hydrogenation
Many of the hydrogenation catalysts described thus far have required a base to catalyst ratio
of up to 20:1 in order for efficient catalysis to proceed,42 which can be incompatable with
certain functionalities. A significant development of the [RuCl2(P^P)(N^N)] system was its
extension to allow the enantioselective hydrogenation of base-sensitive substrates such as
ketones with remote ester and epoxide functionality. Noyori demonstrated that catalysis
using the diphosphine-diamine ruthenium complexes such as (S),(S,S)-98 could proceed
without the need for any added base (Scheme I-26).79 Not only did these catalysts allow the
highly enantioselective preparation of base sensitive products such as those shown, an
increase in activity of around one order of magnitude was observed compared to the original
catalyst precursors in the hydrogenation of acetophenone under identical conditions. Noyori
later attributed this to a less complex and more rapid formation of the catalytic species (See
section 1.4.1).42
Scheme I-26 Hydrogenation of base-sensitive substrates.
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(iv) Supported Catalysts
There is considerable interest in the development of catalysts which are immobilised to a
solid support so that they can be removed from the reaction mixture easily and recycled.
This is particularly important when the metal complexes used are expensive and toxic. Both
the diphosphine and diamine component have been immobilised to a support with varying
degrees of success.
Noyori employed the polystyrene-supported BINAP ligands of Bayston80 to form ruthenium
complexes along with DPEN (Scheme I-27, 102).81 The supported catalyst was found to be
highly active in the hydrogenation of simple ketones, although longer induction periods
were observed than the homogenous system. Enantioselectivity was found to be on par with
the homogeneous system for the hydrogenation 1’-acetonaphthone (97-98% e.e.) and the
catalyst could be reused several times with enantioselectivity reported to remain constant up
until the 14th use. Lemaire and coworkers adopted a different strategy by incorporating
BINAP into the backbone of a polyurea-based polymer.82 However, the most efficient
ligand, poly-NAP (R)-103, when employed with [RuCl2(C6H6)] and (R,R)-DPEN, could
only hydrogenate acetophenone in 68% e.e. compared to 87% in the homogenous system.
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Scheme I-27 Poymer supported diphosphines/diamines
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Other groups have employed this strategy with more success however. The work of Pu has
shown that polymeric BINAP, linked by aryl or biaryl spacers, when used along with a
ruthenium prescursor and enantiopure diamine, are efficient enantioselective catalysts. Pu
demonstrated that polymer (R)-104 along with [RuCl2(C6H6)] and (R,R)-DPEN could
hydrogenate a range of simple ketones with enantioselectivity approaching that observed for
the homogenous system.83 Catalyst containing the polymer (R)-105, composed of alternating
BINAP/BINOL monomers, gave similar results in hydrogenation.84 However, the best
results to date appear to be obtained using the more flexible Noyori system, rather than
where the diphosphine is incorporated in the rigid polymer itself, although
enantioselectivity with the Pu system is approaching that of the homogeneous system.
The diamine component of the catalytic system has also shown to be of use when
immobilised to a solid support. Itsuno has shown that (S,S)-DPEN can be attached to
polystyrene via a benzyl ether linkage through both its phenyl rings, to form a cross-linked
polymer (Scheme I-27).85 Ruthenium catalysts derived from such polymeric ligands and
BINAP-derived diphosphines were shown to be active in the hydrogenation of a range of
simple ketones, carried out in a isopropanol/DMF mixture.86 Enantioselectivities were
almost at the same level as the corresponding homogeneous system. Itsuno reported that the
polymeric catalysts were easily separated from the reaction mixture and recycled a several
times without loss of activity (although he never commented on the effect of recycling of
selectivity). 86
Ding has developed a ‘self-supported’ polymer, whereby catalysts are heterogenised by
homocombination of ligands that are subsequently linked by the metal centre, for example
ligands (S)-110 and (S,S)-111 linked together by ruthenium (Scheme I-28).87 The resultant
polymer are active in the hydrogenation of simple ketones and are easily recovered due to their
insolubility in isopropanol. The polymeric catalyst (S),(S,S)-109 was found to give activity and
enantioselectivity on par with the corresponding homogenous system. Seven cycles of
hydrogenation could be completed with the polymer before any sign of diminished
activity/selectivity was observed and ruthenium leaching was reported to be extremely low
(<0.1 ppm).
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Scheme I-28 Self-supported catalysts
The diphosphine and diamine components of the [RuCl2(P^P)(N^N] catalytic system have
also been immobilised as dendrimers. Fan and coworkers have shown that high
enantioselectivity with the catalyst immobilised through the binaphthyl part of BINAP
(Scheme I-29, (S,S-112-115). Little difference was observed in e.e using the different
generations of dendrimer, with the supported catalyst removed easily by precipitation and
separation.88 The immobilised catalyst could be recycled but activity and e.e. diminished
after only the 3rd use. Fan also demonstrated that the diamine can also be immobilised to
good effect as a dendrimer, (S,S)-116-119.89 When ruthenium complexes of such and (S)-
BINAP were used in hydrogenation, even higher enantioselectivities were observed
compared to the corresponding homogeneous system.
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Scheme I-29 Dendrimer supported ligands
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The diphosphine/diamine ligands have also been immobilised, with some success, on
inorganic materials. Chan showed that silica could be used as a support and BINAP was
immobilised by covalent linkage through the binaphthyl moeity and the ruthenium complex
formed with DPEN (Scheme I-30, 120).90 Hydrogenation of acetophenone and 1’-
acetonaphthone was accomplished successfully however, whilst enantioselectivity was on
par with that for the homogeneous process for the reduction of 1’-acetonaphthone (95 cf
97% e.e.), it was significantly diminished for acetophenone (25 cf. 87% e.e.). The catalyst
was easily separated by filtration using a glass frit and subsequent washing and the catalyst
could be reused up to 5 times with no loss of enantioselectivity and little loss of activity. DPEN
has also been hown to function successfully as a ligand while immobilised on an inorganic
material. DPEN has been attached to the inner surfaces of mesoporous silicates MCM-41 and
MCM-48 materials through organic tether groups, and the corresponding ruthenium catalysts
formed with the matched BINAP enantiomer (Scheme I-30, 121).91 The supported catalysts
were shown to be highly active (TOFs ~ 500 h-1) in the hydrogenation of a large range of simple
ketones, although the homogeneous reactions were twice as fast. No difference in
enantioselectivity was observed between the homogenous system and the supported catalysts,
and was solely dependent on the ligand combination.
Scheme I-39 Silica supported [RuCl2(P^P(N^N) catalysts.
Most attempts at immobilisation have relied upon phase differences that have allow the
catalyst to be easily separated from the reation mixture and reused. The diphosphine has
also been shown to be immobilised on ionic liquids, which can be easily removed from the
reaction medium and reused. Lin and coworkers92 have demonstrated that the polar catalysts
(R),(R,R)-122 and (R),(R,R)-123 can be immobilised to a range of ionic liquids, with
DMPIIm 124 being the most efficient in terms of activity with full conversion within 24
hours at 48 bar hydrogen pressure. Very high enantioselectivity – on par of that with the
best homogeneous systems – were observed when using catalyst (R),(R,R)-122, consistent
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with the work on other 4,4’-disubsituted BINAP (Section I-31). The immobilised catalyst
could be recycled up to 6 times without significant loss of enantioselectivity and no
appreciable leaching of ruthenium was observed.
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Scheme I-31 Ionic liquid-supported catalysts
Chan has also shown that immobilisation of diphosphines upon polyethylene glycol, such as
(R)-125 (Scheme I-32), is also possible and the product can removed from the catalyst via
extraction into organic solvent.93 Hydrogenation of acetophenone and derivatives gave
enantioselectivities comparable to, if not better than, the corresponding homogenous
systems, when the ruthenium complexes of PEG-supported diphosphines (R)-BINAP, (S)-
BINAP, (R)-XylBINAP, and (S)-XylP-Pho, and (R,R)-DPEN were used. Recycling of the
catalyst allowed it to be reused up to four times without a significant decrease in
enantioselectivity, and leaching of the ruthenium into the organic was shown to be less than
0.85 ppm. Catalysts have similarly been immobilised on polyethylene glycol through the
phenyl groups of DPEN. In collaborative work between Johnson Matthey and the
University of Liverpool, ruthenium complexes of PhanePhos and PEG-supported DPEN
have been shown to be highly effective in the hydrogenation of simple aromatic ketones,
with enantioselectivity over 90% with all substrates reported.94 Catalysis could be repeated
3 times with the same supported catalyst with little decrease in acitivty and no loss of
selectivity. Leaching of ruthenium resulted in less than 3 ppm presence in the product.
Scheme I-32 PEG- supported (R)-BINAP.
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1.7 Deviations from the Noyori Blueprint
Recent years has seen the emergence of active and selective catalysts which have deviated
quite significantly from the original Noyori blueprint. New, structurally distinct catalysts
are important in overcoming the significant limitations of the [RuCl2(P^P)(N^N)] system,
such as the expense and synthetic challenges of preparing such catalysts, as well as their
limitation in substrate scope, which hindered the efficient hydrogenation of useful classes of
molecule such as tetralones, bulky ketones, some heterocyclic ketones and alkyl-alkyl
substrates. The need for more practically useful catalysts, with less expensive, easily
accessible building bocks, can also be exploited, by moving away from the original
manifold. The design of catalysts significantly different to the [RuCl2(P^P)(N^N)] structure
is also of great interest to industry as all diphosphine/di-primary-amine complexes of
ruthenium are currently covered by the Noyori patents and can only be used under license
from Takasago International Corporation.95
1.7.1 More Practically Useful/Industrially Relevant Catalysts
(i) Achiral diphosphines
The use of achiral phosphines in combination with homochiral diamines in catalysis is very
appealing due to the expense and often extended routes for preparation of homochiral
diphosphines. Mikami and Noyori first proposed that achiral ligands could be used in
combination with enantiopure diamine in enantioselective hydrogenation by fine control of
relative amount of the matched and mismatched diastereomers of the ruthenium complex in
solution.96 They proposed that the greater presence of the matched diastereomer would lead
to enhanced activity and enantioselectivity. It was shown that using the conformationally
flexible rac-BIPHEP ligand in combination with (S,S)-DPEN, high levels of
enantioselectivity could be imparted upon the substrate. Heating a 1:1 mixture of the
matched catalyst ((S),(S,S)-126) and mismatched catalyst ((R),(S,S)-127), prepared from
racemic BIPHEP and enantiopure DPEN, at 80C was shown to lead to a 3:1 excess of the
(S),(S,S) catalyst (matched) in solution (Scheme I-33).96 Use of the solution led to
enantioenrichment in the hydrogenation of acetophenone of 92%, in contrast to 63% if the
solution was used before heating. Further improvement in the relative amounts of
matched:mistmatched diastereomers was accomplished later by Mikami by use of the racemic
Enantioselective Hydrogenation Using Ruthenium Complexes Chapter I
of Tridentate Ligands Scott Phillips
34
triphos ligand along with (S,S)-DPEN, with the matched complex (S),(S,S)-127 being prepared
almost exclusively and imparting enantioselectivity of up to 85% on the reduction of 1-
acetonaphthone.97
Scheme I-33 Active hydrogenation catalysts prepared from racemic diphosphines.
Mikami expanded this work to show that the achiral tropos ligand
2,2’bis(diphenylphosphino)benzophenone (DPBP) in combination with (S,S)-DPEN, formed
the matched ruthenium complex 128 exclusively.98 This complex demonstrated high levels
of stereoinduction, in some cases in excess of those obtained with the corresponding
enantiopure BINAP complex. This complex remains the benchmark in enantioselective
hydrogenation with achiral diphosphines but work by Li has also shown that moderate to
good levels of enantioselectivity (up to 87% e.e.) could be obtained even when simple,
inexpensive achiral diphosphines such as 129 and 130 are employed in catalysis with
enantiopure diamines (Scheme I-34).99
PPh2
PPh2
PPh2
PPh2
129 130
Scheme I-34 Achiral diphosphines used in the ruthenium-
catalysed hydrogenation of simple ketones giving moderate
to good levels of steroinduction (41-87% e.e.) when used in
combination with (S,S)-DPEN.
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(ii) Aminophosphine Ligands
The group of Morris has demonstrated the hydrogenation of simple ketones by ruthenium
complexes of  β-aminophosphine ligands, which, it is reported, are easily accessible from 
readily available chiral pool amino acids (Scheme I-35, (R)-131/(S)-132) or (R)-
norephedrine ((R,R)-133). The complexes [RuCl2(Pala)2], [RuHCl(Pala)2] and [RuHCl(Ppro)]2
were all shown to be extremely active in the hydrogenation of acetophenone and
derivatives, however, enantioinduction was negligible.100 Combining the aminophosphine
(R-)-131 with (R)-BINAP 11 (complex [RuHCl((R)-BINAP)((R)-Pala)) did give a modest
e.e. of 40%, however, in the hydrogenation of acetophenone. The bis-complex of ligand 133
[RuHCl((R)-133)2] gave enantioselectivities of up to 51% e.e in the hydrogenation of
acetophenone, and this could be enhanced to up to 72% by replacing one of the ligands with
(S)-BINAP.101
Scheme I-35 β-Aminophosphine ligands 
(iii) Other PX Bidentate Ligands
As well as aminophosphine ligands, a number of other bidentate phosphine ligands have
been developed with different secondary donors. Some of these have found application due
to their ease of synthesis and remarkably high activity/selectivity. The QUINAPHOS family
of ligands (Scheme I-36) - with a phosphine and phosphoramidite donor - which have been
shown to be very efficient ligands in a variety of asymmetric processes,102 and described in
some circles as a privileged ligand,103 have also been employed in ketone hydrogenation.
The ruthenium complex of (Ra,SC)-enantiomer and (S,S)-DPEN was shown to be highly
enantioselective in the hydrogenation of acetophenone and derivatives. Although the full
scope of this catalyst system has not been explored, and its activity not quantified,
QUINAPHOS is another addition to the toolbox of highly selective ligands.
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Scheme I-36 Bidentate PN ligands
Phosphine-oxazoline ligands have also been shown to be remarkably efficient ligands,
despite not having an N-H group, which was deemed to be a prerequisite for activity and
good enantioselectivity in the hydrogenation of simple ketones (see section 1.4). Such
ligands have received attention due to their ease of synthesis and favourable coordinating
properties.104 The best of these ligands, 135 (Scheme I-36), when employed in situ with
[RuCl2(PPh3)2] has been shown to give remarkably high enantioselectivity, above 95% e.e.,
for a range of acetophenone derivatives and TON of up to 40,000.104 More recently, the
ruthenocycle derivative of 135 (replacement of Fe with Ru) has also been shown to be
highly active and enantioselective in the hydrogenation of simple ketones.105
(iv) Monodentate Phosphorus Donors
A major deviation from the original [RuCl2(P^P)(N^N)] blueprint has been to replace the
diphosphine component with two monophosphine donors. It has been proposed that the use of
monophosphines has a significant advantage in terms of practicality as such ligands are less
expensive and more readily available than most bidentate ligands,106 and as such, potentially
more relevant to industrial application. The work in this area was triggered by the observations
of Noyori24 and Morris107 that active and enantioselective catalysis could still occur with
replacement of the diphosphine component by two simple triphenylphosphine ligands.††
Although enantioselectivity was only 60% in the hydrogenation of acetophenone, Ding
subsequently demonstrated that, analagous to the parent Noyori system, increasing the steric
bulk upon the phosphorus substituents led to more selective catalysts, with enantioselectivity of
up to 96% (Table I-5).109
†† The presence of a diphosphine was previously believed to be a conditio sine qua non108 and these observations
triggered a great amount of interest in this area.
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Entry Phosphine Diamine Conversion[%] ee [%]
1a 136 (R,R)-DACH >99 60 (S)
2 136 (R,R)-DPEN >99 77 (S)
3 137 (R,R)-DPEN 96 77 (S)
4 138 (R,R)-DPEN >99 87 (S)
5 139 (R,R)-DPEN >99 89 (S)
6 140 (R,R)-DPEN >99 89 (S)
7b 140 (R,R)-DPEN >99 96 (S)
Table I-5 Hydrogenation of acetophenone using ruthenium complexes of
monodentate achiral phosphines and chiral diamines, as reported by Morris
(entry 1) and Ding (entries 2-7). General conditions: ruthenium catalyst (0.1
mol%), KOtBu (2 mol%), iPrOH, H2 (21 bar), 25C, 10 h. a neat, no iPrOH, 3
bar H2, < 8 h. b n-propanol as solvent.
This work has been has since been extended to employ chiral monophosphines with bulky
substituents. Wills conceived that the MonoPhos ligand 143 – shown to have outstanding
activity and selectivity in the hydrogenation of C=C bonds when two such ligands are
complexed to rhodium110,111 - could be employed as the monophosphine component in
ruthenium complexes for ketone hydrogenation. Similar binaphthophosphepine ligands have
also been employed in the highly enantioselective hydrogenation of β–keto esters.112 Indeed
MonoPhos was found to give moderate selectivity in the hydrogenation of simple ketones
(Table I-6), but optimisation of the catalyst structure, and strategic placement of an ortho
substituent on the phosphine’s phenyl substituent gave the most selective catalyst, with
enantioselectivity up to 99%.106,113,114 Wills commented that while enantioselectivities are
generally excellent in such systems, catalyst loading (typically in the range 0.05-02 mol%) and
pressures were higher (50-80 bar) than those employed with BINAP-based catalysts.24 Since
then the easy accessibility of such phosphoramidite ligands through robotic parallel synthesis
protocols has allowed the screening of a diverse range of potential ligands.77 Feringa and de
Vries identified ligand (S)-145 via such studies, which gave a catalyst on complexation with
ruthenium/chiral diamine that can hydrogenate simple ketones whilst maintaining
enantioselectivity above 90% for a range of substrates.108 However, the problems of higher
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catalyst loadings and high hydrogen pressure remain pertinent for the bulkier phosphoramidite
ligands.
Entry Phosphine Diamine
Catalyst
Loading
(mol%)
PH2
(bar) Ar =
Conversion
[%] ee [%]
1 (S)-143 (S,S)-DPEN 0.1 10 Me >99 54 (R)
2 (S)-144 (S,S)-DPEN 0.1 10 Me >99 88 (R)
3 (S)-145 (S,S)-DPEN 0.05 50 Me >99 90 (R)
4 (S)-145 (S,S)-DPEN 0.05 10 p-CH3Ph >99 96 (R)
5a (S)-145 (S,S)-DPEN 0.05 50 o-BrPh >99 99 (R)
6a (S)-145 (S,S)-DPEN 0.05 60 o-IPh >99 99(R)
7b (S)-146 (S,S)-DACH 0.1 25 Me >99 97 (R)
Table I-6 Hydrogenation of simple ketones using ruthenium complexes of BINOL-derived chiral
monophoshine ligands and chiral diamines, as reported by Morris (entries 1-6) and Feringa and De
Vries (entry 7). General conditions: ruthenium catalyst, KOtBu (10 eq wrt catalyst loading), iPrOH,
H2, rt, 20 h. a 8 h. b 24 h, 5 equivalent of KOtBu wrt catalyst loading.
Work has also been undertaken in using monophosphine ligands that are chiral at
phosphorus but enantioselectivities have so far only been modest, with high catalyst loading
and high pressure (although ligands were used in situ and the catalyst wasn’t isolated)
(Scheme I-37).115 This remains an underdeveloped area, and is perhaps limited by the
synthetic challenges associated with P-chiral phosphines.
Scheme I-37 Hydrogenation of acetophenone with the ruthenium complex
of P-chiral phosphine (R,R)-148 and 1,4-diaminobutane. Reaction
conditions: [Ru(C6H6)Cl2] (1 mol%), (±)-1,4-diaminocyclobutane
(1mol%), ligand (R,R)-148 (1.1 mol%), KOtBu (10 mol%), iPrOH, H2 (30
bar), rt, 18 h
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(iv) Phosphine Free Catalysis
There has been relatively little attention paid to the development of phosphine free
catalysts, despite the obvious benefits to catalyst synthesis. The most successful transfer
hydrogenation catalysts of the type [RuCl(TsDPEN)(η6-arene)] contain no phosphine
ligand38 but tend to be inactive in H2-hydrogenation (and vice versa, [RuCl2(P^P)(N^N)] are
generally inactive in transfer hydrogenation). This difference in reactivity has been
attributed to the electronic properties of the Ru centre; H2-hydrogenation catalysts need
electron donating phosphorus donors (presumably to facilitate hydrogen activation) whereas
transfer hydrogenation catalysts have an electron-withdrawing tosylamido ligand.47 Ikariya
has shown that ligands isoelectronic to those employed in transfer hydrogenation, but with
less electron-withdrawing characteristics, such as ligand (S)-150 (Scheme I-38), are
however active in H2-hydrogenation with enantioselectivity in the range 64-95%.47
Scheme I-38 Transfer hydrogenation catalysts that can be employed in H2-hydrogenation.
It has also been shown that more typical phosphine-free transfer hydrogenation catalysts,
such as (S,S)-151 and (S,S)-152 (Scheme I-38), can be transformed into active H2-
hydrogenation catalysts. Noyori has reported that such complexes, can be converted into
H2-hydrogenation catalysts by switching to acidic conditions.116 The theoretical work of Lei
and Fang,117 and kinetic evidence of Rauchfuss,118 has suggested that the addition of acid
facilitates the coordination of dihydrogen to the ruthenium centre in such cases compared to
the acid free process. Excellent enantioselectivity has been obtained in the hydrogenation
of the tricky 4-chromanone substrates, generally over 95% e.e. 116 although to date this area
of study remains underdeveloped and the full substrate scope has not been delineated.
A further example of a phosphine-free hydrogenation system was reported by Kitamura,
employing the tetradentate Goodwin-Lions type ligands (Scheme I-39).119 In combination
with [Ru(π-CH2C(CH3)CH2)2(COD)], ligand (R)-153 was shown to be highly active and
enantioselective in the reduction of a range of acetophenone derivatives (generally above
86% e.e.). The system has the advantage over the original diphosphine/diamine system in
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that base is not required for reactions to proceed and so is useful in the hydrogenation of
configurationally unstable substrates.119 Lemaire demonstrated that tetradentate ligands
derived from (R,R)-DPEN (Scheme I-39), could be also used as a ligands in the asymmetric
hydrogenation of acetophenone although enantioselectivities were generally only moderate
(below 80% e.e).120 Substitution of the aryl groups with bulky substituents did not enhance
enantioselectivity but the best selectivities were obtained with the N-substituted tosyl
derivative 155.
Scheme I-39 Tetradentate Amine Ligands
(v) Hydrogenation with Other Metals
In recent years, a plethora of research has taken place into enantioselective hydrogenation
using catalysts based on metals other than ruthenium, including Rh(II),121 Cu(I),14 Ir(I)122
and Fe(II)123, in an attempt to discover more efficient, more commercially viable
alternatives. To date, ruthenium catalysts still set the standard as regards high catalytic
activity and enantioselectivity. An in-depth discussion of alternative metal systems is
outwith the remit of this review, however such systems have been reviewed in the
references given.
1.7.2 Catalysts for Difficult Substrates
(i) Bulky substrates
Noyori reported that the original [RuCl2(P^P)(N^N)] catalytic system was poor for the
hydrogenaton of bulkier ketones, with hydrogenation of α,α,α-trimethylacetophenone being 
achieved in only 6% yield using [RuCl2((S)-BINAP)((S,S)-DPEN)].24 It was postulated that
this was due to steric congestion near the mechanistically important NH2 groups.72 The
hydrogenation of bulky ketones is a comparatively underdeveloped area of research
compared to acetophenone and derivatives, depite the utility of the corresponding alcohol
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products (see Chapter II). Study in this area has focussed on the preparation of new
catalysts with a more open coordination environment to allow the approach of bulkier
ketones to the ruthenium hydride. Work in this group has found a highly efficient system to
hydrogenate such ketones with good enantioselectivity (up to 94% e.e.) using ruthenium
complexes of tridentate P^N^N ligands,73,124,125 and this shall be discussed in detail in
chapter II.
Subsequent to our work which began in 2004, Noyori has also reported a highly
enantioselective system for the hydrogenation of tert-alkyl ketones, making use of the
unsymmetrical NH2/pyridine ligand, α-picolylamine (PICA).72 This ligand incoporates the
terminal amine deemed to be required for efficient catalysis with a planar pyridine
secondary donor, which allows for the approach of bulkier substrates. Noyori also notes that
ethanol is the solvent of choice for this system, whereas isopropanol was used in the
original [RuCl2(P^P)(N^N)] system.72
Table I-7 Hydrogenation of tert-alkyl ketones using [RuCl2((S)-BINAP)(PICA)] 156. General conditions: substrate
(1 eq.), ruthenium catalyst (0.05 mol%), KOtBu (1 mol%), EtOH, H2 (5-8 bar), 25-27C, 5 h. a 12 h, b 5:1 E:Z, data for
E-isomer. c 20 h.
A number of tert-alkyl ketones have been reduced with good enantioselectivity using this
system (Table I-7) with ee’s generally above 90%.72 The system has been found to be
Entry Ketone Conversion[%] ee [%]
1 157 >99 97 (S)
2 158 >99 97 (S)
3a 159 >99 97 (R)
4 160 >99 97 (R)
5 161 >99 98 (R)
6 162 >99 97 (S)
7 163 >99 98 (R)b
8 164 >99 98 (S)
9c 165 >99 90 (S)
10 166 >99 98 (S)
11 167 >99 97 (S)
12 168 >99 82 (S)
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tolerant of aliphatic, aromatic, heteroaromatic and olefinic ketones, and reactions proceed
smoothly with S/C ratios as high as 100,000.
Noyori and coworkers have extended the hydrogenation of more bulky substrates using
ruthenium complexes of the related DMAPEN ligand and BINAP. It has been shown that
hydrogenation of α-branched aromatic ketones can be accomplished in over 90% e.e and 
>98% d.e. (Table I-8).126 The absence of steric bulk upon the ligand away from the
mechanistically important NH2 appears to give a more open coordination environment for
the approach of more bulky ketones, with enantioselectivity determined by steric interations
between the phosphine substituents and the substrates in the original system. Indeed,
Ohkuma has shown that incorporating more bulky N-dimethyl substituents upon DMAPEN
(giving a more congested active site) leads to a decrease in activity and reduced
enantioselectivity.127
Table I-8 Hydrogenation of α-branched ketones using [RuCl2((S)-
BINAP)((R)-DMAPEN)] 169. General conditions: substrate (1 eq.),
ruthenium catalyst (0.05-0.1 mol%), KOtBu (1 mol%), EtOH, H2 (5-8
bar), 25-30C, 10-24 h.
Entry Ketone
Isolated
Yield
[%]
ee [%] dr Configuration
1 170 95 97 na (R)
2 171 97 93 na (R)
3 172 91 97 na (R)
4 82 94 95 na (S)
5 173 90 98 >99:1 (1R,2R)
Enantioselective Hydrogenation Using Ruthenium Complexes Chapter I
of Tridentate Ligands Scott Phillips
43
(ii) Dialkyl ketones
The enantioselective hydrogenation of dialkyl ketones remains a challenging problem in
asymmetric catalysis with only isolated examples in the literature, where one alkyl group is
bulky allowing for sufficient stereodifferentiation. To date, only the alkyl-alkyl ketones
reduced in high enantiopurity via ruthenium catalysed hydrogenation are pinacolone and
cyclopropyl and cyclohexyl methyl ketones 24 and 25 (Scheme I-5).‡‡ This remains an
under-developed area of research despite the huge value of potential chiral products.
1.8 Project Aims
When this project commenced in 2004, only simple model ketones could be hydrogenated
effectively using the Noyori system, and the hydrogenation of bulky ketones was completely
underdeveloped. As mentioned in section 1.7.2, work in this group led to the discovery of an
efficient system for the enantioselective hydrogenation of bulky compounds, based on
ruthenium complexes of tridentate P^N^N ligands. The scope of the original work was
somewhat limited, but exhibited potential for the hydrogenation of a range of substrates. The
current worked aimed to fully delineate the scope of this new breed of catalyst and demonstrate
its utility in preparing synthetically useful chiral molecules. It was felt that due to the modular
nature of the ligand design there was potential for tuning of the ligand structure, not just to
improve activity/selectivity, but in order to hydrogenate difficult substrates, many of which still
remain problematic for the Noyori and the other systems discussed in this chapter. In order to do
this rationally, it was felt a greater understanding of the reaction mechanism and origin of
enantioselectivity was highly desirable. Thus the principal aims of this work were to (a)
delineate the full substrate scope of the present system, (b) gain a detailed understanding of the
reaction mechanism and origin of enantioselectivity, leading to (c) the tuning of catalyst
structure to give both more active/selective catalysts as well as catalysts capable of
hydrogenating difficult substrates, including bulky, heteroaromatic and dialkyl ketones. The
work carried out to further these aims will be presented in the ensuing pages.
‡‡ There are also limited examples of ruthenium catalysed transfer hydrogenation of alkyl-alkyl
ketones.128
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Chapter II
Exploring the Scope and Application of [RuCl2(P^N^N)L] Catalysts
Preliminary work from this group1 has shown that the [RuCl2(P^N^N)L] catalyst (R,R)-174 is
active and enantioselective in the hydrogenation of bulky ketones (Table II-1); substrates which
were shown to be problematic using [RuCl2(P^P)(N^N)] systems. It was proposed that the more
open coordination environment created by combining the chiral diamine and phosphine
components – shown to be crucial for successful catalysis in the Noyori system – into one chiral
tridentate ligand, would allow easier access for such ketones, and thereby increase their activity
in hydrogenation. This was indeed the case and it was shown that enantioselectivity improved as
steric bulk of the R group was increased (Table II-1). The Noyori [RuCl2(P^P)(N^N)] catalyst
(S),(S,S)-14 is almost completely inactive in the hydrogenation of bulky ketones such as ,,-
trimethylacetophenone (Table II-1, Entry 4).2
Entry R = Catalyst Conversion(yield) [%] ee [%]
1 Me (R,R)-174 >99 (99) 0
2 iPr (R,R)-174 93 48 (S)
3 tBu (R,R)-174 >99 (99) 74 (S)
4 tBu (S),(S,S)- 14 6 61
5 -C(CH3)2CH2CH3 (R,R)-174 >99 (99) 90 (S)
Table II-1 The hydrogenation of bulky ketones using catalyst (R,R)-174,1 and
comparison with hydrogenation using Noyori’s catalyst (S),(S,S)-14.3
The scope of ketone substrate that could be hydrogenated using catalyst (R,R)-174 had not been
fully explored in the original work. In order to be a synthetically useful catalyst, it must be
demonstrated that the catalyst can hydrogenate a variety of substrates, not just selected model
substrates such as entries 1-5 in Table II-1. It is also important to demonstrate the utility of the
catalyst and its ability to prepare chiral secondary alcohols which are of direct synthetic use. In
this chapter, the need for chiral secondary alcohols and their derivatives in organic synthesis
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will be outlined, and how catalyst (R,R)-174 can be employed to prepare such useful molecules.
The preparation of several chiral secondary alcohols with direct synthetic use will be examined
in this chapter, but more generally the compatibility of various functional groups with the
[RuCl2(P^N^N)L] catalytic system has also been a key part of this study.
2.1 Chiral Secondary Alcohols in Organic Synthesis
Chiral secondary alcohols are of vast importance in organic synthesis as not only are they a
structural motif that is ubiquitous in a range of biologically relevant molecules, they also serve
as a functional group which can be transformed into a plethora of important chiral products.
Thus, to the synthetic organic chemist, chiral secondary alcohols can be both a crucial target in
the synthesis of complex products, and a vital precursor, opening the door to the synthesis of
other important molecules.
A brief search of the chemical literature displays a variety of natural products and
biologically relevant molecules containing the secondary alcohol functionality. It can be seen
from Scheme II-1 that chiral secondary alcohols are a salient feature of a variety of important
classes of compound (although only a tiny fraction of important chiral secondary alcohols
(probably <<1%) are depicted here). Whereas technology exists to prepare a number of these in
homochiral form by catalytic asymmetric hydrogenation,4 extended syntheses, often involving
the use of stoichiometric amounts of reagent for chiral induction, is required to incorporate the
chiral secondary alcohol component in large molecules such as epothilone A 175,5 for example.
Scheme II-1 Examples of chiral secondary alcohols which are salient features of both natural products (175-179) –
many of which having important therapeutic properties – and other biologically-relevant molecules, such as the
important pharmaceuticals 180 and 181.
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Chiral secondary alcohols are also often manipulated by the organic chemist to take part in a
multitude of functional group transformations, and are thus vital precursors in the synthesis of
many important molecules. As depicted in Scheme II-2, chiral secondary alcohols can be
transformed by nucleophilic substitution (via the mesylate or tosylate ester) into a number of
chiral products such as amines and phosphines. Synthetically important chiral esters, carbamates
and ethers can also be prepared from these valuable precursors. There are hundreds, probably
thousands, of commercially available chiral molecules that can be made from chiral secondary
alcohols.
Scheme II-2 Some of the most important synthetic transformations of chiral secondary alcohols and potential targets
which could be made via such valuable precursors.
Introducing chirality into molecules by preparing chiral secondary alcohols has become
an important tool of the synthetic chemist in recent times due to their straightforward
preparation from prochiral ketones via asymmetric hydrogenation. However, as discussed
previously, the range of substrates that can be hydrogenated with good activity and high
enantioselectivity is limited. Thus there is a considerable interest in widening the scope of
asymmetric hydrogenation catalysts in order to be able to prepare every class of chiral
secondary alcohol. In this chapter, the substrate scope of the [RuCl2(P^N^N)L] catalyst (R,R)-
174 is explored, with particular regard for functional group compatability and the preparation of
useful chiral molecules.
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2.2 Preparation of Sterically Demanding Chiral Secondary Alcohols
The conclusions of the original work using catalyst (R,R)-174 were based on a relatively small
pool of model substrates. It was felt that in order to gain a better understanding of the catalyst’s
capabilities, as well as showing its synthetic use, other ketonic substrates needed to be explored
in hydrogenation. It was postulated that by increasing the steric bulk, or ‘volume’, of the R
substituent of the ketone (Scheme II-3), the extent of the catalyst’s capability could be assessed.
The chiral alcohol products of such reactions, despite being potentially useful synthetic
intermediates, had never been prepared previously via enantioselective hydrogenation due to the
inactivity of Noyori and related catalysts in the hydrogenation of such sterically demanding
substrates. In the design and optimisation of drugs, for example, studies that aim to extend
lipophilicity or steric bulk make the ability to prepare alcohols across the full range of steric
properties important. From a more fundamental point of view, there was considerable interest in
how big the R group substituent on the ketone could be before diminished activity and/or
enantioselectivity was observed. Previous work in this group demonstrated that
enantioselectivity of 90% can be achieved for substrate 182 but the significantly bulkier ketone
185 was found to be totally resistant to hydrogenation with catalyst (R,R)-174.6 Thus, it was
decided that compounds 183 and 184 would be prepared – more sterically demanding than
substrate 182 but less so than 185 – in order to probe whether catalyst (R,R)-174 could tolerate
such bulk in hydrogenation, and to observe whether selectivity was diminished, or indeed
enhanced.
Scheme II-3 More sterically demanding ketone substrates for hydrogenation with [RuCl2(P^N^N)L] catalyst 174.
2.2.1 Synthesis
It was envisaged that the substrate 2-methyl-1,2-diphenylpropan-1-one 183, could be prepared
in a variety of ways, from the commercially-available compounds, isobutyrophenone 82 or 1,2-
diphenylethanone 186. Initially, the palladium-catalysed -arylation of isobutyrophenone with
bromobenzene, as developed by Hartwig,7 was employed due to the scope of the methodology
for preparing a wide variety of other substrates (Scheme II-4). This method successfully
Enantioselective Hydrogenation Using Ruthenium Complexes Chapter II
of Tridentate Ligands Scott Phillips
53
furnished the ketone 183, albeit in a moderate yield of 49% after column chromatography.
Increased temperature, prolonged reaction times, higher catalyst loading and substitution of the
aryl bromide for iodobenzene failed to increase the conversion to the arylated product.
Scheme II-4 Pd-catalysed -arylation of
isobutyrophenone, 82. Reaction Conditions:
82 (1 eq.), Pd(dba)2 (2 mol%) , DtBPF (2.5
mol%), PhBr (1.1 eq.), NaOtBu (1.5 eq.),
THF, 50C, 6 h, 49%.
This synthesis was not optimised further due to the discovery of a higher yielding, although less
elaborate and less customisable, alternative route. This involved the exhaustive methylation of
1,2-diphenylethanone 186, via its potassium enolate, with iodomethane. Use of 2.2 equivalents
of base and alkylating agent, converted all starting material to the desired product in 16 h
(Scheme II-5). Purification was carried out in a facile manner by short-path distillation using
Kugelrohr apparatus to give ketone 183 in 83% yield. Samples of 183 made via both routes
were employed in subsequent hydrogenation reactions.
Scheme II-5 Preparation of 2-methyl-1,2-
diphenylpropan-1-one 183 via exhaustive
methylation of 1,2-diphenylethanone 186.
Reaction Conditions: 186 (1 eq.), KOtBu (2.2
eq.), MeI (2.2 eq.), tetrahydrofuran, 0C → 
rt, 16 h, 85%.
The synthesis of methyl-1,2-diphenylpropan-1-one 184 was accomplished in a similar manner,
by alkylation of 1,2-diphenylethanone, via its potassium enolate, with iodoethane (Scheme II-6).
Scheme II-6 Preparation of 2-ethyl-1,2-
diphenylbutan-1-one 184 via exhaustive
alkylation of 1,2-diphenylethanone 184.
Reaction Conditions: 186 (1 eq.), KOtBu (3
eq.), EtI (3 eq.), tetrahydrofuran, 0C → rt, 
16 h, 66%.
2.2.2 Catalysis
Hydrogenation of substrates 183 and 184 was carried out using the original catalyst precursor
(R,R)-174, prepared according to the literature.1 Both ketones were reduced quantitatively by
catalyst (R,R)-174 in 16 h using 40 bar hydrogen pressure at 70C. It was found that while a
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high degree of enantioselectivity was maintained in the secondary alcohol products (Table II-2),
there was a small but significant decrease from that observed for the hydrogenation product of
ketone 184 (the stereochemical configuration of alcohols 187 and 188 was tentatively assigned
as (S) akin to that of entries 2,3 and 5 in Table II-1. All products display the same sense of
optical rotation and order of elution from the chiral HPLC).
Entry R = PH2[bar]
T
[C]
Conversion
(yield) [%] ee [%]
1 Me 40 70 >99 (79) 84
2 Et 40 70 62 75
Table II-2 The hydrogenation of ketones 183 and 184 using catalyst
(R,R)-174. General conditions: ketone (~1 mmol), catalyst (R,R)-174
(0.5 mol%), potassium tert-butoxide (1 mol%), isopropanol (3 mL),
molecular H2, 16 h.
The results suggest that as the R substituent of the ketone substrate gets larger than that of
ketone 183, the preference for the attack of the ruthenium hydride at the Si-face of the ketone is
somewhat diminished, perhaps due to enhanced steric repulsion between the ligand and the
bulky substrate. Thus, as well as showing that catalyst (R,R)-174 is effective in producing useful
bulky secondary alcohols with good enantioselectivity, these results give clues to the possible
direction of catalyst optimisation, which shall be discussed more extensively in Chapter IV.
The reductions of substrates 183 and 184 were also studied in a microwave-assisted transfer
hydrogenation protocol, developed in this group,6 employing isopropanol as the hydride source.
It was gratifying to observe that alcohols 187 and 188 could be furnished with good
enantioselectivity (Table II-3). Reaction temperatures had to be tuned to give enantioselectivities
approaching that of the H2-hydrogenation system for the hydrogenation of 183 but this led to
poor conversions when the temperature was lowered. Good enantioselectivity was also obtained
in the transfer hydrogenation of 184 but the conversion was again poor. It is likely that further
optimisation of reaction conditions, in particular increasing the reaction time and base loading,
would improve the yield of enantiomerically enriched product. However, this was not
considered an important objective given that this has been demonstrated for other substrates by
Diaz and Clarke.6 We have nevertheless demonstrated that the transfer hydrogenation procedure,
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albeit requiring further optimisation, gives an alternative route to chiral secondary alcohol
building blocks, without the need for high pressure equipment. This is particularly convenient in
the research laboratory which does not always have the facilities for H2-hydrogenation. H2-
hydrogenation however, is normally preferred at a commercial scale and having a catalyst which
can operate in both systems is highly beneficial.
The similarly high enantioselectivity observed for substrates 183 and 184 in H2-hydrogenation
and transfer hydrogenations also suggests a common pathway in the enantio-determining step in
each process, and this shall be discussed further in Chapter III.
Entry R = t[min]
T
[C]
Conversion
(yield) [%] ee [%]
1 Me 20 120 55 71
2 Me 40 100 31 75
3 Et 20 120 18 83
Table II-3 The transfer hydrogenation of ketone 183 and 184 using
catalyst (R,R)-174. General conditions: ketone (~1 mmol), catalyst
(R,R)-174 (0.5 mol%), potassium tert-butoxide (1 mol%),
isopropanol (3 mL).
2.3 Preparation of Chiral Secondary Alcohols with Distinct Electronic Properties
In light of the proposed mechanism for ketone hydrogenation with Noyori’s [RuCl2(P^P)(N^N)]
catalyst system, it is conceivable that altering the electronic environment at the substrate
carbonyl functionality could impact both activity and enantioselectivity in such reactions. For a
catalyst to be synthetically useful it must be shown that it can tolerate a variety of electronically
different substrates as well as steric bulk. Studies into the effect of substituents upon catalysis
can also shed light upon the mechanism by which the catalytic cycle operates. It was shown for
the Noyori system that electron-poor substrates, such as p-trifluoromethylacetophenone, were
hydrogenated up to 11 times faster than electron-rich substrates such as p-
methoxyacetophenone, although this is a smaller effect than the substituent effect on reduction
with sodium borohydride.2 It was also demonstrated by Noyori that the electronic effects of
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para substituents on enantioselectivity are relatively small and thus efficient enantioselective
hydrogenation with such catalysts can tolerate a range of ring substituents.8 Noyori does suggest
however, that substrates with an electron donating susbstituent gives rise to high
enantioselectivity due to the greater stabilisation of an NH/π interaction between the diamine 
ligand and the aryl component of the substrate.9
In order to investigate this issue for the hydrogenation of bulky ketones with the
[RuCl2(P^N^N)L] catalytic system, a range of derivatives of ,,-trimethylacetophenone were
prepared, to cover a spectrum of electronic influences on the carbonyl functionality of the
substrate (Scheme II-8). The para-methoxy derivative 197 was prepared as an example of an
relatively electron-rich substrate compared to ,,-trimethylacetophenone 159, while para-
chloro and para-trifluoromethyl derivatives, 198 and 199, were prepared as relatively electron-
poor substrates, and their performance in catalysis was compared and contrasted. To investigate
whether ortho substitution can also be tolerated by the [RuCl2(P^N^N)L] system, where steric
influences also becomes a factor, the ortho-methoxy derivative 200 was prepared and its
performance in catalysis was explored.
Scheme II-8 Para- and ortho-substituted ,,-trimethylacetophenone derivatives
prepared to probe the effect of the electronic environment at the carbonyl group.upon
productivity and enantioselectivity.
2.3.1 Synthesis
The syntheses of the tert-butyl ketones 197-200 were carried out in moderate to good yields
from commercially available acid chlorides by adaptation of literature procedures (Scheme II-
9).10,11 The tert-butyl cuprate was first generated by reaction of copper(I) bromide
dimethylsulfide complex with tert-butyllithium in THF at 0C. Addition of the requisite aroyl
chloride and stirring overnight yielded the desired product in each case. Purification by short-
path distillation using Kugelrohr apparatus was carried out before each substrate was
investigated in catalysis.
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Scheme II-9 Preparation of para- and ortho-substituted ,,-
trimethylacetophenone derivatives. Reaction Conditions: acid
chloride (1 eq.), CuBr.SMe2 (1.1 eq.), tert-butyllithium (1.1 eq.,
1.6 M solution in pentanes), tetrahydrofuran, 0C → rt, 16 h. 
2.3.2 Catalysis
Hydrogenation of the substituted ,,-trimethylacetophenone derivatives 197-200 with
catalyst (R,R)-174 at 50 bar hydrogen pressure and 50C resulted in the quantitative conversion
in each case to the corresponding alcohol (Table II-4). The para-substituted derivatives show
consistently high levels of enantioselectivity, generally slightly higher than that of ,,-
trimethylacetophenone itself. The similarities in selectivity suggests that modifying the
electronic environment at the carbonyl functionality has little effect on selectivity in
hydrogenation with catalyst (R,R)-174. Unlike in the [RuCl2(P^P)(N^N)] system, there is a
small but significant drop in enantioselectivity for the ortho-substituted methoxy-derivative 200.
This may be attributed to the increase in steric bulk near the carbonyl functionality, making
differentiation between each face of the ketone substrate more challenging for the present
catalyst.
Entry Ketone X= PH2[bar]
T
[C]
Conversion
(yield) [%] ee [%]
1 159 H 50 50 >99 (99) 74 (S)
2 197 p-OMe 50 50 >99 (79) 77 (S)
3 198 p-Cl 50 50 >99 (97) 80
4 199 p-CF3 50 50 >99 (84) 76
5 200 o-OMe 50 50 >99 (69) 69
Table II-4 The hydrogenation of para- and ortho-substituted ,,-
trimethylacetophenone derivatives 197-200 using catalyst (R,R)-174. General
conditions: ketone (~1 mmol), catalyst (R,R)-174 (0.5 mol%), potassium tert-
butoxide (1 mol%), isopropanol (3 mL), molecular H2, 16 h.
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The catalytic performance of substrates 197-200 has shown that hydrogenation
[RuCl2(P^N^N)L] catalyst (R,R)-174 can tolerate a range of substrate electronic effects, as all
substrates were hydrogenated quantitatively in 16 hours and differences in enantioselectivity
with the unsubstituted ,,-trimethylacetophenone were minimal; in some cases
enantioselectivity was elevated, perhaps due to steric effects. Our results bode extremely well for
the catalysts applicability in synthesis, expanding the scope of substrate greatly.
2.4 Preparation of Heteroaromatic Chiral Secondary Alcohols
Heterocycles are so-called “privileged structures” in medicinal chemistry and provide a scaffold
for many pharmaceutically active molecules. “Privileged structures” commonly consist of the
rigid heteroaromatic ring, which presents appended residues in well defined orientations
required for target recognition. Thus, it is incredibly important to be able to control the
stereochemistry adjacent to the heterocyclic core in order to control the orientation of appended
residues. Heteroaromatic chiral secondary alcohols are thus a versatile building block in
preparing pharmaceutically active molecules, an example of which is depicted in Scheme II-10.
Scheme II-10 An example of a
heteroaromatic chiral secondary
alcohol (205) as an important
building block in the preparation of
the phosphodiesterase-IV inhibitor
206. 12
Despite the importance of such heteroaromatic chiral secondary alcohols, their preparation by
the enantioselective hydrogenation of heteroaromatic ketones is an underdeveloped area, and
wasteful resolution techniques are still often required. Heteroaromatic substrates have proved
problematic in catalytic hydrogenation as they can preferentially bind to the metal centre
through heteroatoms at the expense of the carbonyl group, thus deactivating the catalyst.13 There
is also precedent for hydrogenation of the heteroaromatic ring itself13 and under some
conditions, cleavage of the ring.14 While some good solutions now exist for the enantioselective
catalytic hydrogenation of simple heteroaromatic ketones,12,15 there are still no efficient catalysts
for the reduction of bulky, heteroaromatic ketones, and inefficient resolution procedures are still
commonplace (Scheme II-11).
205
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S
OH
F3C CF3
OMOM
HF2CO
O
N
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Scheme II-11 The bulky heteroaromatic chiral alcohol 207 is a precursor to the potent cathepskin K inhibitor 208, but
is prepared in racemic form and then separated by chiral preparatory HPLC.16
In light of the success of catalyst (R,R)-174 in the enantioselective hydrogenation of sterically-
demanding aromatic ketones, it was thought worthwhile to investigate the catalyst’s
performance in hydrogenation of bulky ketones containing heteroaromatic functionality. A panel
of heteroaromatic ketones were chosen to explore the catalyst’s tolerance of a range of
heteroaromatic functionalities (Scheme II-12).
Scheme II-12 The panel of heteroaromatic substrates for investigation
in hydrogenation with catalyst (R,R)-174, probing the catalyst’s
tolerance of the pyridyl, furyl, thienyl and isoxazolyl functionalities.
Of the heteroaromatic scaffolds to be investigated, the pyridine structure is of particular
importance in medicinal chemistry as the conformational space around the scaffold can be
explored in a variety of ways by varying the substituent at the five positions around the ring.17
Introducing a chiral ‘handle’ through asymmetric hydrogenation of prochiral pyridyl ketones is
worthwhile in order to equip the medicinal chemist with the tools to fully explore this space. It
was decided to look at the hydrogenation of 4-pyridyl ketone 209 in hydrogenation with catalyst
(R,R)-174 to expand the scope of this technology in preparing synthetically valuable chiral
alcohols.
2.4.1 Synthesis
It was envisaged that the 4-pyridyl ketone 209 could be prepared by adaption of a procedure
described by Moberg,18 in which the 4-lithiopyridine is first prepared by reaction of 4-
bromopyridine with n-butyllithium. It was thought that subsequent addition of pivalonitrile then
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hydrolysis would furnish the desired product 209. However, in practice this was not the case
and a complex mixture of products was obtained. This was potentially a result of competing
ortho-lithiation of the pyridine ring, and subsequent reaction, rather than lithium-halogen
exchange as desired.19 Attention was thus diverted to a more practical route into compound 209.
Preparation of the desired 4-pyridyl ketone 209 was furnished in moderate yield by exhaustive
methylation of 4-acetylpyridine 213, employing sodium hydride as base (Scheme II-13). While
conversion to product was typically high in this reaction, isolated yields were only moderate due
to the affinity of the product for silica, employed during purification, and this remains un-
optimised.
Scheme II-13 Preparation of 2,2-dimethyl-1-(pyridin-4-yl)propan-
1-one 209. Reaction Conditions: 213 (1 eq.), NaH (10 eq.), MeI
(10 eq.), THF, 0C → rt, 16 h, 57%. 
The furyl ketone 210 was prepared by Clarke and Fuentes in this group20 following a previously
described route,21 by addition of t-butylmagnesium chloride to 2-formylfuran, and subsequent
oxidation of the secondary alcohol.
A facile route to the thienyl ketone 211 was achieved through the Friedel Crafts acylation of
thiophene 214, using stannic chloride and pivaloyl chloride. Acylation was selective at the 2-
position and furnished the desired product in excellent yield.
Scheme II-14 Preparation of 1-(thien-2-yl)-2,2-dimethylpropan-1-
one 211. Reaction Conditions: 214 (1 eq.), SnCl4 (1 eq.), pivaloyl
chloride (1 eq.), toluene, 0C → rt, 2 h, 95%;  
The final example on the test panel of heteroaromatic substrates, was the elaborate isoxazolyl-
based substrate 212. Not only was this substrate chosen to investigate the tolerance of the
catalytic system to such a heteroaromatic group but also whether hydrogenation could be
accomplished on a relatively large complex molecule, without fragmentation or other possible
side reactions.
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Substrate 212 was prepared via a recently published literature procedure.22 The synthesis
culminated in the microwave-assisted 1,3-dipolar cycloaddition of alkyne 220 – prepared by
Sonagashira coupling of acid chloride 218 and terminal alkyne 219 – with the in-situ generated
nitrile oxide 221, prepared in two steps from para-methoxybenzaldehyde 215. This gave the
desired product in poor overall yield, but in sufficient quantities for subsequent use in catalysis.
The protocol was hampered by the competing dimerisation of nitrile oxide 221 in the
microwave-assisted step.
The procedures described all furnished the desired heteroaromatic ketones in sufficient yield
and purity for investigation in catalysis with catalyst (R,R)-174.
2.4.2 Catalysis
Hydrogenation of the pyridyl ketone 209 with catalyst (R,R)-174 at 70 bar hydrogen pressure
and 70C resulted in the quantitative conversion to alcohol product (Table II-5). The reaction
was sluggish compared to hydrogenation of the phenyl derivative 159 and thus elevated
temperature and pressure were required to drive the reaction to full conversion. It was gratifying
however that moderate/good enantioselectivity was observed for such a substrate, for which no
efficient catalyst exists. It was also pleasing that the ketone could be hydrogenated
quantitatively without signs of catalyst deactivation, although the sluggish reaction at low
temperatures may be attributed to prohibitive heteroatom-catalyst interactions. Indeed, Noyori
Scheme II-15 Preparation of isoxazolyl ketone 212. Reaction
Conditions: (i) 215 (1 eq.), NH2OH.H2O (1.1 eq.), NaOH,
H2O, EtOH, 25-30C, 1 h, 71%; (ii) 216 (1 eq.), NCS (1 eq.),
DMF, 0C, 1 h, 65%; (iii) 218 (1 eq.), 219 (1 eq.),
(PPh3)2PdCl2 (2 mol%), CuI (4 mol%), NEt3 (1.1 eq.), THF,
rt; (iv) 220 (1 eq.), 221 (1 eq.), μW, 90C, 30 min, 21% (two
steps).
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found the need to use a borate additive to prevent such interactions when investigating the
hydrogenation of simple pyridyl ketones.12 Isolated yields were low for pyridyl alcohols in our
study due to their affinity for silica, which was encountered during purification.
Entry Ketone Ar= PH2[bar]
T
[C]
Conversion
(yield) [%] ee [%]
1 209 4-pyridyl 70 40 20 70
2 209 4-pyridyl 70 70 >99 (61) 69
3 210 2-furyl 50 50 >99 (89) 74
4 211 2-thienyl 70 70 <5 na
Table II-5 The hydrogenation of heteroaromatic ketones 209-210 using
catalyst (R,R)-174. General conditions: ketone (~1 mmol), catalyst
(R,R)-174 (0.5 mol%), potassium tert-butoxide (1 mol%), isopropanol
(3 mL), molecular H2, 16 h.
The 2-furyl derivative 210 was also hydrogenated quantatively using catalyst (R,R)-174, at 50
bar hydrogen pressure and 50C, giving the chiral secondary alcohol product 223 with
enantioselectivity on par with the non-heteroaromatic derivative 159. The milder reaction
conditions in comparison with those needed for the hydrogenation of pyridyl ketone 209 may be
down to the lone pair on the furan oxygen being less available for interaction with the metal
catalyst, and thus less energy is needed to overcome such an interaction. Disappointingly,
however, it was found that the 2-thienyl derivative 211 was totally resistant to hydrogenation
with catalyst (R,R)-174, even at elevated temperature and pressure. This may be attributed to the
greater availability of the lone pair upon sulfur to interact with the metal catalyst. This problem
was overcome somewhat by Fuentes and Clarke in this group,20 who made use of a (R,R)-
[RuCl2(P^N^O)L] catalyst that could hydrogenate ketone 211 with 65 % conversion in 65 h,
and with 64 % enantioselectivity (S-enantiomer), at 50 bar hydrogen pressure and 50C.23 This
suggests that perhaps rather than an interaction between the heteroatom lone-pair and the metal
centre prohibiting efficient hydrogenation, that interaction between the heteroaromatic ring and
the amine ligand may be important.
Hydrogenation of the more elaborate isoxazolyl ketone 212 with catalyst (R,R)-174 was
successfully accomplished, almost quantatitively, at 70 bar hydrogen pressure and 40C,
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without any competing side reactions. Pleasingly, alcohol 225 was also furnished with 67%
enantiomeric excess. The mere fact that alcohols containing heteroaromatic function as well as
sterically demanding structures can be hydrogenated with catalyst (R,R)-174 is extremely
gratifying as few, if any, catalysts exist that can tackle such substrates. The additional bonus of
good enantioselectivity bodes well for the development of second generation [RuCl2(P^N^N)L]
catalysts, which can deliver such complex structures with enhanced enantio-enrichment (see
chapter IV).
Scheme II-16 The hydrogenation of heteroaromatic ketone 212 using
catalyst (R,R)-174. Reaction conditions: ketone 212 (1 eq.), catalyst
(R,R)-174 (0.5 mol%), potassium tert-butoxide (1 mol%), isopropanol (3
mL), molecular H2 (70 bar), 40C 16 h, 98%.
It has been demonstrated in this work that a range of heteroaromatic functionalities can be
tolerated by the present catalytic system: pyridyl,† furyl and isoxazyl ketones can be
hydrogenated by catalyst (R,R)-174, in many cases with good enantioselectivity. Such reactions
can be used to produce valuable chiral heteroaromatic scaffolds, which are privileged structures
in medicinal chemistry.
2.4.3 Preparation of Heteroaromatic Bis-Diols
There is a huge scope in asymmetric synthesis for the use of C2-symmetric diols as chiral
‘inducers,’ whether it be in the preparation of chiral auxiliaries - for a range of reactions such as
stereoselective additions to C=O, C=N or C=C-C=O - or as chiral ligands, for important
catalytic processes such as the enantioselective addition of diethylzinc to aldehydes or titanium-
catalysed asymmetric oxidation and Diels Alder reactions.24 In addition to this, such diols are
† In collaboration with Professor Marcia B. France, Washington and Lee University, VA, United States, and Mary E.
Gunn, University of St Andrews, during a summer training project, it was found that 2,2-dimethyl-1-(pyridin-2-
yl)propan-1-one could also be hydrogenated quantitatively by catalyst (R)-174, with 60% e.e. (S) at 70 bar H2 and
70C, after 16 h.
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synthons in the synthesis of important chiral diamines and diphosphines. This makes C2-
symmetric diols one of the “most sought after molecules in the area of asymmetric synthesis.”24
Many C2-symmetric diols are prepared directly from chiral pool precursors but such resources
are limited in scope. Asymmetric hydrogenation provides a convenient route into such
molecules from prochiral bis-ketones. Previous work in this laboratory has demonstrated that
chiral C2-symmetric diols can be prepared in up to 93% e.e. by using catalyst (R,R)-174 to
hydrogenate bis-ketones.25 In light of the current work of the hydrogenation of heteroaromatic
ketones, it was decided to investigate catalyst (R,R)-174 in the hydrogenation of bis-ketones
with a heteroaromatic core. This would furnish a C2-symmetric diol that might find use as a
tridentate ligands, either as itself or after further manipulation.
The bis-ketone 226 was prepared in this laboratory by Clarke and Fuentes.20 It was found that
the diol 227 could be furnished quantitatively from bis-ketone 226 using catalyst (R,R)-174 in
16 h at 50 bar hydrogen pressure and 50C (Scheme II-17).
Scheme II-17 The hydrogenation of bis-ketone 226 using catalyst (R,R)-174.
Reaction conditions: ketone 226 (1 eq.), catalyst (R,R)-174 (0.5 mol%),
potassium tert-butoxide (1 mol%), isopropanol (3 mL), molecular H2 (50 bar),
50C, 16 h, >99% conversion.
Enantioselectivity in the reaction was hugely amplified relative to the hydrogenation of related
monoketone 210 (Table II-5, entry 3) with the major enantiomer produced in almost enantiopure
form. This amplification is accounted for by the Horeau effect, whereby multiple
enantioselective transformations on the same molecule by the same catalyst, lead to an increase
in product e.e. relative to that expected for a single reaction, due to the formation of the meso
diastereomer which allows for the removal of racemic material (Scheme II-18).26 Based on 74%
enantioselectivity for a single transformation, statistical analysis predicts that 95% e.e. will be
obtained after hydrogenation of the two ketones. This assumes that the catalyst selectivity is the
same at both sites, i.e. the first formed stereocentre has no influence on further selectivity.27 This
may not be the case in our system and the slightly higher selectivity obtained may be accounted
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for by the steric impact of the bulky substituents at the first stereocentre influencing selectivity at
the second centre. The diastereomeric ratio ((R,R)+(S,S):meso)) for our system is slightly lower
than what is predicted and this may be explained by similar reasoning.
Scheme II-18 The Horeau Effect and its statistical impact on product distribution in the hydrogenation of the bis-
ketone 226.
The price paid for such an amplification of enantioselectivity however is the large material lost
as the meso compound (which increases relative to the magnitude of enantioselectivity). While
this can often be separated easily by column chromatography, it is not desirable to produce such
quantities of undesired material, and in this case, efficient separation was problematic in initial
attempts.
Despite this, utility of [RuCl2(P^N^N)L] catalysts in preparing synthetically useful, almost
enantiopure diols has been demonstrated, products with a variety of potential uses, whether it be
as chiral ligands, or as precursors to a range of other important chiral products. Diol 227 has
potential use as a chiral ligand as it contains a third potential metal coordination point, through
the oxygen lone pair, which one would assume would more a conformationally rigid structure,
ideal for the relay of stereochemical information to other molecules in catalysis. This is just
another example of the range of valuable chiral products that the current technology has the
potential to exploit.
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2.5 Preparation of Chiral Secondary Alcohols with an Adjacent Gem-Dimethyl Group
Geminal dimethyl groups are key features of many biologically important molecules and their
analogues (Scheme II-19). Such groups can lock structures in certain conformations thus
maximising receptor affinity compared to their CH2 analogues.28 Gem-dimethyl groups are also
effective in increasing metabolic stability by blocking parts of molecules to nucleophilic
attack.29,30 As well as this, gem-dimethyl groups are also salient in organic synthesis as they can
be exploited in a variety of ways, whether it be by preventing nucelophilic attack at sensitive
functionality,31 or in aiding the relay of stereochemical information by providing conformational
rigidity in chiral auxiliaries/ligands,32 or even enhancing the rate of some ring-forming reactions
(Thorpe-Ingold Effect).33
Scheme II-19 Biologically important molecules containing gem-dimethyl substituents (a) for structural rigidity and
maximising receptor affinity (175 and 176), (b) for metabolic stability (228)30 and (c) for both prevention of
endocyclic cleavage of the ring by nucleophilic attack, and structural rigidity for transfer of stereochemical
information in this important class of chiral auxiliary (231). 31,32
Despite being extraordinarily useful molecules, there is little precedent in the literature for the
preparation of chiral secondary alcohols with an adjacent gem-dimethyl group via asymmetric
hydrogenation. This is primarily due to the limitations of the Noyori [RuCl2(P^P)(N^N)]
catalytic system in the hydrogenation of such bulky ketones. The [RuCl2(P^N^N)L] has shown
great potential, however, for the enantioselective hydrogenation of this class of substrate, giving
quantitative conversion of ketone 183 to alcohol product in 84% e.e. (Table II-2). It was decided
to explore the performance of catalyst (R)-174 further in the hydrogenation of such ketones. The
aim of this study was both to demonstrate the activity and selectivity of the [RuCl2(P^P)(N^N)]
in preparing chiral secondary alcohols with adjacent gem-dimethyl groups, but also to furnish
molecules as potential analogues of biologically important compounds.
It was felt that as well as having adjacent gem-dimethyl substituents, chiral secondary alcohols
with ‘handles’ for further modification must be prepared in order to exhibit the catalyst’s
potential in preparing useful products which were previously inaccessible by asymmetric
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hydrogenation. Two substrate targets were in mind: ketones 230 and 231, with a distal nitrile
group and benzyl ether-protected alcohol group, respectively, for further chemical modification,
(Scheme II-20).
OH
230
CN
OH
231
O Ph
Scheme II-20 Chiral secondary alcohols
containing synthetically-useful remote
functionality.
Nitriles such as 230 are of extreme versatility in synthesis as they can be transformed to a
number of useful products: hydrolysis of 230 yields carboxylic acids; reduction leads to primary
amines or imines (aldehydes upon hydrolysis); alcohol nucleophiles can furnish esters upon
hydrolysis, and alkyl/aryl based nucleophiles can give ketones. Nitrile groups can also undergo
displacement via SN2 reactions with certain nucleophiles, which opens the door to a whole new
range of useful products. Likewise, deprotection of the benzyl ether 231 unlocks the primary
alcohol functionality which can be manipulated in a variety of ways to give an array of chiral
products.
It was also desirable to investigate the potential of the present catalytic system in preparing
gem-dimethyl analogues of antifungal agents such as econazole 232 and miconazole 233
(Scheme II-21). To date, the only successful preparation of the precursor to such compounds,
chiral alcohol 234, via asymmetric hydrogenation was accomplished using a transfer
hydrogenation system employing [RuCl(N-tosylDPEN)(cymene)] and formic acid as hydride
source, in up to 99% e.e.34 Whilst transfer hydrogenation is a mild and convenient technique to
prepare such chiral alcohols in the research lab, pressure hydrogenation is preferred in industry
due to its scaleability, as well as molecular hydrogen being a relatively cheap and readily
available hydride source. Thus, efficient H2-hydrogenation catalysts are still desirable for the
enantioselective reduction of such ketones and analogues.
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O
N
N
Cl
Cl Cl
R
232, R = H, econazole
233, R = Cl, miconazole
OH
N
N
Cl Cl
234
Scheme II-21 The antifungal agents econazole 232 and miconazole 233, and their
synthetic precursor, 1-(2,4-dichlrophenyl)-2-imidazol-1-ylethanone 234.
Previous work in this group has demonstrated that the CH2 analogue 235 can be prepared
quantitatively in 61 % e.e by H2-hydrogenation with catalyst (R)-174 (Scheme II-22). In light of
the present catalytic system’s ability to hydrogenate bulky subtrates, and its tolerance of
heteroaromatic functionality, it was decided to investigate the hydrogenation of ketone 236, to
demonstrate the catalyst’s utility in preparing useful chiral analogues of biologically important
molecules.
OH
N
N
236
OH
N
N
235
Prepared in 61% e.e.
using catalyst (R,R)-174
Scheme II-22 Analogues of the important synthetic precursor to the
antifungal agents, econazole 232 and miconazole 233,.
.2.5.1 Synthesis
The strategy for preparation of the ketone precursors to 230 and 231 was by functionalisation of
the α-carbon of isobutyrophenone 82. It was envisaged that substrate 237 could be prepared by
the conjugate addition of the potassium enolate of isobutyrophenone 82 to acrylonitrile, in a
procedure similar to that reported by Campbell et al.35 This was successfully accomplished,
albeit in low un-optimised yield, and the desired product was easily recovered, giving the pure
ketone in sufficient quantities for investigation in catalysis (Scheme II-23). It should be noted
here that this is a quick and facile route into such compounds and it can be imagined that a large
number of functionalised derivatives could be prepared by such methods from relatively cheap,
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commercially-available starting materials. Thus, there is potential to create a expanded range of
functionalised chiral secondary alcohol products.
Scheme II-23 Preparation of 4,4-dimethyl-5-oxo-5-phenylpentanenitrile 237. Reaction
Conditions: 82 (1 eq.), acrylonitrile (1 eq.), methanolic KOH solution (30%), dioxane,
50C, 24 h, 21%.
The preparation of substrate 239 proved more troublesome. Isobutyrophenone 82 was first
converted to the keto-alcohol 238 in good yield by aldol condensation with paraformaldehyde in
the presence of trifluoroacetic acid, and subsequent base hydrolysis of the trifluoracetate ester
(Scheme II-24). Multiple attempts to prepare the benzyl protected form of the alcohol (thought
to be required to provide steric bulk for efficient enantioselective catalysis) failed however. This
was likely due to retro-Aldol reaction taking place under the forcing basic conditions needed in
ether synthesis, yielding isobutyrophenone as the primary product.
Scheme II-24 Attempted preparation of substrate 239. Reaction Conditions: (i) 82 (1 eq.),
paraformaldehyde (1.3 eq.), trifluoroacetic acid, 60C, 16 h then 2M NaOH, rt, 2 h, 74%;
(ii) 238 (1 eq.), BnBr (1 eq.), tBuNI (0.015 eq.) H2O, Me-THF, reflux, 16 h or 238 (1 eq.),
BnBr (1 eq.), NaH (2.5 eq.), THF or DMF, reflux, 16 h.
A second route was thus needed, which could prepare substrate 239 in a good yield in few steps,
but which could be customisable in preparing a range of derivatives. It was decided to make use
of the catalytic monoalkylation protocol of Onomura and co-workers36 to first prepare the
monobenzylated 1,3-diol 241 in an easy, high-yielding and customisable step (Scheme II-25).
Subsquent oxidation, addition of arylmagnesium bromide reagent (opening the door to potential
preparation of substituted derivatives), and final oxidation step, furnished the desired product.
Although this is not an elegant process, the product is delivered using easy, high-yielding
reactions.
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Scheme II-25 Successful preparation of substrate 239. Reaction Conditions: (i) 240 (1 eq.), BnBr (1.5
eq.), K2CO3 (1.5 eq.), p-fluorobenzene boronic acid (0.1 eq.), DMF, rt, 36 h, 80%; (ii) 241 (1 eq.),
(COCl)2 (2 eq.), DMSO (4 eq.), NEt3 (4 eq.), CH2Cl2, -78C → rt, 2 h, 81%; (iii) 242 (1 eq.), PhMgBr
(1.2 eq.), Et2O, -78C → rt, 16 h; (iv) 231 (1 eq.), (COCl)2 (2 eq.), DMSO (4 eq.), NEt3 (4 eq.),
CH2Cl2, -78C → rt, 2 h, 69 % (step (iii) and (iv)). 
The imidazole-functionalised ketone substrate 244 was prepared by modification of a procedure
by Bildstein (Scheme II-26),37 presumably via an SN1 mechanism, with the second equivalent of
imidazole acting to neutralise the HBr which is formed. This procedure provided ketone 244 in
good yield and purity for subsequent use in catalysis.
Scheme II-26 The synthesis of 2-(1H-imidazol-1-yl)-2-
methyl-1-phenylpropan-1-one 244. Reaction conditions:
243 (1 eq.), imidazole (2 eq.), EtOH, reflux, 3 d, 62%.
2.5.2 Catalysis
Hydrogenation of both the functionalised ketone substrates 237 and 239 with catalyst (R,R)-174
at 50 bar hydrogen pressure and 50C resulted in the quantitative conversion in each case to
alcohol product (Table II-6). It was gratifying to find that substrate 237 was hydrogenated with
enantioselectivity on par with that of the model ketone ,,-trimethylacetophenone 159. The
uses of the chiral alcohol product 237 will be underlined further in section 2.5.3. It was pleasing
to find that catalysis is tolerant of the useful nitrile functionality, given that ruthenium catalysed
nitrile hydrogenation is a well known reaction.38,39
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(R,R)-174
N
H2
NH P
Ru
Cl
Cl S
O
Ph
O
Ru Cat
KOtBu, iPrOH
H2
16h
R
237, R= CH2CH2CN
239, R = CH2OBn
Ph
OH
R
230, R= CH2CH2CN
231, R = CH2OBn
Entry Ketone R= PH2[bar]
T
[C]
Conversion
(yield) [%] ee [%]
1 237 CH2CH2CN 50 50 >99 74
2 239 CH2OBn 50 50 >99 50
Table II-6 The hydrogenation of ketones with gem-dimethyl substituents using
catalyst (R,R)-174. General conditions: ketone (~1 mmol), catalyst (R,R)-174 (0.5
mol%), potassium tert-butoxide (1 mol%), isopropanol (3 mL), molecular H2, 16 h.
Chiral alcohol 231 was furnished in only moderate enantioselectivity upon hydrogenation with
catalyst (R,R)-174. This may be due to the significant extension of the substrate structure away
from the ketone function, resulting in unfavourable interactions with the catalyst structure.
However, bearing in mind the limited number of catalysts which can hydrogenate such ketones
with bulk around the carbonyl group, this result is still promising and catalyst optimisation has
the potential of leading to more selective catalysts.
Hydrogenation of the gem-dimethyl substituted ketone 244 was again accomplished
quantitatively in 16 h by catalyst (R,R)-174 at 70 bar hydrogen pressure and 40C.
Disappointingly, however, levels of enantioselectivity were slightly diminished for this
substrate, relative to that obtained in producing the less sterically demanding derivative 235.
Scheme II-27 The hydrogenation of 2-(1H-imidazol-1-yl)-2-methyl-1-
phenylpropan-1-one 244 using catalyst (R,R)-174. Reaction conditions: ketone
244 (1 eq.), catalyst (R,R)-174 (0.5 mol%), potassium tert-butoxide (1 mol%),
isopropanol (3 mL), molecular H2 (70 bar), 40C, 16 h, >99% conversion, 86%
yield.
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Despite achieving only moderate enantioselectivity, these results are encouraging bearing in
mind that this class of substrate is envisaged to be of low reactivity using Noyori-type catalysts,
and such useful chiral products cannot be prepared by existing H2-hydrogenation technology.
Hopefully, the moderate level of enantioselectivity can be elevated by catalyst optimisation, and
some important preliminary steps towards this have been achieved in chapter IV.
2.5.3 Practical Uses of Chiral Alcohol Products
It has been demonstrated that useful chiral secondary alcohol 237, with gem-dimethyl
substituents, and remote functionality, can be prepared with good enantioselectivity using
catalyst (R,R)-174. In order to showcase the utility of such chiral products, it was undertaken to
employ 237 in the preparation of the chiral cyclic ester (-butyrolactone) 248, and show that
enantioselectivity could be preserved throughout the process.
Scheme II-28
The cyclic ester component constitutes a frequently encountered structural motif within a huge
variety of natural products and biologically active compounds. Furthermore, the lactone
functionality exists in common flavour components and is thus employed in the perfumery and
food industry.40,41 Derivatives of lactones also play important roles as sex attraction pheromones
of different insects, and plant regulators42,43 as well as being building blocks in the synthesis of
natural products, such as alkaloids and terpenoids,44,45 and other biologically active compounds,
such as antitumour, antidepressant and antiviral agents (Scheme II-29).46,47
While a variety of methods exist for the preparation of enantiomeric pure γ- (five membered 
ring) and δ-lactones (six-membered), many of these rely on asymmetric induction from 
stoichiometric amounts of chiral auxialliary or chiral reducing agent, or require problematic
enzyme based reductions.48,47,49 The use of a metal-based catalyst to hydrogenate functionalised
ketones enantioselectively and subsequent intermolecular ring closing is an underdeveloped
technology, and only limited reports of such exists in the literature to date, making use of first
generation Noyori [Ru(P^P)L2] catalysts to enantioselectively hydrogenate β-ketoesters and γ-
ketoacids.50,51 To the best of our knowledge, enantioselective synthesis of δ-lactones from 
enantio-enriched hydroxy nitriles is unprecedented. Our plan was to employ the chiral
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secondary alcohol 237, prepared via enantioselective hydrogenation using catalyst (R,R)-174, in
a ring-closing reaction to prepare lactone 248, whilst maintaining the enantioselectivity
introduced in the hydrogenation step.
Scheme II-29 Examples of the cyclic ester motif in biologically active compounds including perfumery ingredients,
insect pheromones and compounds of pharmaceutical interest. 40,41,42,43,44,45,46,47
Scheme II-30 The intermolecular ring-closing of functionalised chiral alcohol 237 to
give the chiral δ-lactone 248. Reaction Conditions: 237 (1 eq.), KOH (5 eq.), ethylene
glycol, reflux, 24 h then 10% HCl (aq), 76%. The HPLC traces show the retention of
the high levels of enantioselectivity in the ring-closing step.
237, 74% e.e. 248, 74% e.e.
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It was pleasing to find that ring-closing to form the lactone 248 could be accomplished by
treating the chiral alcohol 237 with excess potassium hydroxide in ethylene glycol and refluxing
the mixture for 24 h. Subsequent treatment with 10% aqueous hydrochloric acid furnished the
desired product in good yield. Analysis of the product lactone by chiral HPLC, showed that
enantioselectivity was indeed retained during the ring-closing step (Scheme II-30).
Having developed a method for preparing enantio-enriched δ-lactones from the products of 
[RuCl2(P^N^N)]-catalysed enantioselective hydrogenation, it was felt worthwhile to widen the
scope of potential lactone products. It was envisaged that by making use of Noyori-type
[RuCl2(P^P)(N^N)] catalysts to prepare highly enantio-enriched chiral secondary alcohols
containing the nitrile functionality, a wider range of chiral lactone products could be prepared
using this approach. It was thus necessary to demonstrate the use of Noyori-type catalysts in
such protocols.
Ketone 252 was prepared in two good yielding steps from the vinyl ketone 249 (Scheme II-31),
making use of protocols developed by Wessig.52 The conjugate addition of the stabilised anion
of 250 to 249 yielded ketone 251 which underwent facile Krapcho decarboxylation to yield the
desired functionalised ketone 252.
Scheme II-31 Preparation of 5-oxo-5-phenylpentanenitrile 252. Reaction Conditions: (i) 249 (1 eq.), 250 (2 eq.),
K2CO3 (0.11 eq.), 18-crown-6 (0.12 eq.), THF, rt, 1 h; (ii) 251, NaCl (1.1 eq.), H2O, DMSO, reflux, 24 h, 62% over
two steps).
Despite the success of this methodology, it was felt that the development of a more
customisable route into ketones such as 252 from commercially available starting materials was
highly desirable (Scheme II-32). Making use of a method described in a very early patent,53
ketone 252 could indeed be prepared in one step from acetophenone via an amine-catalysed
Michael addition. This opens the door to a wide variety of analogues of 252 and this type of
organocatalytic Michael addition to acrylonitrile without over-addition would be an interesting
topic for further investigation. Ketone 252 prepared by both methods were used in subsequent
hydrogenation.
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Scheme II-32 Preparation of 5-oxo-5-phenylpentanenitrile 252 in one step from acetophenone 81. Reaction
Conditions: (i) acetophenone 81 (4 eq.), acrylonitrile 237 (1 eq.), cyclohexylamine (0.2 eq.), hydroquinone (0.02 eq.),
acetic acid, Δ, 16 h, 62%.
Attempts at the hydrogenation of substrate 252 employing Noyori-type catalysts 254-256 and
14 that had previously been shown to be active in the hydrogenation of a wide range of simple
aromatic ketones,54,55 proved to be unsuccessful, with low levels of conversion to product (Table
II-7, entries 1-5) even with more forcing conditions (entry 4). It was thought that the distal
nitrile functionality may lend to its use to efficient catalysis without the need for the diamine
component. However, attempts using [RuCl2((S)-BINAP]n 257 again proved futile (Entry 6).
Entry Catalyst PH2[bar] B:C
T
[C]
Conversion
(yield) [%] ee [%]
1 (S),(R,R)-254 50 50:1 50 5 nd
2 (S),(R,R)-255 50 50:1 50 <5 nd
3 (S),(S,S)-256 50 50:1 50 14 65
4 (S),(S,S)-256 70 50:1 70 21 56
5 (S),(S,S)-14 50 50:1 50 <5 nd
6 (S)-257 50 - 50 <5 nd
7 (S,S)-151 - - 40 0 -
8 (R,R)-174 50 2:1 50 14 54
9 (R,R)-174 70 2:1 70 >99 49
Table II-7 Hydrogenation of simple nitrile functionalised ketones. General conditions using H2-
hydrogenation catalysts: Ru catalyst (0.5 mol%), KOtBu (if required), iPrOH, H2, 16 h. Conditions
using transfer hydrogenation catalyst: Catalyst (S,S)-151, HCO2H (3 eq.), NEt3 (2.6 eq.), 3 d.
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The only literature examples of the hydrogenation of ketones with nitrile functionality, are
transfer hydrogenations using catalysts such as (S,S)-151.56,57 The transfer hydrogenation of 252,
using catalyst (S,S)-151 and formic acid/triethylamine as hydride source, was attempted but no
product was observed (Entry 7).
Since the [RuCl2(P^N^N)] catalytic system did show activity in the hydrogenation of the bulky
ketone 237 with distal nitrile functionality, it was decided to employ catalyst (R,R)-174 in the
hydrogenation of the simple derivative 252. Pleasingly, this proceeded quantitatively and in
49% e.e at 70 bar and 70C. Although enantioinduction was only moderate, these results are
significant as no other system was capable of the reduction of such ketones and thus has a
number of potential uses.
The nitrile functionalised alcohol 253 could be ring-closed to give the chiral δ-lactone 258 by
treatment at reflux with potassium hydroxide in ethylene glycol for 3 days followed by acidic
work-up (Scheme II-33). The level of enantioinduction was preserved throughout the process.
OH
CN
O
258
O
253
(ii)
Scheme II-33 The intermolecular ring-closing of
functionalised chiral alcohol 253 to give the chiral δ-lactone 
258. Reaction Conditions: 253 (1 eq.), KOH (5 eq.), ethylene
glycol, reflux, 3 d then 10% HCl (aq), 62%.
It has been demonstrated that using this hydrogenation/ring-closure methodology, both simple
chiral δ-lactones, and those with more sterically demanding substituents, can be prepared in 
moderate to good enantioselectivity from readily accessible starting materials. There is thus
potential to prepare a variety of valuable chiral lactone products. The tolerance of such catalysts
for a variety of electronically-distinct and heteroaromatic substituents, as well as the potential to
form different sized lactone rings, increases the scope of this methodology significantly
(Scheme II-34).
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Scheme II-34 Potential scope of asymmetric hydrogenation/ring-
closure technology in the preparation of highly enantio-enriched
lactone products employing [RuCl2(P^N^N)L] catalysts.
2.6 Conclusions
The current work has demonstrated the huge potential of [RuCl2(P^N^N)L] catalysts in
preparing a wide range of enantio-enriched chiral products. The current system is
complementary to the Noyori system, being particularly efficient in the enantioselectivity of
more bulky aromatic ketones, giving ee’s of up to 98%. The system is tolerant of a wide range
of electronically and sterically demanding substituents and can hydrogenate a wide range of
both aromatic and heteroaromatic substrates, giving rise to an exponentially large substrate
scope. The utility of the system has been demonstrated and has been shown to be effective in
the preparation of a number of synthetically useful chiral alcohols, whether it be for use as a
functionalised scaffold in medicinal chemistry, or to undergo further elaboration to give other
valuable chiral products such as lactones, or for use as chiral inducers in asymmetric synthesis.
2.7 Progression
While enantioselective hydrogenation with catalyst (R,R)-174 has allowed the preparation of a
range of important chiral products, scope still exists for the optimisation of catalyst structure to
prepare alcohols in close to enantiopurity. The modular nature of the ligand structure allows the
ligand to be tuned in a variety of ways to potentially improve reactivity and selectivity. It was
decided that in order to aid the rational design of new ligands, a better understanding of the
mechanism of hydrogenation by [RuCl2(P^N^N)L] catalysts, and the origin of enantioselectivity
in these reactions, must be gained through detailed experimental observations. A proposed
mechanism for hydrogenation using the [RuCl2(P^N^N)L] catalytic system, and the
experimental evidence which supports this, is described in full in Chapter III. The rational
design of new ligands, based on this improved mechanistic understanding, is subsequently
presented in Chapter IV.
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Chapter III
Towards Rational Catalyst Design: The Mechanism of Hydrogenation Using
[RuCl2(P^N^N)L] Catalysts and the Origin of Enantioselectivity
The work to date in this group has shown catalyst (R,R)-174 to be very effective in the
asymmetric hydrogenation of a variety of ketone substrates, tolerating a wide variety of
electronically and sterically demanding functionalities, and having the ability to prepare a range
of useful chiral products, inaccessible via other hydrogenation protocols. However, while
enantioselectivities in the reactions have been very encouraging - typically in the range 50-90%
for substrates with one ketone functionality - it is believed that optimisation of the catalyst
structure would lead to increased selectivity, approaching that needed to be generally appliable
(>90% e.e.).1 Also, more active catalysts are highly desirable due to the need for low catalyst
loading driven by economic factors.
PNR
N
R'2
Ru
Cl
Cl*
Chiral
backbone
P-N
linker
P-substituents
N-substituents
Ancillary
Ligand
Scheme III-1 The modular design of the
[RuCl2(P^N^N)L] catalyst (R,R)-174 allows for tuning at a
number of positions to facilitate catalyst optimisation. A
greater understanding of the reaction mechanism allows
this to be done more rationally from the development of
catalyst structure-activity relationships.
The modular ligand design employed in this research allows for the preparation of a range of
catalyst derivatives in order to improve activity and enantioselectivity (Scheme III-1). However,
rather than preparing a large library of new [RuCl2(P^N^N)L] catalysts, it was felt that an
investigation of catalyst structure-activity relationships would be of more benefit, leading to
rational catalyst design. In particular, we were interested in the role of the diamine component
of the ligand structure, since Noyori identified the primary diamine as crucial to activity and
enantioselectivity using [RuCl2(P^P)(N^N)] systems. This shall play a large part in an extensive
study into the mechanism of hydrogenation using [RuCl2(P^N^N)L] catalysts, with the principal
Enantioselective Hydrogenation Using Ruthenium Complexes Chapter III
of Tridentate Ligands Scott Phillips
81
aim of aiding the design of more active and selective catalysts for a wider range of ketone
substrates.
3.1 The Role of Diamine Component in Catalyst Productivity
The initial design of [RuCl2(P^N^N)L] catalyst (R,R)-174 envisaged hydrogenation would be
facilitated by the primary amine terminus of the ligand, in a coordination environment that is
more accessible for bulky substrates. However, the presence of a secondary amine component in
the ligand structure offers a second potential hydrogen bond donor for interaction with an
incoming ketone substrate, which could similarly facilitate hydrogenation via the bifunctional
mechanism. A third possibility exists that neither outer sphere mechanism is operational, and
the [RuCl2(P^N^N)L] system operates by a completely independent mechanism, perhaps via
coordination of the substrate to the metal centre itself. Knowledge of the precise mechanism by
which the catalytic system proceeds could allow rational tuning of the catalyst structure shown
in Scheme III-1.
In order to probe whether the terminal amine or the secondary amine component is responsible
for productivity in [RuCl2(P^N^N)L] catalysts, it was decided that a number of achiral
derivatives of catalyst (R,R)-174 would be prepared (Scheme III-2). We aimed to investigate the
effect of removing the hydrogen bond donor capacity of first the terminal NH2 group (Catalyst
264) and then both the terminal and secondary amine component (Catalyst 265), by the
incorporation of methyl groups at the requisite positions. The achiral derivative of catalyst
(R,R)-174, 263, was also prepared for a direct comparison with derivatives 264 and 265. This
was all done assuming that the increased steric bulk created by the appended methyl group had
little effect other than to block potential hydrogen bonding interactions.
PPh2NH
N
H2
Ru
Cl
Cl
S
O
PPh2NH
N
Me2
Ru
Cl
Cl
S
O
PPh2NMe
N
Me2
Ru
Cl
Cl
S
O
263 264 265
Scheme III-2 Achiral derivatives of the [RuCl2(P^N^N)L]
catalyst (R,R)-174 prepared to investigate the requirement for a
terminal or secondary amine component in the catalyst
structure, in terms of catalyst productivity.
It was envisaged that kinetic analysis of each catalyst in the hydrogenation of ,,-
trimethylacetophenone would shed light on the relative activity of each catalyst and would give
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clues as to the requirements of catalyst structure, in particular the diamine component, for
maximum TOF.
3.1.1 Synthesis of Catalysts
The new achiral ligands 263-265 were all prepared from commercially available starting
materials. Ligand 263 was prepared following a procedure performed previously in this group
by Lamb,2 by careful dropwise addition of a solution of 2-(diphenylphosphino)benzaldehyde
266 in degassed ethanol to a dilute solution of ethylenediamine 267 also in degassed ethanol,
and the reaction mixture stirred under a nitrogen atmosphere (Scheme III.3). It was ensured that
diamine 267 was present in a suitably large excess to prevent the undesired difunctionalisation
of the diamine. Monitoring of the reaction mixture by 1H and 31P NMR spectroscopy showed
the disappearance of signals corresponding to 2-(diphenylphosphino)benzaldehyde 266 (δH
(C6H6) = 10.3 ppm (CHO, d, J 5), δP (C6H6) = -10.8 ppm) and the appearance of a signals at δH
(C6H6) = 9.51 ppm (CH=N, d, J 4) and δP (C6H6) = -12.0 ppm corresponding to that of the imine
species. Complete conversion of 2-(diphenylphosphino)benzaldehyde 266 to the imine was
accomplished after 5 h. The imine was reduced to the secondary amine by addition of sodium
borohydride to the mixture and was complete within 12 h. This was indicated by the
disappearance of the signal corresponding to the CH=N proton of the imine species in the 1H
NMR spectrum, and the appearance of a new signal at -16.0 ppm in the 31P NMR spectrum,
corresponding to the reduced species 268. Careful aqueous work-up under a nitrogen
atmosphere, removed the excess ethylenediamine furnishing ligand 268 in 72% yield and in
sufficient purity (>95%) for complexation. An analytically pure sample for characterisation
could be obtained by formation of the hydrochloride salt of the ligand and crystallisation from
dichloromethane.
Scheme III-3 The synthesis of complex 263, the achiral derivative of the original
[RuCl2(P^N^N)L] catalyst 174. Reaction conditions: 2-(diphenylphosphino)benzaldehyde
266 (1 eq.), ethylenediamine 267 (3 eq.), EtOH, 45C → rt, 5 h; (ii) NaBH4 (4 eq.), EtOH,
rt, 12 h; (iii) 268 (1 eq.), [RuCl2(DMSO)4] (1 eq.), THF, μw, 120C, 20 min.
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Complexation of ligand 268 was successfully accomplished employing the microwave-assisted
protocol developed in this group.3 Ligand 268 and [RuCl2(DMSO)4] were dissolved in degassed
THF in an inert environment and microwave heating for 20 min at 120C resulted in the
quantitative conversion to complex 263. Complexation was confirmed by the appearance of a
signal with a downfield shift in the 31P NMR spectrum at +44.5 ppm (CDCl3) and disappearance
of the signal corresponding to the unbound ligand at -16.1 ppm (CDCl3). Signals corresponding
to the protons upon carbon atoms adjacent to the coordinating nitrogens are also shifted
downfield when the ligand is bound to ruthenium. Each of these protons also becomes
inequivalent due to the formation of the stereogenic centre at the secondary amine atom in the
complex and thus individual signals appear for each. The one dimethylsulfoxide molecule that
remains bound to the ruthenium centre becomes desymmetrised as a result of this and signals
corresponding to the two methyl groups appear at 2.98 and 2.56 ppm in the 1H NMR. This
pattern is characteristic of complexes with meridional P^N^N and DMSO ligands, with chloride
ligands occupying the remaining axial positions. All NMR observations were consistent with
that seen for catalyst 174, for which an X-ray crystal structure has been obtained, giving us
confidence that the coordination mode of ligands are analogous to that of the original catalyst,
and as shown in Scheme III-3. Accurate mass analysis of the pure complex confirmed the
molecular ion ([M+Na]+) to be that of the desired complex, with an excellent match to the
theoretical isotope model.
The dimethylated ligand 270 was prepared in a similar manner to that of ligand 268, although
without the possible complications of difunctionalisation of the diamine. Thus, equimolar
amounts of N’N’-dimethylethylenediamine 269 and 2-(diphenylphosphino)benzaldehyde 266
were dissolved in degassed ethanol and the reaction mixture stirred at room temperature
(Scheme III-4). Again the reaction was monitored by 1H and 31P NMR spectroscopic analysis of
the crude reaction mixture and the characteristic signals are presented in Scheme III-4. After
aqueous work-up, the ligand was deemed of good purity and reacted immediately with
[RuCl2(DMSO)4], giving analytically pure complex 264 in 95% yield after column
chromatography. Similar trends in the spectroscopic data were observed to those described for
complex 263, supporting the assignment.
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Scheme III-4 The synthesis of complex 264, the dimethylated derivative of complex 263.
Reaction conditions: 2-(diphenylphosphino)benzaldehyde 266 (1 eq.), N’,N’-
dimethylethylenediamine 269 (1 eq.), EtOH, rt, 5 h; (ii) NaBH4 (4 eq.), EtOH, rt, 12 h; (iii)
270 (1 eq.), [RuCl2(DMSO)4] (1 eq.), THF, μw, 120C, 20 min.
Recrystallisation by vapour diffusion from CHCl3/hexane gave crystals of 264 which despite
being small allowed X-ray diffraction studies to be conducted by Prof. Alexandra Slawin. The
representation of the molecular structure that was produced (Figure III-1, (a)) supports the
expected ligand coordination mode to ruthenium, where the P^N^N ligand is coordinated in a
meridional manner with a sulfur-bound dimethylsulfoxide molecule occupying the final
meridional site. Chloride ligands in a trans-relationship are present at the remaining coordination
sites. An interesting molecular structure was observed when the complex was crystallised from
acetonitrile (Figure III-1, (b)). The dimethylsulfoxide ligand was replaced by a nitrogen bound
acetonitrile molecule, with the chloride ligands now having a cis-relationship. This suggests that
the DMSO ligand is labile and may not remain bound to the metal centre throughout catalysis.
Figure III.1 (a) Representation of the molecular structure of 264, from X-ray diffraction studies, supporting the
expected coordination mode of the ligands. Two molecules of chloroform omitted for clarity. (b) Representation of the
molecular structure of the complex that was crystallised from acetonitrile.
(a) (b)
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A modified procedure was required in order to furnish ligand 265 containing methyl groups
both on the primary and secondary amine component. The original methodology failed to
promote the full conversion to the intermediate iminium species. The transformation was
accomplished by the direct reductive amination of 2-(diphenylphosphino)benzaldehyde 266 and
N,N’,N’-trimethylethylenediamine 271 in dichloromethane, employing sodium
triacetoxyborohydride as the reducing agent and acetic acid as the proton source. The mixture of
these components was stirred at room temperature for 4 hours, after which 1H and 31P NMR
spectroscopic analyses showed the complete conversion of aldehyde to a new species at δP = -
17.8 ppm (C6D6). Flash chromatography, using a basic triethylamine/acetone mixture as eluting
solvent, allowed the separation of the product from the reaction mixture and ligand 272 was
obtained in high yield. Complexation was accomplished in a straightforward manner as before
using [RuCl2(DMSO)4] as metal precursor, and flash chromatography of the crude product
yielded analytically pure complex 265 for use in catalysis. Complex 265 appeared to be
somewhat unstable in solution in acetone and column fractions needed to be concentrated
immediately to give pure material.
Complexation was again indicated by the downfield shift of the signal in the 31P NMR spectrum
to δP (CDCl3) = + 49.7 ppm and the characteristic pattern of signals corresponding to
inequivalent DMSO methyl groups in the 1H NMR spectrum (CDCl3) at 2.80 and 2.40 ppm.
Accurate mass analysis on the molecular ion was not possible for this complex despite being
identified in low resolution studies. However, it was possible to obtain accurate mass for the
fragment [M-DMSO-Cl]+, a common fragmentation mode for such complexes.
Scheme III-5 The synthesis of complex 265, the trimethylated derivative of complex
265. Reaction conditions: 2-(diphenylphosphino)benzaldehyde 266 (1 eq.), N,N,N’-
trimethylethylenediamine 272 (1 eq.), NaBH(OAc)3 (1.5 eq.), AcOH (3 eq.), DCM;
(ii) 273 (1 eq.), [RuCl2(DMSO)4] (1 eq.), THF, μw, 120C, 20 min.
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Each of the new complexes were used in subsequent kinetic studies as analytical pure material,
together with pure samples of catalyst (R,R)-174 which was prepared according to the original
procedures.3
3.1.2 Hydrogenation of ,,-Trimethylacetophenone
It was found that each complex – the original catalyst (R,R)-174, the achiral derivative 263, and
the di- and tri- methylated derivatives 264 and 265 repectively – all hydrogenated the bulky
ketone 165 quantitatively within 16 hours at 50C and 50 bar hydrogen pressure, with a 0.5
mol% base loading. These initial findings were intriguing as it is generally accepted that
hydrogenation with related Noyori catalysts of the type [RuCl2(P^P)(N^N)] requires a terminal
amine functionality to be productive, and the same was anticipated to be true for the
[RuCl2(P^N^N)L] system.
Kinetic analysis of the hydrogenation of ,,-trimethylacetophenone using each of the
catalysts was undertaken using data obtained from specialist pressure equipment whereby the
hydrogen consumption was measured over the course of the reaction. As hydrogen gas was
consumed in the reaction vessel, it was replaced from a linked burette containing an elevated
hydrogen pressure, separated from the main vessel by a non-return valve, thus maintaining the
desired pressure in the reaction vessel. The decrease in hydrogen pressure in the burette
‘reservoir,’ corresponding to that uptaken by the reaction mixture, was monitored using an
electronic probe and visualised through Picolog software.
Prior to commencing each experiment, it was necessary to check the system for the presence of
leaks, due to the high pressures typically involved. A control experiment was thus carried out
before each experiment, over a period of no less than one hour, to make sure no hydrogen was
‘consumed,’ i.e. leaked from the system, at the desired pressure and temperature. Once the
system was acscertained to be leak-free, the reaction mixture – composed of the requisite
catalyst, the ketone substrate and isopropanol under a nitrogen atmosphere – was first injected
with potassium tert-butoxide to initiate the reaction, then immediately transferred to the
autoclave (depressurised to allow transfer of the reaction mixture, under a hydrogen
atmosphere), which was subsequently repressurised. Experiments were carried out with 70 bar
pressure of hydrogen gas in the autoclave, and an initial pressure of 100-120 bar hydrogen gas
in the burette. This was found to be optimal conditions for the comparison of the activity of the
Enantioselective Hydrogenation Using Ruthenium Complexes Chapter III
of Tridentate Ligands Scott Phillips
87
four catalysts. Measurement of hydrogen consumption was commenced immediately after
repressurisation with hydrogen and continued until no more hydrogen was consumed.†
The crude data for hydrogen consumption was normalised by assuming 100% conversion of
ketone to alcohol product at maximum hydrogen uptake, and this was checked by 1H NMR
spectroscopy of the crude reaction mixture. Crude reaction profiles of conversion versus time
allows a qualitative comparison of each of the four catalysts used in this study, and from such
plots average initial turnovers frequencies were abstracted for a quantitative comparison.
Processing of the crude data allowed the reaction rate to be plotted over the course of the
reaction profile. This gave more clear insights into individual events of the catalystic cycle, i.e.
the induction period of each catalyst, the point at which maximum TOF is reached and its
magnitude, and the point at which catalyst decomposition becomes evident. To give an
approximation of reaction order with respect to substrate concentration, and the rate constant
for each reaction, the data were also processed as ‘graphical rate equations’ as proposed by
Blackmond in her work on reaction profile kinetic analysis.5 The assignment of reaction order
was substantiated by the classical fitting to the requisite rate equation.6
The unprocessed reaction data for hydrogenation of ,,-trimethylacetophenone, together with
average initial turnover frequencies for each of the four complexes are presented in Figures III-
2 and III-3. Comparison of the performance of each catalyst shows that the original catalyst
(R,R)-174 turns over substrate quickest with the reaction complete in 50 min with an initial
average TOF of 350.46 mol prod.mol cat-1.h-1. This is in good agreement with a previous limited
study which showed the reaction to be complete in approximately 40 min under similar
conditions.4
Figure III-2 Reaction profiles from unprocessed data
for the hydrogenation of ,,-trimethylacetophenone
with complex (R,R)-174, complex 263, complex 264
and complex 265. Reaction conditions: ,,-
trimethylacetophenone (0.615 mol l-1), Ru complex
(0.5 mol%), potassium tert-butoxide (1 mol%), iPrOH
(20 mL), H2 (70 bar), 70C.
‡
† Although theoretically the reaction may have commenced prior to pressurisation with hydrogen due to
transfer hydrogenation processes, these were deemed negligible as previous work has shown pressure
hydrogenation to be the dominant factor in this system.4 All attempts were made to ensure quick transfer
of the reaction mixture to the autoclave immediately once potassium tert-butoxide solution was added to
initiate the reaction.
‡ No product was observed in the absence of catalyst.
(R,R)-174
263
265
264
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There is a significant drop in activity going from catalyst (R,R)-174 to its achiral variant catalyst
263. The reaction goes to completion in around 5.6 hours, nearly 7 times longer than catalyst
(R,R)-174, and turns over at 106.27 mol prod.mol cat-1.h-1. The decrease in productivity going
from catalyst (R,R)-174 to catalyst 263 suggests importantly that the shape of the catalyst, and
perhaps the geometry at the ruthenium centre, has a very significant influence on catalyst
productivity (this will be discussed more in chapter IV). Unpublished work by Fuentes and
Clarke has also demonstrated that productivity is diminished even further by substituting the 2
carbon backbone of catalyst 263 for a 3 carbon backbone, further supporting the proposition that
a well-defined geometry at ruthenium is important for productivity. These observations suggest
that if an N-H bond (whether it be secondary or terminal) is crucial for productivity then its
orientation, controlled by the geometry around ruthenium, is also salient.
Replacing the NH2 on complex 263 for a NMe2 group (catalyst 264) gives a catalyst with very
similar average intial TOF (114.66 mol prod.mol cat-1.h-1). However, this catalyst takes longer
to reach completion (7.8 h, off-scale), likely due to catalyst decomposition events. The
similarity of the reaction rates of catalyst 263 and 264, suggest that a terminal NH2 is not of
critical importance to turnover. This is surprising due to the fact that Noyori states that a
terminal NH2 group is crucial for activity in hydrogenation with the closely related
[RuCl2(P^P)(N^N)] system.7,8 These observations cast significant doubt upon the primary
amine-assisted transition state that would have seemed likely with [RuCl2(P^N^N)L] catalysts
and point toward the secondary NH component being important to productivity.
Of most surprise, was that catalyst 265, containing no N-H containing groups at all for
association with an incoming substrate, should catalyse hydrogenation of unfunctionalised
ketones. The premise of Noyori’s work was that in order for such a reaction to take place, a
secondary binding point, i.e. a N-H group to form a hydrogen bond, must be available, thus
orienting the substrate in the correct manner for successful transfer of hydride. Despite this, the
trimethylated catalyst 265, successfully catalysed the hydrogenation of ,,-
Figure III-3 Average initial turnover frequencies for
the hydrogenation of ,,-trimethylacetophenone
measured over the first 2000 s. Reaction conditions
as described in Figure III-2.
(R,R)-174 263 264 265
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trimethylacetophenone, albeit after a prolonged reaction time compared to the catalysts
containing hydrogen bond donors. The reaction was complete after 18.6 hours (offscale).
3.1.3 Kinetic Analysis of Hydrogenation with Catalyst (R,R)-174
More detailed kinetic analysis of the hydrogenation of ,,-trimethylacetophenone with each
catalyst provided further information about the reaction profile, in particular individual events
that make up the catalytic process. Kinetic analysis of the reaction using catalyst (R,R)-174 is
presented in Figure III-4. Scrutiny of the reaction rate over time (Figure III-4 (c)), constructed
from the data in plots (a) and (b), shows that the reaction rate increases to a maximum around
600 s (20% of the total reaction time) after initiation of the reaction. By referring back to graph
(a), the maximum turnover frequency can be abstracted by differentiation of the curve around
this point and was shown to be 655 moles of product per mole of catalyst per hour. Although
this is two orders of magnitude slower than the best [RuCl2(P^P)(N^N)] catalysts in the
hydrogenation of acetophenone,7,8 it is worth reiterating that such catalysts are practically
inactive for the hydrogenation of ,,-trimethylacetophenone. Graph (c) also presents clearly
an induction period in the first 600 s of the reaction as the reaction rate gradually rises towards
its maximum. It is believed that this induction period involves the formation of ‘real’ catalyst
from the precatalyst (R,R)-174. The nature of the ‘real’ catalyst will be discussed further in
section 3.4.
Processing the data as a graphical rate equation (graph (d)) gives further kinetic information
about the reaction. Excluding the induction period, it can be seen that the reaction follows
positive order kinetics, with the rate increasing as substrate concentration increases. The data
has a good fit to the first order integrated rate equation (graph (e), k = 0.002 s-1, R2 = 0.99). We
can say that the reaction with catalyst (R,R)-174 is following pseudo-first order kinetics, if we
incorporate the catalyst concentration, base concentration and hydrogen concentration – which
are all assumed to be constant throughout the reaction – into the rate constant. The rate law for
such reactions, if we assume that the reaction is practically irreversible due to the abundance of
isopropanol to take part in the reverse reaction, takes the form:
 2211 ]H[][][][
][ kbasecatksubstratek
dt
substrated zyx (1)
The operation of first order kinetics is insightful as it suggests that the reaction is limited by an
event involving the substrate, and not by the harnessing of molecular hydrogen. This suggests
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that either the association of the substrate with the catalyst, the transfer of the hydride to the
substrate, or the release of the substrate after hydride transfer is implicit is limiting the reaction.
3.1.4 Kinetic Analysis of Hydrogenation with Catalyst 263
By conducting similar kinetic analysis on the hydrogenation of ,,-trimethylacetophenone
using the achiral derivative 263, it can be seen that the reaction profiles are very similar, albeit
progressing more slowly towards completion (Scheme III-5).
Figure III-4 Kinetic analysis of the hydrogenation
of ,,-trimethylacetophenone employing
complex (R,R)-174. Reaction conditions: ,,-
trimethylacetophenone (0.615 mol l-1), complex
(R,R)-174 (0.5 mol%), potassium tert-butoxide (1
mol%), iPrOH (20 mL), H2 (70 bar), 70C.
(a) (b)
(c) (d)
(e)
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Processing of the data in graphs (a) and (b) gives the plot of rate against time shown in graph
(c). From this we can see that the maximum rate is achieved after approximately 2000s and the
TOF at this point can be calculated, as before, to be 652 mole product per mole catalyst per
hour. This is broadly similar to the maximum rate achieved by the original catalyst (R,R)-174.
However, it can be clearly seen that a longer induction period is involved (first 2000s) and the
Figure III-5 Kinetic analysis of the hydrogenation of ,,-
trimethylacetophenone employing complex 263. Reaction conditions:
,,-trimethylacetophenone (0.615 mol l-1), complex 263 (0.5
mol%), potassium tert-butoxide (1 mol%), iPrOH (20 mL), H2 (70
bar), 70C.
(a) (b)
(c) (d)
(e)
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reaction takes longer to proceed to completion. This implies that the shape of the catalyst, and
geometry around Ru, are important both during the induction period, i.e. for formation of the
real catalytic species, and in catalysis itself.
Observing the graphical rate equation (graph d), it can be seen that positive order kinetics are
being followed and the data has a good fit to the first order rate equation (k = 0.0003 s-1, R2 =
0.98, graph (e)), bearing in mind previous assumptions. We can consider catalyst 263 as also
following the rate law set out in equation (1). These results suggest that like catalyst (R,R)-174,
the rate of reaction with catalyst 263 is limited by an event involving the ketone substrate.
Further to this, since similar kinetics appear to be observed (suggesting a similar reaction
mechanism), this supports our proposition that the shape of the catalyst and geometry around Ru
is important for the productivity of such catalysts as the rate constant for the reaction is roughly
one order of magnitude less compared to catalyst (R,R)-174.
3.1.5 Kinetic Analysis of Hydrogenation with Catalyst 264
Kinetic analysis was also carried out for the reaction with the dimethylated complex 264.
Observing the plot of rate versus time (Scheme III-6, graph (c)), constructed from data in graphs
(a) and (b)), it can be seen that the maximum TOF occurs after 2000 s and is slightly diminished
compared to catalysts (R,R)-174 and 263, turning over at 403 mol prod.mol cat-1.h-1. The
induction time of 2000s is similar to that of catalyst 263 suggesting that the presence of methyl
groups on the terminal amine has no effect on the formation of the active catalyst. This plot also
shows that while broadly similar rates of reaction are observed to catalyst 263 there is a
dramatic drop in catalyst activity after 4000 s, perhaps due to catalyst
deactivation/decomposition. Data obtained in the early part of the reaction (2000-4000 s) and
the latter part (13000-28500 s) do hint at the presence of pseudo-first order kinetics (more
obvious in graph (d)) and the data does have a fit to the first order rate equation albeit with a
reduced R2 value. However, positive order kinetics appear to be predominant and again this
suggests that the reaction is limited by an event involving the substrate.
The similarities in the behaviour of catalyst 264, containing the primary amine functionaility,
and catalyst 263, without such, argues that the terminal amine is not as important to productivity
in this system as one would expect from knowledge of the Noyori system. Although this system
is complicated by the decomposition/dramatic slowing of reaction rate, the most substantial part
of the reaction behaves similar to the NH2 catalyst 263. In particular, the first 50% of the
reaction is similar, which would seem to rule out demethylation of the ligand, and the NH2
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species operating. This points towards the potential involvement of the secondary amine
function in a bifunctional mechanism as it would allow the well-defined transition state required
both for productivity (see previous section) and for high enantioselectivity. Work in this
laboratory by Fuentes and Clarke has also shown that replacing the terminal NH2 in the original
catalyst 174 for a hydroxyl group gives an equally efficient catalyst with marginally enhanced
enantioselectivities (Table III-1), supporting this hypothesis.9
O OH
159 273
264
N
Me2
NH PPh2
Ru
Cl
Cl S
O
Figure III-6 Kinetic analysis of the hydrogenation of ,,-
trimethylacetophenone employing complex 264. Reaction conditions:
,,-trimethylacetophenone (0.615 mol l-1), complex 264 (0.5 mol%),
potassium tert-butoxide (1 mol%), iPrOH (20 mL), H2 (70 bar), 70C.
(a)
(c)
(b)
(d)
(e)
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Entry Catalyst Ketone R= Conversion(yield) [%] ee [%]
1 (R,R)-174 81 Me >99 (99) 0
2a (R,R)-274 81 Me >99 (99) 15
3 (R,R)-174 82 iPr 93 48 (S)
4a (R,R)-274 82 iPr 99 (97) 52 (S)
5 (R,R)-174 159 tBu >99 (99) 74 (S)
6b (R,R)-274 159 tBu 98 80 (S)
Table III-1 Comparison of the hydrogenation of ,,-
trimethylacetophenone with complex (R,R)-1743 and (R,R)-2749,10 (work
carried out by Fuentes and Clarke). Reaction conditions: ,,-
trimethylacetophenone, complex (R,R)-174 or (R,R)-274 (0.5 mol%),
potassium tert-butoxide (1 mol%), iPrOH, H2 (50 bar), 50C, 3 h. a 2.5
mol% KOtBu. b 5 mol% KOtBu.
3.1.6 Kinetic Analysis of Hydrogenation with Catalyst 265
Finally, the hydrogenation of ,,-trimethylacetophenone with the trimethylated complex 265
was subjected to kinetic analysis. It can be seen by first glance at the reaction profile (Scheme
III-7,graph (a)) that the reaction follows different kinetics from the preceding three catalysts,
and there seems little dependency of rate upon substrate concentration. Indeed, there is a good
fit of the data to the classic zero order raw equation as shown in graph (b).6 Although the rate
remains fairly constant throughout the reaction, in the initial period it is slower with an average
initial TOF of 35 mol prod.mol cat-1.h-1, rising to 187 mol prod.mol cat-1.h-1 as the reaction nears
completion. This is perhaps due to an elongated induction period. The graphical rate equation
shows more clearly that reaction rate is independent of ketone concentration and that the
reaction likely follows pseudo-zero order kinetics. This proposal is supported by separate batch
experiments carried out at different concentrations of ketone substrate. The data, presented in
graph (d) also shows that the rate is independent of the concentration of the substrate. The
kinetics for hydrogenation with catalyst 265, outwith the induction period, can be expressed:
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 2211 ]H[][][
][ kbasecatkk
dt
substrated zyx (2)
These findings suggest that hydrogenation with catalyst 265 follows a different mechanism to
that employed by the catalysts containing NH hydrogen bond donors. Rather than being limited
by an event involving the substrate, it is more likely that the reaction is limited by another
process, perhaps by the harnessing of molecular hydrogen. This may implicate the presence of a
hydrogen bond donor in the activation of hydrogen with the original catalyst (R,R)-174, as has
already been suggested.
3.1.7 Hydrogenation with Other Catalysts with No Hydrogen Bond Donors
The observation that catalyst 265 with no hydrogen bond donors still catalyses the
hydrogenation of ,,-trimethylacetophenone with zero order dependence on substrate was
intriguing and it was felt worthwhile exploring Noyori-type catalysts without hydrogen bond
donor groups to compare their activity with catalyst 265. A search of current literature only
furnished one example of a [RuCl2(P^P)(N^N)] catalyst which was shown to efficiently catalyse
the hydrogenation of unfunctionalised ketones despite having no H-bond donors. Bergens and
Figure III-7 Kinetic analysis of the hydrogenation of
,,-trimethylacetophenone employing complex 265.
Reaction conditions: ,,-trimethylacetophenone (0.615
mol l-1), complex 265 (0.5 mol%), potassium tert-
butoxide (1 mol%), iPrOH (20 mL), H2 (70 bar), 70C.
(a) (b)
(c) (d)
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coworkers reported that complexes such as 277 and 278 could catalyse the hydrogenation of
acetophenone and 1’-acetonaphthone (Scheme III-6).11,12 The small but significant e.e. values in
these reactions – the correct values are published in an erratum to reference 12 - suggest that
enantioselectivity is induced in a different manner to Noyori catalysts conataining N-H
hydrogen bond donors.
P
P
Ru
Cl
Cl
N
N
277, P^P = (S,S)-279
278, P^P = (R,S)-280
Ar
O
Ar
OH
12, Ar = Ph,
cat 277, >99% (24 h)
e.e.= 48% (R)
276, Ar = 1-Naphth
cat 278, 96% (48 h)
e.e.= 14% (R)a
(i)
PPh2
PPh2
279
(S,S)-Skewphos
FePh2P
PCy2
280
(R),(S)-Josiphos
81, Ar = Ph
275, Ar = 1-Naphth
Schemee III-6 Hydrogenation of unfunctionalised ketones with catalysts not
containing N-H hydrogen bond donors.11,12 Reaction conditions: 81 or 275, catalyst
277 (0.2 mol%) or 278 (0.04 mol%), potassium tert-butoxide (4 eq. per Ru), iPrOH,
H2 (4 bar), 60C. a The e.e. was initially reported as 98% (S) but later corrected.
It was decided to prepare complex 285 by methods already described by the groups of
Wilkinson13 and Bergens12 (Scheme III-7) in order to examine its behaviour in the
hydrogenation of acetophenone. It was found that the final step could be more conveniently
carried out using microwave assisted heating for 1 hour and subsequent crystallisation of the
precipitate from dichloromethane/hexane. This gave small orange crystals which gave a single
signal in the 31P NMR spectrum at +41.0 ppm (CDCl3)( lit.12 +40.9 (CD2Cl2)), that were of
analytical purity as determined by microanalysis.
P
P
Ru
Cl
Cl
N
N
Ph2
Ph2
Ru
Cl
Cl
N
N
Ru
Cl
Cl
HN
NH
RuCl2
n
RuCl3.xH2O
(i) (ii) (iii) (iv)
285284283282281
69%65 % (2 steps)80%
Scheme III-7 The synthesis of the ‘non-NH’ Noyori-type catalyst 285.11,12, Reaction conditions: (i) 281,
norbornadiene, EtOH, rt, 24 h; 13 (ii) 282, piperidine, acetone, rt, 16 h;12 (iii) 283, pyridine, CH2Cl2, rt, 2 h;12 (iv) 284,
(R)-BINAP, CHCl3, μW, 120 C, 60 min.
It was found that catalyst 285 was active in the hydrogenation of acetophenone - a substrate the
catalysts of the type [RuCl2(P^P)(N^N)] typically hydrogenate with high TOF and in high
selectivity -with 91% conversion being obtained after 5.5 h, giving an average TOF of 33 mol
prod.mol cat-1.h-1, several orders of magnitude slower than the best N-H containing catalysts.8
This process gave a modest e.e. of 15%. The performance of complex 285 in the hydrogenation
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of acetophenone was examined at different substrate concentrations in batch experiments and,
akin to hydrogenation with catalyst 265, it was found that reaction rates appeared to have no
dependence upon ketone concentration (Figure III-8).
These results show that the reactions are pseudo-zero order in ketone concentration, and this is
in contrast to the kinetics described for [RuCl2(BINAP)(DPEN)] which shows pseudo-first
order kinetics under similar conditions.§ Like in hydrogenation with catalyst 265, hydrogenation
with catalyst 285 is not limited by a ketone binding/reduction process, and in terms of activity, a
hydrogen activation step is the most important feature. This work also potentially opens the
door to a new variety of non-NH catalysts, once potential problems with hydrogen activition are
overcome.
3.1.8 Hydrogenation of Styrene
It was felt worthwhile exploring the activity of each of the four catalysts in the hydrogenation of
substrates which are thought to operate by a different mechanism. The hydrogenation of
unfunctionalised alkenes by ruthenium complexes is thought to proceed exclusively via an inner
sphere mechanism whereby the alkene coordinates directly to the metal centre.15 Simple alkenes
do not have hydrogen bond acceptors to form ligand-substrate interactions in the outer sphere.
We therefore postulated that the presence/absence of hydrogen bond donor groups would have
no effect upon the hydrogen transfer step of the hydrogenation of alkenes such as styrene. The
activation of hydrogen could involve the NH functionality (and so similar ligand effects as
before) or could be completely independent of the NH function since there is no longer such
potential for acid/base chemistry.
It was found that hydrogenation of styrene with each of the four catalysts proceded to full
conversion within 12 hours (Scheme III-9, graph (a)). The initial and maximum turnover
§ First order kinetics are observed, but at very low catalyst loadings these can become independent of
ketone.14
Figure III-8 Kinetic analysis of the hydrogenation of
acetophenone employing complex 285. Reaction
conditions: acetophenone, complex 285, potassium tert-
butoxide (2 equiv. per Ru), iPrOH, H2 (50 bar), 50C, 2h.
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frequencies (Graphs (b) and (c) respectively) are very similar for each of the four catalysts, with
the presence or absence of NH2 functionality having no effect upon reaction rate.
These results argue that the effect of the secondary NH group (and the sensitivity to ligand
shape) is specific for ketone hydrogenation where an outer sphere bifunctional mechanism can
take place. From this, it is likely that the alkene hydrogenation catalytic cycle shares little with
that of ketone hydrogenation, with the cycle operating being relatively insensitive to ligand
structure.
3.1.9 Summary
From the rigorous kinetic analysis outlined, a number of proposals can be made:
1. The shape of the catalyst/geometry at Ru is crucial for productivity in ketone
hydrogenation. It has been shown that going from the original catalyst 174 to its achiral
derivative 265 has a significant impact on productivity.
2. The terminal NH2 is not important to productivity; the secondary N-H is implicated.
Blocking the hydrogen bonding capacity of the terminal amine (catalyst 264) has negligible
impact on productivity compared to catalyst 263, but blocking both the secondary and
terminal amines (catalyst 265) significantly reduces productivity. The induction times are
286 287
PPh2NR
N
R2
Ru
Cl
Cl
S
O
Figure III-9 Kinetic analysis of the hydrogenation of
styrene employing complexes 174, 263, 264 and 265.
Reaction conditions: styrene, Ru complex (0.5 mol%),
potassium tert-butoxide (1 mol%), iPrOH, H2 (70 bar),
70C. Graph (b) shows initial average turnover frequency
for each catalyst (first 2000 s) and Graph (c) shows the
maximum turnover frequency.
(a)
(b) (c)
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similar for catalysts with a NH function but are elongated in the absense of a secondary
amine. We propose that the secondary amine is important in the binding/reduction of the
ketone substrate, which limits the rate of these reactions and this secondary amine also
facilitates hydrogen activation significantly. Work carried out by Fuentes and Clarke9 in this
group has also demonstrated that derivatives of the original catalyst 174 containing a
hydroxyl group in the place of the primary amine group, can catalyse the reduction of ,,-
trimethylacetophenone quantitatively in 3 hours, with enantioselectivity marginally higher
than with the original catalyst. This suggests that this catalyst operates by the same
mechanism as the original catalyst and supports our conclusion that the terminal amine is not
responsible for catalyst productivity (or enantioselectivity) and that the secondary NH is
perhaps more important.
3. Non-NH catalysts can still catalyse hydrogenation of unfunctionalised ketones; a
different mechanism is operational. Catalyst 265 is still productive but with slower TOFs
then NH containing catalyst. Rates are not limited by ketone binding/reduction suggesting
that another process is severely hampered by the lack of an NH, most likely the activation of
hydrogen.
4. The ketone hydrogenation cycles using all four catalysts are likely to have a different
mechanism than alkene hydrogenation, which we would suggest is a classic inner
sphere hydrogenation.
3.2 The Role of Base
Hydrogenation of unfunctionalised ketones using [RuCl2(P^P)(N^N)] catalysts is highly
dependent upon base concentration. Noyori has suggested that base plays an important role not
just in formation of the real catalytic species but also in accelerating the catalytic cycle itself
(Chapter II, section 1.5.1). It was felt in order to get a better understanding of the mechanism of
hydrogenation employing [RuCl2(P^N^N)L] catalysts, it would be remiss not to include a more
detailed study of concentration effects upon catalyst activity. Previous work in this group4
demonstrated, in a limited study, that at least two equivalents of potassium tert-butoxide were
required in order for the reaction with catalyst (R,R)-174 to proceed at 50C and 50 bar
hydrogen pressure,. Using less than 2 equivalents resulted into no reaction occurring. This
suggests that the 2 equivalents of base are required to form the real catalysts from precatalyst
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due to the apparent non-linear relationship between productivity and base concentration at base
concentrations less than 2.
It was felt worthwhile to examine the behaviour of the reaction at increased base concentration
to determine whether elevation of base has effect on the turnover of the catalytic cycle itself.
Noyori observed that reaction rates increase towards a maximum when the base to catalyst ratio
is 20 and suddenly drops at higher concentrations (Chapter I, Figure I-2). Hydrogenation of
,,-trimethylacetophenone using catalyst (R,R)-174 was thus carried out with base loading in
the range 2-20 equivalents per ruthenium complex, and the reaction mixture was sampled
throughout the course of the reaction to determine the reaction profile (Scheme III-10).
Figure III-10 Reaction profiles of the hydrogenation of ,,-trimethylacetophenone with complex (R,R)-174, with
2-20 equivalents of base with respect to catalyst in (a) the first 16 h and (b) the first 8 h. Reaction conditions: ,,-
trimethylacetophenone, complex (R,R)-174 (0.5 mol%), potassium tert-butoxide (1-10 mol%), iPrOH, H2 (50 bar),
50C.
From graphs (a) and (b) is can be seen that increasing the base loading from 2 to 10 equivalents
per ruthenium leads to a reduction in the time taken for the reaction to go to completion.
Increasing this further to 20 equivalents however results in a loss of activity and the reaction is
still uncomplete after 16 hours.
A closer look at the reaction profiles using 2 and 10 equivalents indicates that pseudo-first order
kinetics are still in operation and substrate concentration is still limiting turnover. Rates of
reaction in the initial part of the reaction (first 20%) seem to be very similar at both base
loadings but further base, beyond the two equivalents needed to form the active species, do not
speed up the induction period. It appears that increasing the base loading increases turnover
after the induction period, implicating base effects in the catalytic cycle itself. However, when
even more base is used, 20 equivalents relative to ruthenium complex, the rate of reaction is
significantly diminished. A potential explanation for these observation is perhaps that the
addition of base facilitates deprotonation of a hypothetical dihydrogen complex giving active
(a) (b)
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dihydride species, but too much base hinders productive proton transfer between solvent and
amido complex, stalling the catalytic cycle.
The enantioselectivity of the reaction remains unaffected by these changes in base loading.
These results are insightful as not only do they give valuable clues to the mechanism of the
reaction they also allow the tuning of base concentration to give higher turnover, without any
effect upon the selectivity in the reaction.
3.3 Electronic Environment at the Metal Centre
It is quite likely that the electronic environment at the metal centre plays an important part in the
operation of the catalytic cycle, and tuning of this could lead to more active, and perhaps more
selective catalysts. Indeed, since the reaction rate is believed to be limited by an event involving
ketone coordination/hydride transfer, it is plausible that rates could be enhanced by fine tuning
of the electron density upon the ruthenium metal.
To get a better understanding of the effect of changing the electronic environment at the
ruthenium centre, it was decided to explore the effect of electronically different substituents on
the phosphorus aryl groups upon the rate of hydrogenation. [RuCl2(P^N^N)L] catalysts with
both electron-rich and electron-deficient components were targeted. The ruthenium complex
(R,R)-286, somewhat deactivated by para-chloro substituents, was prepared in this laboratory
by Kuntz et al (Scheme III-9).16 They found that this complex was totally inactive in
hydrogenation of ,,-trimethylacetophenone, even at elevated temperature and pressure.
It was decided to focus on preparing an electron-rich derivative of this complex and
testing its performance in hydrogenation. With the requisite 2-(diarylphosphino)benzaldehyde
287 in hand (prepared by Wawrzyniak and Clarke),16 the ruthenium complex was prepared in a
analogous manner to the published route into these compounds (Scheme III-8).3,9 The ligand
could only be prepared in 80% purity due to the sensitive nature of the electron rich phosphine,
thus it was complexed immediately and after column chromatography, analytically pure
complex (R,R)-290 was obtained. The usual characteristics of the complexed ligand were
observed.
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Complex (R,R)-290 hydrogenated ,,-trimethylacetophenone cleanly at 50C and 50 bar H2
pressure (Scheme III-9). Kinetic analysis of the reaction suggests that hydrogenation is less
positive order, with respect to ketone concentration, than the parent catalyst (R,R)-174, and is
perhaps tending towards zero order kinetics (Figure III-10). This was checked by experiments at
different substrate concentrations that showed that the reaction rate was indeed dependent upon
ketone concentration and is more likely following pseudo-first order kinetics (Figure III-11),
albeit proceeding slower than the original catalyst (R,R)-174. Enantioselectivity is practically
identical using both catalysts.
Scheme III-9 Hydrogenation with catalysts (R,R)-286 and (R,R)-290. General conditions:
ketone 159, catalyst (R,R)-286 or (R,R)-290 (0.5 mol%), potassium tert-butoxide (1 mol%),
isopropanol (3 mL), molecular H2 (50 bar), 50C, 16 h.
Scheme III-8 Synthesis of catalyst (R,R)-290. Reaction
conditions: (i) 287 (1 eq.), (R,R)-diaminocyclohexane (3 eq.),
EtOH, 45C → rt, 5 h; (ii) (R,R)-288 (1 eq.), NaBH4 (4 eq.),
EtOH, rt, 16 h; (iii) (R,R)-289 (1 eq.), [RuCl2(DMSO)4] (1
eq.), THF, μw, 120C, 20 min.
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Figure III-10 Kinetic analysis of the hydrogenation
of ,,-trimethylacetophenone with catalyst
(R,R)-290. Reaction conditions shown in Scheme
IV-8. ♦ Catalyst (R,R)-174; ■ Catalyst (R,R)-290; ▬
e.e. (Catalyst (R,R)-174); ▬ e.e. (Catalyst (R,R)-
290)
The observation that pseudo-first order kinetics are still in operation in hydrogenation with
catalyst (R,R)-290, and that enantioselectivities are almost identical to those obtained with
catalyst (R,R)-174, suggest that a similar mechanistic pathway exists for both species. The
decrease in activity, with the half-life of catalyst (R,R)-290 almost double that of the original
catalyst (R,R)-174, suggests that the increase in electron density at the metal centre, brought
about by the electron-donating substituents upon the phosphorus aryl ring, retards the rate
limiting step, believed to involve either the coordination of the ketone substrate or transfer of the
hydride to the ketone.
The observations made here, accompanied by that made by Kuntz et al, suggest that a fine
balance between electron rich and electron poor properties is required in the most efficient
catalysts, and the best to date is the original catalyst (R,R)-174. More subtle modification of the
phosphorus substituents is needed to find the optimal electronic environment but this is outwith
the scope of the current work. It is gratifying however that enantioselectivity remains similar
when using catalysts (R,R)-174 and (R,R)-290 as it would be expected that further modification
of the electronic properties of the ligand could be carried out with erosion of enantioselectivity.
3.4 Comparisons with Transfer Hydrogenation
Much of the original work looking at the mechanism of ruthenium-catalysed hydrogenation of
unfunctionalised ketones was conducted on the related transfer hydrogenation system. Such
systems, despite employing a different hydride source, such as isopropanol or a formic
acid/triethylamine mixture, were thought to transfer the hydride to the ketone substrate through
the same transition state.8 Not many catalysts have been identified as being able to catalyse both
Figure III-11 Rate versus substrate concentration
plot for the hydrogenation of ,,-
trimethylacetophenone with catalyst (R,R)-290,
showing a dependence of rate on substrate
concentration, suggesting pseudo-first kinetics are
in operation.
Enantioselective Hydrogenation Using Ruthenium Complexes Chapter III
of Tridentate Ligands Scott Phillips
104
transfer and H2-hydrogenation however, suggesting different pathways leading to the formation
of the real catalyst.17 Some catalysts, including the present system, have the capability of
catalysing both. Previous work in this group by others,4 and that described in chapter II, has
shown that catalyst (R,R)-174 can hydrogenate a variety of substrates with enantioselectivities
broadly similar to those obtained by H2-hydrogenation in rapid time using microwave heating.
This indeed implies that a similar transition state exists, between substrate and catalyst, in the
hydride transfer step when using the present catalytic system in both transfer and H2-
hydrogenation.
The microwave-accelerated transfer hydrogenation protocol does not so easily lend itself to
kinetic investigation, but conversion to product using the four catalysts – (R,R)-174, 263, 264
and 265 – was compared after 20 and 40 minutes of heating at 90C. It was found that all four
catalysts are active in the microwave-assisted transfer hydrogenation of ,,-
trimethylacetophenone to some degree (Figure III-12). Like in H2-hydrogenation, the original
catalyst (R,R)-174 was superior in terms of productivity, with complete conversion to product in
around 20 minutes. The achiral derivative 263 catalyses the reaction with diminished rate
although goes to full conversion within 40 minutes. The absence of terminal NH2 groups
appears to have a larger effect. The dimethyl catalyst 264 is significantly less productive than
catalyst 263 and the trimethyl derivative 265 is slightly slower again.
More firm conclusions would require further kinetic investigation but this was felt to be of little
value. However, these results suggest that the terminal NH2 is more important to productivity in
the transfer hydrogenation system than in the H2-hydrogenation system.**
Figure III-12 The transfer hydrogenation of ,,-trimethylacetophenone employing complex (R,R)-174, complex
263, complex 264 and complex 265 (8 individual experiments). Reaction conditions: ,,-trimethylacetophenone
(1 mmol), Ru complex (1 mol%), potassium tert-butoxide (2 mol%), iPrOH (3 mL), μW, 90C.
** This is in agreement with work by Fuentes and Clarke10 that has shown that the [RuCl2(P^N^O)L]
system is considerably less active in transfer hydrogenation (non microwave-assisted) than their
corresponding [RuCl2(P^N^N)L] catalysts, indicating that the terminal NH2 is salient to productivity in
the transfer process.
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3.5 Conclusions
We have drawn a number of conclusions from our work which will assist us with the rational
design of novel, more active, more selective catalysts based on the original ligand design. For
good activity in H2-hydrogenation, a catalyst needs a well-defined shape with the geometry at
ruthenium perhaps also being salient. The vicinal nature of the two amine coordinating group
has also been shown to be required for productive catalysis. The secondary amine seems to
facilitate hydrogen activation making this step facile. The rate limiting step of the reaction is
probably the ketone coordination/hydride transfer step and the transition state formed between
the secondary N-H and a ketone substrate is likely to be important in determining the
enantioselectivity of the alcohol product, and a potential model is represented in Scheme III-11.
Scheme III-11 A potential model for the origin of enantioselectivity in
hydrogenation with [RuCl2(P^N^N)L] catalysts.
We have found the optimal base concentration for efficient catalysis, noting that at least 2
equivalents of base are required for efficient catalysis and above 10 equivalents appears to
retard the reaction rate. A fine balance of electronics at the metal centre is required in order for
the best rates, with electron poor metal centre leading to a complete loss of activity. These are
all crucial considerations in rational tuning of the catalyst to produce more efficient catalysts,
which shall be discussed in the next chapter.
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Chapter IV
Rational Design of Novel [RuCl2(P^N^N)L] Catalysts
Our knowledge of the present system, as well as the closely related [RuCl2(P^P)(N^N)] system,
combined with the detailed kinetic studies described in Chapter III, put us in a position to
rationally design new catalysts, with the potential for enhanced productivity and selectivity, and
for hopefully accessing some new, previously inaccessible, chiral alcohols. Fine tuning of the
ligand structure has the potential to create more selective and highly enantioselective catalysts
for a range of sometimes difficult substrates. In this chapter, the preparation of a number of
rationally designed, novel catalystic systems are described, and their performance in catalysis
scrutinised. To allow this work to take place, a facile screening method was developed, and this
will first be described.
4.1 In situ screening method
It was highly desirable to develop an in situ protocol which could be used to analyse the
performance of potentially useful P^N^N ligands in hydrogenation. Often such ligands are very
air sensitive, forming the phosphine oxide rapidly, even after minimal exposure to air.
Therefore, the use of the protected form of such ligands, i.e. their borane adduct, directly in
catalysis was felt to be useful. The in situ deprotection and complexation of the ligand would
hopefully lead to the same catalytic species. Conveniently, it was known that heating
phosphine-boranes in the presence of alcoholic solvents can lead to the deprotection of
phosphine-boranes.1 As isopropanol is the reaction solvent it was anticipated that this could be
achieved in a straightforward manner before subsequent complexation and catalysis in situ.
A number of ruthenium precursors were screened in the hydrogenation of ,,-
trimethylacetophenone with the borane protected form of the original ligand, (R,R)-293 (Table
IV-1).† A solution of the phosphine borane 293 and the ruthenium precursor in isopropanol was
first stirred at rt, before addition of ,,-trimethylacetophenone and potassium tert-butoxide.
The reaction mixture was then placed under 50 bar hydrogen pressure and stirred for 16 hours at
50C.
† This was prepared by adding borane.THF complex dropwise to a solution of the original ligand in THF
over a period of two hours. This gave one main broad signal in the 31P NMR spectrum at +18.3 ppm
(CDCl3), in the characteristic range for phosphine boranes. This adduct was used directly in catalysis.
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Entry Ru Precursor Conversion(yield) [%] ee [%]
1 RuCl3 5 -
2a RuCl3 <5 -
3 Ru(acac)3 5 -
4a Ru(acac)3 <5 -
5 RuCl2(DMSO)4 >99 78 (S)
6a RuCl2(DMSO)4 <5 -
Table IV-1 The in situ hydrogenation of ,,-
trimethylacetophenone using a ruthenium precursor and phosphine
borane (R,R)-293. General conditions: ,,-trimethylacetophenone
159, Ru precursor (0.5 mol%), Ligand (R,R)-293 (0.7 mol%), KOtBu
(1 mol%), iPrOH, H2 (50 bar), 50C, 16 h. a Without KOtBu.
It was found that efficient hydrogenation was only apparent when the ruthenium precursor
[RuCl2(DMSO)4] was employed in the presence of base. Gratifyingly, similar high levels of
stereoinduction to hydrogenation using the preformed catalyst were obtained, indicating that the
same active catalyst was being formed. The relative activities of the two systems were not
measured in this study, but these results were pleasing as the use of [RuCl2(DMSO)4] as the
precursor led to quantitative conversion of ketone to product within a practical timescale, and
thus this protocol can be considered as a useful alternative to the use of well-defined catalysts.
4.2 Novel Catalysts by Modification of Phosphorus Substituents
4.2.1 P-Chiral Phosphine Component
From our knowledge of the mechanism of hydrogenation using [RuCl2(P^N^N)L] catalysts, a
working model for the origin of enantioselectivity has been constructed and was presented in
Chapter III. The hydride transfer step is believed to be aided by a hydrogen bonding interaction
between the secondary N-H group of the ligand and the carbonyl oxygen of the incoming ketone
(Chapter III, Scheme III-11). The transition state can be visualised more easily by
superimposing the incoming ketone substrate upon the molecular structure of catalyst (R,R)-
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174, derived from X-ray diffraction studies.2 The representation shown in Figure IV-1 illustrates
the transition state which is believed to lead to the major enantiomer in the hydrogenation of
,,-trimethylacetophenone ((S)-enantiomer), which makes use of hydrogen bonding
interactions between the substrate and the secondary N-H component of the ligand structure. We
cannot categorically say which interactions lead to the preferred facial selectivity (although
potential clashes between the bulky ketone R group and the diamine backbone is possible),
however from the model it can be seen that tweaking of the phosphorus subsituents that are in
close proximity to the ‘active site’ of the catalysts, could have a large effect upon the
enantioselectivity of the reaction.
In order to probe the effect of placing sterically different phosphorus substituents in close
spacial proximity to the mechanistically important secondary N-H, a number of P-chiral P^N^N
ligands were trialled in the hydrogenation of unfunctionalised ketones. These ligands, available
as phosphine-boranes, were prepared by Dr Nina Kann and Kristian Andersson at the Chalmers
University in Gothenburg, Sweden, who specialise in the synthesis of P-chirogenic
molecules.3,4,5 The ligands were employed in the in situ hydrogenation protocol described
previously, and their performance in the reduction of acetophenone and ,,-
trimethylacetophenone examined (Table IV-2).
It was interesting to observe similar levels of enantioselectivity in the hydrogenation of ,,-
trimethylacetophenone 159 when employing ligand (R,R),(S)-294 in combination with
[RuCl2(DMSO)4], as with the original P^N^N catalyst (R,R)-174. It appears that changing the
linker between the diamine component and the phosphine component to a simple three-carbon
alkyl chain has no effect on enantioselectivity. The ortho-methyl group on the phosphorus aryl
substituent, expected to be in close spacial proximity to the mechanistically important secondary
N-H, has little observable effect on the enantioselectivity of this reaction. However, quite
interestingly, enantioselectivity is significantly enhanced in the hydrogenation of acetophenone,
relative to that of hydrogenation with the original catalyst (R,R)-174, in which racemic material
Figure IV-1 A representation of the
proposed transtition state which leads to
the major enantiomer ((S)) in the
hydrogenation of ,,-
trimethylacetophenone (R = tBu).
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was produced. The configuration of product observed suggests that the bulkier o-OMe group of
ligand (R,R)(S)-294 creates a clash between phenyl group of acetophenone and the phosphorus
substituents that clearly is not present in the parent catalyst. If we remove the steric bulk at this
position, i.e. replace the o-OMePh group for a simple methyl substituent, ligand (R,R),(S)-295,
then enantioselectivity is considerably eroded for both substrates, supporting this proposal.
Incorporating the more bulky cyclohexyl substituent upon phosphorus, as in ligand (S,S),(S)-
296, elevates enantioselectivity for both substrates once again but activity decreases, possibly
due to increased steric congestion at the active site.
Entry Ligand Ketone R= Conversion(yield) [%] ee [%]
1 (R,R)(S)-294 81 Me >99 29 (S)
2 (R,R)(S)-294 159 tBu >99 74 (S)
3 a (R,R)(S)-295 b 81 Me >99 17 (S)
4 a (R,R)(S)-295 b 159 tBu >99 11 (S)
5 a (S,S)(S)-296 c 81 Me 73 33 (R)
6 a (S,S)(S)-296 c 159 tBu 11 42 (R)
Table IV-2 In situ hydrogenation of ketones with [RuCl2(DMSO)4] and P-
chiral phosphines. General conditions: ketone 81 or 159, [RuCl2(DMSO)4]
(0.5 mol%), phosphine borane (R,R),(S)-294, (R,R),(S)-295 or (S,S),(S)-296
(0.7 mol%), potassium tert-butoxide (1 mol%), isopropanol (3 mL),
molecular H2 (50 bar), 50C, 16 h. a 70C. b 90% e.e. c 81% e.e.
These results suggest that modifying the substituents on phosphorus, particularly those close to
the mechanistically important secondary N-H, has a significant effect on the enantioselectivity
of hydrogenation. In was envisaged that strategic placement of steric bulk upon the phosphorus
substituents could lead to enhanced enantioselectivity in the hydrogenation of such
unfunctionalised ketones.
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4.2.2 Bulky Phosphorus Substituents
It was thought that the use of ligands (R,R)-297 and (R,R)-298 (Scheme IV-1) would show
particularly enhanced enantioselectivity in the reduction of acetophenone and ,,-
trimethylacetophenone, since increased steric bulk on the phosphine aryl substituents proximal
to the catalyst’s ‘active site’ upon complexation, would increase the preference for the phenyl
ring of the substrate to be on the opposite side of the catalyst to the phosphine group.
NH2
NH P
tBu
tBu
tBu
tBu
(R,R)-298
NH2
NH P
Me
Me
Me
Me
(R,R)-297
Scheme IV-1 P^N^N ligands containing bulkier
aryl subsitutents.
In was envisaged that both of these ligands could be prepared by condensation of the requisite
2-(diarylphosphino)benzaldehyde with (R,R)-diaminocyclohexane. The aldehyde precursor to
(R,R)-297 is commercially available, however, the precursor to (R,R)-298 needed to be first
prepared. This was achieved by adapting a procedure previously developed in this group for
certain other diarylphosphinobenzaldehydes, by the reaction of the freshly prepared lithio-
derivative of 2-bromobenzaldehyde ethylene acetal 299 with a 10-fold excess of phosphorus
trichloride in tetrahydrofuran at -78C to give the dichloride species 300 (Scheme IV-2). The
solvent and excess phosphorus chloride were then removed before the residue was redissolved
in THF immediately and reacted with two equivalents of (3,5-di-tert-butylphenyl)lithium,
freshly prepared from 3,5-di-tert-butylbromobenzene and n-butyllithium. This furnished the
protected aldehyde 301 after column chromatography, in moderate yield, which was easily
converted to the aldehyde 302 by treatment at reflux with p-toluenesulfonic acid in acetone for 2
hours, in a high yielding process. After column chromatography, this gave analytically pure
aldehyde 302 as a bright yellow solid.
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P
O
O
PCl2
O
OBr
O
O
(i) (ii) (iii)
301
40%
P = - 3.7 (CDCl3)
P
H
O
302
92%
P = -11.8 (CDCl3)
tBu
tBu tBu
tBu tBu
tBu tBu
tBu
299 300
Scheme IV-2 Synthesis of 2-(bis(3,5-di-tert-butylphenyl)phosphino)benzaldehyde 302. General
conditions: (i) 299 (1 eq.), nBuLi (1.1 eq.), THF, - 78C, 2 h; PCl3 (10 eq.), THF, - 78C, 0.5 h (ii)
300 (1 eq.), (3,5-di-tert-butylphenyl)lithium (2 eq.), THF, - 78C→rt, 2 h  (iii) 301 (1eq.), p-
TsOH.H2O (0.1 eq.), acetone, Δ, 2 h. 
Ligands 297 and 298 were then prepared by dropwise addition of a solution of the requisite
aldehyde in degassed ethanol to a dilute solution of (R,R)-diaminocyclohexane 294, also in
degassed ethanol. It was ensured that diamine 294 was present in a suitably large excess to
prevent the undesired difunctionalisation of the diamine. This furnished the imine species after
stirring for 2-5 hours. Subsequent reduction with sodium borohydride yielded ligands (R,R)-304
and (R,R)-305 after careful work-up in an inert atmosphere. The reactions were monitored using
1H and 31P NMR spectroscopy and the key signals are shown in Table IV-3. Ligand (R,R)-298
could only be obtained in ~60% purity due to the sensitivity of the phosphine and thus full
characterisation data could not be obtained. Despite this, both ligands were complexed with
[RuCl2(DMSO)4] following the usual microwave-assisted protocol and analytically pure
material was obtained after column chromatography. Complexation was confirmed by the
downfield shift of the signal in the 31P NMR spectrum as well as the downfield shifts of the
CHN protons in the 1H NMR spectrum. The remaining coordinated DMSO ligand becomes
desymmetrised by the process and individual signals are seen for the protons attached to each
methyl group. The methyl/tert-butyl groups upon the phosphorus aryl substituents also become
inequivalent upon complexation due to restricted rotation/exchange between face-on/edge-on
rings.
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Entry Complex δP (CDCl3)(aldehyde)
δH (C6D6)
(CH=N, imine
species)
δP (C6D6)
(imine
species)
δP (C6D6)
(amine
species)
δP (C6D6)
(Ru
complex)
1 (R,R)-297 -13.4 9.52 (d, J 4) -12.2 -15.7 +40.6
2 (R,R)-298 -11.8 9.50 (d, J 4) -8.6 -13.5 +45.2
Table IV-3 Synthesis of bulky catalysts (R,R)-297 and (R,R)-298. General conditions: (i) 303
or 302 (1 eq.), (R,R)-diaminocyclohexane (3 eq.), EtOH, 45C → rt, 2 h; NaBH4 (4 eq.),
EtOH, rt, 8 h; (ii) (R,R)-304 or (R,R)-305 (1 eq.), [RuCl2(DMSO)4] (1 eq.), THF, μw, 120C,
20 min. Table shows NMR signals corresponding to each species formed.
The relative performance of each catalyst in the hydrogenation of model substrates 81 and 159
was examined (Table IV-4). Pleasingly, increasing the steric bulk on the phosphine substituents
led to increased enantioselectivity in the hydrogenation of both acetophenone 81 and ,-
dimethylpropiophenone 159 as predicted. This effect was more pronounced in the reduction of
acetophenone with catalyst (R,R)-298, yielding the (S)-enantiomer of phenethyl alcohol in up to
60% e.e. despite the original catalyst (R,R)-174 only giving racemic material. However, an
undesirable consequence of this was the accompanying decrease in activity brought about by
increased steric bulk on the catalyst structure. Quantitative conversion to product employing
catalysts (R,R)-297 and (R,R)-298 could only be accomplished by elevation of temperature in
the hydrogenation of ,,-trimethylacetophenone. This resulted in the erosion of
enantioselectivity in the case of hydrogenation with the bulky catalyst (R,R)-298.
Although highly efficient catalysts exist for the hydrogenation of acetophenone 81 and
derivatives, and the preparation of further catalysts was not our aim, these results demonstrated
that the catalyst scaffold can be tuned for particular substrates. A significant increase in
enantioselectivity was observed from 0% e.e. when using the original catalyst to 60% e.e. when
the bulky derviative (R,R)-298 was employed.
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R
O
R
OH
81, R = Me
159, R = tBu
Ru Cat
KOtBu, iPrOH
H2
16h
N
H2
NH P
Ru
Cl
Cl S
O
tBu
tBu
tBu
tBu
N
H2
NH P
Ru
Cl
Cl S
O
Me
Me
Me
Me
(R,R)-297 (R,R)-298
12, R = Me
273, R = tBu
Entry Catalyst Ketone R= Conversion(yield) [%] ee [%]
1 (R,R)-174 81 Me >99 0
2 (R,R)-297 81 Me >99 35 (S)
3 (R,R)-298 81 Me 24 56 (S)
4a (R,R)-298 81 Me 84 60 (S)
5b (R,R)-298 81 Me >99 58 (S)
6 (R,R)-174 159 tBu >99 74 (S)
7 (R,R)-297 159 tBu >99 77 (S)
8 (R,R)-298 159 tBu 5 83 (S)
9a (R,R)-298 159 tBu 21 85 (S)
10c (R,R)-298 159 tBu >99 67 (S)
Table IV-4 The effect of increasing steric bulk on the phosphine
component of the ligand structure upon hydrogenation of ketones 81 and
159. General conditions: ketone 81 or 159, catalyst (R,R)-297 or (R,R)-
298 (0.5 mol%), potassium tert-butoxide (1 mol%), isopropanol (3 mL),
molecular H2 (50 bar), 50C, 16 h. a 70C. b 70C, 24 h c 90C.
4.3 Novel Catalysts by Modification of Diamine Component
It has been shown that the shape of [RuCl2(P^N^N)L] catalysts, and the geometry at the
ruthenium centre, are highly important to catalyst productivity. A vicinal diamine is preferable
and maximum TOF is obtained when the diamine component is locked in conformation by a
cyclic carbon backbone. It is likely that this ‘locking’ of conformation orientates the N-H bond
in such a manner that promotes efficient interaction with an incoming ketone substrate and in
such a way that the hydride can be easily transferred from the metal centre. DPEN is one of the
most important chiral ligands and has been combined with many transition metals to give highly
enantioselective catalysts for a range of organic transformations.6 It was envisaged that the
complexation of DPEN to ruthenium would give a catalyst with a similar or smaller bite angle
than the original catalyst (R,R)-174, as the vicinal phenyl groups would orientate themselves as
far away spacially as possible after complexation, reducing the dihedral angle between the
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vicinal amine groups, creating a rigid structure around the ruthenium centre. It was felt
worthwhile therefore to incorporate DPEN as the diamine component of [RuCl2(P^N^N)L]
cataysts.
Ligand (R,R)-301 was prepared, first by the condensation of (R,R)-1,2-
diphenylethylenediamine, (R,R)-299, (a three-fold excess in ethanol) with 2-
(diphenylphosphino)benzaldehyde 266, furnishing the corresponding imine species (R,R)-300
after 4 hours (Scheme IV-3). The presence of the imine species was indicated by the appearance
of a signal at δP (C6D6) = -7.9 ppm in the 31P NMR spectrum and a signal at at δH (C6D6) = 9.17
ppm (d, J 5), corresponding to the CH=N proton, in the 1H NMR spectrum. Reduction of the
imine with sodium borohydride resulted in the formation of species (R,R)-301 after stirring for
16 hours, shown by a signal at δP (C6D6) = -9.6 ppm in the 31P NMR spectrum. However, after
aqueous work-up, two further species were observed, with signals at δP (C6D6) = -15.9 and -16.2
ppm. Due to the apparent inseparability of these species it was decided to use the crude mixture
directly in the complexation reaction. This gave phosphorus containing species with signals
observed at δP (CDCl3) = +42.4, -16.4 and -16.9 ppm (~3:1:1). It was believed that the species at
δP (CDCl3) = +42.4 corresponded to the desired complex and indeed following column
chromatography on silica, analytically pure complex (R,R)-302 was furnished.
Scheme IV-3 The synthesis of complex (R,R)-302. Reaction conditions: 2-
(diphenylphosphino)benzaldehyde 266 (1 eq.), (R,R)-1,2-diphenylethylendiamine (R,R)-299 (3 eq.),
EtOH, rt, 4 h; (ii) (R,R)-300 (1 eq.), NaBH4 (3 eq.), EtOH, rt, 16 h; (iii) (R,R)-301 (1 eq.),
[RuCl2(DMSO)4] (1 eq.), THF, μw, 120C, 20 min.
Pleasingly, catalyst (R,R)-302 was found to be active in the hydrogenation of a number of
ketone substrates (Scheme IV-5). The hydrogenation of acetophenone produced practically
racemic material when employing catalyst (R,R)-302. However, like the original catalyst (R,R)-
174, the new catalyst was found to be highly selective in the reduction of bulkier ketones. A
meaningful but small increase in enantioselectivity was observed in the hydrogenation of ,,-
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trimethylacetophenone compared to the original catalyst (80% e.e. versus 74% e.e.). The
enantioselectivity was slightly diminished in the reduction of the more bulky ketone 183.
Entry Ketone Conversion(yield) [%] ee [%]
1 81 >99 3 (S)
2 159 >99 80 (S)
3 183 >99 67
4 244 >5 nd
5 226 >99 98a
6 303 >99 9
7b 304 >99 na
Table IV-5 Hydrogenation with the catalyst
(R,R)-302. General conditions: ketone (1 eq.),
catalyst (R,R)-302 (0.5 mol%), potassium tert-
butoxide (1 mol%), isopropanol (3 mL),
molecular H2 (50 bar), 70C, 16 h. a 5 mol%
KOtBu. a ((R,R)+(S,S)):meso 3.1:1. b cis:trans
10:1
Disapointingly, catalyst (R,R)-302 was found to be practically inactive in the hydrogenation of
the heteroaromatic ketone 244 despite encouraging results using catalyst (R,R)-174. However,
hydrogenation of the heteroaromatic diketone 226 gave the useful alcohol product 327 in near
enantiopurity. Ketones with sterically similar groups proved to be active substrates but little
stereoinduction was observed. It was also demonstrated that the reduction of the achiral ketone
304 could be accomplished with good regioselectivity using catalyst (R,R)-302.
These studies show that the DPEN-derived catalyst is a viable alternative to the original catalyst
and is worth screening when new hydrogenations are attempted in the future. Catalysts derived
from other small bite angle chiral diamines are also well worth investigation.
4.4 Conclusions
This work has shown that tuning of the ligand design in [RuCl2(PNN)L2] systems, directed by
experimental observations, can lead to more enantioselective catalysts for the hydrogenation of
model substrates. We have shown that such catalysts are efficient in preparing chiral secondary
alcohols in up to 98% e.e., many of which are important precursors in synthesis and of
biological significance. It is anticipated that further catalyst optimization, by tuning of the
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modular ligand design, has the potential to lead to very active and selective catalysts for
preparing a variety of chiral secondary alcohols, based on this knowledge and current
observations.
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Conclusions and Future Work
The first aim of his work was to fully delineate the substrate scope of hydrogenation catalysed
by [RuCl2(P^N^N)] complexes. The scope of the technology was successfully extended to even
bulkier substrates than those outlined in the original work. Phenyl, dimethyl phenyl ketones
were shown to be reduced quantitatively using catalyst (R,R)-174 giving the corresponding
alcohol in 84% e.e. Even bulkier phenyl, diethyl phenyl ketones were also hydrogenated
effectively albeit in slightly lower e.e. The catalytic system was shown to be tolerant of a range
of electronically different substituents upon the phenyl group of the substrate – para-OMe, -Cl
and –CF3 as well as ortho-OMe substituents – giving the corresponding alcohol quantatively in
each case whilst maintaining high levels of enantioenrichment in the product (69-80% e.e.). The
system was also tolerant of heteroaromatic functions – pyridyl, furanyl and isoxazolyl bulky
ketones were all hydrogenated quantatitively with good to excellent enantioselectively (67-98%
e.e.), giving products often unobtainable by other methods. It was demonstrated that analogues
of synthetically useful chiral alcohols with adjacent gem-dimethyl groups could be prepared in
good enantioselectivity using catalyst (R,R)-174. We also sucessfully showed that the current
technology could be employed to prepare nitrile functionalised chiral secondary alcohols in 74%
e.e. that could be transformed further into chiral lactones, a class of compound that is important
in the frangrance industry, and despite its ubiquity has not previously been accessible through
asymmetric hydrogenation/lactonisation techniques.
The current system has been shown to be of great use as a synthetic tool, and a complimentary
method to the use of the Noyori catalysts. Although the current research aimed to illustrate the
wide scope of potential substrates - and the wealth of chiral products that can potentially be
furnished - future work would aim to demonstrate that the current system could be used in the
preparation of current commercial targets, showing that this methodology can fulfil its potential
in the industrial synthesis of chiral molecules.
The design of second generation [RuCl2(P^N^N)] catalysts was also an important aim of this
work, to increase the activity and selectivity of catalysts. We decided that a good way of doing
this was using a rational approach based on a greater understanding of the mechanism of the
system. We felt that knowledge of the role of the diamine component of the ligand, and whether
interactions between the ligand and the substrate in hydrogenation exist, was key to future
catalyst design. Achiral derivatives of the original [RuCl2(P^N^N)] catalyst were prepared: one
containing a simple two carbon backbone between the primary and secondary amine
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components, another analagous to the first but with the primary NH2 replaced with an NMe2
group, and a third complex analagous to the second but with the secondary amine group also
replaced with NMe. Kinetic analysis of each catalyst, including the original, in the
hydrogenation of α,α,α-trimethylacetophenone, gave a number of valuable insights. Firstly, for 
good activity the catalyst needs a well-defined shape, with the geometry around ruthenium
being important. Secondly, the presence of a terminal NH2 group is not as salient as the
presence of a secondary N-H for good activity. Thirdly, the absense of the terminal and
secondary amine functions dramatically diminished activity although hydrogenation still
progresses slowly. In the hydrogenation of styrene (where no substrate/ligand interactions are
likely) there were no differences in the reaction profile of each catalyst. These observations
allowed us to postulate that hydrogenation using the [RuCl2(P^N^N)] system proceeds via an
interaction between the secondary N-H component and the incoming substrate, and that the
secondary amine is particularly good at promoting hydride activation.
The mechanistic evidence gave us a more focussed, rational approach for the design of new
catalysts: consulting the possible transition state, modification of the ligand phosphine
substituents would likely have an effect on enantioselectivity. Indeed, 3,5-di-subsitution of the
phosphine aryl groups led to more enantioselective hydrogenation in many cases. This was most
evident in the hydrogenation of acetophenone, where the incorporation of 3,5-di-tert-butyl
groups led to an increase in enantioselectivity of 60% compared with hydrogenation using the
original catalyst, which furnished racemic material. An unfortunate consequence of the increase
bulk on the phosphorus substituents, however, was a reduction in activity in the hydrogenation
of more bulky compounds.
Our mechanistic work also pointed to the need of catalysts for vicinal diamines with a well
defined geometry around the metal centre. A catalyst based on the diamine DPEN, was
prepared. Such a diamine is likely to have a well defined conformation when bound to a metal
centre due to the repulsion between adjacent phenyl groups, locking it in its conformation. The
new catalyst was found to be active in the hydrogenation of several substrates, with increased
enantioselectivity compared to the diaminocyclohexane catalysts for a number of substrates (for
example 80% vs. 74% for the hydrogenation of α,α,α-trimethylacetophenone).  
The work has shown that due to the modular nature of the ligands, the catalyst structure can be
tuned for greater selectivity, based on a greater mechanistic understanding. Future work is
anticipated to extend this further and modification of the DPEN catalyst framework, possibly
combining DPEN with a more bulky phosphine substituent, has the potential to lead to even
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greater selectivities. A greater understanding of the mechanism over time will lead to other
avenues of potential catalyst modification.
I feel that this work has contributed significantly to the understanding of the current system – its
scope, likely mechanism, and possibilities for catalyst tuning - and gives a sound basis for the
development of the next generation of catalyst for preparation of such important chiral building
blocks.
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Chapter V
Experimental
5.1 General
Dry, degassed solvents were used for reactions that were carried out under an N2 atmosphere
unless otherwise indicated. Normal grade solvents were used for chromatography and work-up
procedures under aerobic conditions. Solvents were removed by rotary evaporation on a
Heidolph labrota 4000. Flash column chromatography (eluents given in brackets) was
performed using Davisil silica gel Fluorochem 60 Å, particle size 35-70 micron. Thin-layer
chromatography (TLC) was performed on pre-coated Aldrich TLC plates (POLYGRAM SIL
G/UV254). All microwave syntheses were carried out in a Biotage Initiator Microwave reactor
using 5ml heavy-walled vials equipped with an air tight septum. Melting points were
determined with a Gallenkamp melting point apparatus Nº 889339 and are uncorrected. 1H
NMR, 13C NMR, 31P NMR and 19F NMR spectra were recorded either on a Bruker Avance 300
(1H 300 MHz, 13C 75.5 MHz, 31P 121.4 MHz and 19F 282 MHz) or Bruker Avance 400 (1H 400
MHz, 13C 100 MHz and 31P 162 MHz) instrument. 13C NMR spectra were recorder using the
DEPTQ sequence and internal deuterium lock. Chemical shifts are reported in ppm from
tetramethyl silane (TMS) with the solvent resonance as the internal standard. Chemical shift
values for 31P spectra are reported downfield of phosphoric acid, and chemical shifts values for
19F spectra are relative to CFCl3. Proton resonance multiplicities are given as s (singlet), d
(doublet), t (triplet), q (quartet), m (multiplet), br (broad) or a combination of them. When
appropriate, coupling constants (J) are quoted in Hz and are reported to the nearest 0.1Hz. All
spectra were recorded at room temperature and the solvent for a particular spectrum is given in
parentheses. Infrared spectra were recorded on a Perkin Elmer Paragon 1000 Spectrum GX FT-
IR system. Compounds were analysed using disposable PTFE IR card with an aperture diameter
of 15mm obtained from Aldrich. When disposable IR cards were not available, liquids were
analysed as films, and solids were analysed as KBr disks. Absorptions maxima are reported in
wavenumbers (cm-1). The characteristic absorption is reported as strong (s), medium (m) or
weak (w). Mass spectrometry was performed by the EPSRC National Mass Spectrometry
Service Centre, Swansea University, using Waters ZQ4000, Thermofisher LTQ Orbitrap XL
and Finnigan MAT 900 XLT instruments, or by Mrs Caroline Horsburgh at the University
of St Andrews using a Waters Micromass GCT (Time of flight) fitted with lockspray for
accurate mass (ESI) or GCT (CI). Only major peaks are reported and intensities are quoted as
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percentages of the base peaks. Isotope profiles for ruthenium complexes are presented in
Appendix B. Optical rotations were measured on a Perkin Elmer 241 polarimeter using a 1ml
cell with a 1 dm path length at room temperature using the sodium D-line, and a suitable solvent
that is reported along with the concentration (c = g/100ml). Microanalysis for carbon, hydrogen
and nitrogen were performed using a EA 1110 CHNS CE instruments elemental analyser by
Mrs Sylvia Williamson or Miss Donna McColl at the University of St Andrews or by Mr
Stephen Boyer at the London Metropolitan University. X-Ray crystallography data were
recorded at the University of St Andrews by Alex Slawin in a Bruker SMART CCD
Diffractometer and the data are presented in Appendix B. HPLC analysis has been determined
using a Varian Prostar operated by Galaxie workstation PC software.
5.2 General Reagents
Dichlorotetrakis(dimethyl sulfoxide) ruthenium (II)
Prepared by modification of a literature procedure.1 Ruthenium trichloride trihydrate (0.86 g,
4.13 mmol) was refluxed in dimethyl sulfoxide (5 mL) for 5 min under nitrogen. The volume
was then reduced to half in vacuo and acetone added prompting formation of a yellow solid.
The precipitate was filtered off, washed with acetone and dried in vacuo. Recrystallisation from
dimethyl sulfoxide yielded complex (0.87 g, 44 %) as yellow crystals, mp 190 oC (lit.1 193 oC).
5.3 General Procedures
5.3.1 Preparation of [RuCl2(P^N^X)L] Complexes
To dichlorotetrakis(dimethylsulfoxide) ruthenium(II) (1 equivalent) in a sealed microwave tube
under nitrogen was added a solution of the requisite ligand (1 equivalent) in tetrahydrofuran (3
mL). The reaction was heated in the microwave for 15 min at 120 C. The mixture was filtered
to removed excess ruthenium(II) precursor and the solvent was removed in vacuo. Purification
by column chromatography yielded pure complex, unless otherwise stated.
5.3.2 Hydrogenation Using [RuCl2(P^N^X)L] Catalysts
A solution of substrate (ca 1 mmol), catalyst and potassium tert-butoxide (1 M solution in
pentane) in degassed isopropanol (3 mL) was prepared in a microwave vial under an atmosphere
of nitrogen. The microwave tube was then placed inside a steel autoclave with two syringe
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needles piercing the lid of the vial. The autoclave was then sealed and flushed three times with
hydrogen before being charged with hydrogen to the required pressure. The reactions were
stirred at the same speed for the desired times at the required temperature using a stainless steel
heating jacket connected to a thermocouple and heater. After the desired time passed, the
autoclave was opened and the reaction mixture concentrated in vacuo. The conversion of
substrate to product was calculated by 1H NMR spectroscopy (In these experiments only
starting material and product were observed negating the use of an internal standard). The
products were isolated by column chromatography or short-path distillation and characterised
by comparison of NMR, IR, MS, optical rotation and where appropriate melting point data, with
authentic samples. The enantiopurity of the product (where applicable) was determined using
high performance liquid chromatography with the chiral stationary phase noted for each
product.
5.3.3 Microwave-Accelerated Transfer Hydrogenation Using RuCl2(P^N^X)L] Catalysts
A solution of substrate (ca 1 mmol), catalyst and potassium tert-butoxide (1 M solution in
pentane) in degassed isopropanol (3 mL) was prepared in a microwave vial under an atmosphere
of nitrogen. The vial was then place inside the heating cavity of the microwave and heated for
the required period at the desired temperature. After the desired time passed, the microwave vial
was opened and the reaction mixture concentrated in vacuo. The conversion of substrate to
product was calculated by 1H NMR spectroscopy. The products were isolated by column
chromatography or short-path distillation and characterised by comparison of NMR, IR, MS,
optical rotation and, where appropriate melting point data, with authentic samples. The
enantiopurity of the product (where applicable) was determined using high performance liquid
chromatography.
5.3.4 Racemic Reduction with Sodium Borohydride
To a solution of the substrate (1 equivalent) in absolute ethanol was added powdered sodium
borohydride (3 equivalents) in small portions to avoid vigorous reaction and the mixture stirred.
The reaction was monitored by thin layer chromatography and upon completion quenched with
10 % hydrochloric acid solution. The mixture was then extracted with dichloromethane and
washed with water and brine before drying with magnesium sulfate, filtration and concentration
in vacuo yielded the product.
Enantioselective Hydrogenation Using Ruthenium Complexes Chapter V
of Tridentate Ligands Scott Phillips
124
5.3.5 Kinetic Analysis of Hydrogenation Using [RuCl2(P^N^X)L] Catalysts
The requisite ruthenium precatalyst (0.5 mol%) was dissolved in isopropanol (20 mL) and to
this was added substrate (0.0123 mol) under a nitrogen environment at rt. The solution was
stirred for 15 min and immediately prior to the transfer of the solution, potassium tert-butoxide
(1M solution in tert-butanol, 1 mol%) was added. All hydrogenation experiments were
performed under isobaric conditions in a Parr autoclave using an automatic gas-measuring
apparatus. Experiments were carried out at 70°C and 70 bar pressure of hydrogen. Prior to
commencing each experiment, a control experiment was carried out in order to detect leaks at
the same temperature and pressure. This was typically carried out over a period of no less than
one hour. Once it was ascertained that the system was leak-free, the reaction mixture,
immediately after addition of potassium tert-butoxide, was transferred to the autoclave, which
was repressurised and gas-uptake was measured immediately. The method of data collection
used means that, despite the heating jacket being adaptive to the internal temperature, there will
be a short period of time where the temperature of the solution is stabilising. However, we
estimate this to be the first minute of reaction, and thus conclude the induction period observed
(in some cases 30 minutes) is not a result of this equilibration, but a chemical process (i.e.
formation of Ru-hydride). The main source of error in the experiments stems from temperature
control of the laboratory and consequently the ballast vessel, and is not considered to have any
significant implication to the conclusions made. Measurements were continued until no more
hydrogen was consumed. The data were normalised by assuming 100% conversion at maximum
gas uptake (confirmed by 1H NMR). Analysis of the data was conducted in a similar manner to
the graphical rate equation tutorial of Blackmond.2
5.4 Synthesis of 2-(Diarylphosphino)benzaldehyde Ligand Precursors
2-(Diphenylphosphinobenzaldehyde 266 and 2-[bis(3,5-
dimethylphenyl)phosphino]benzaldehyde 303 were purchased commercially and used as
received.2-(bis(4-Methoxyphenyl)phosphino)benzaldehyde was prepared by Piotr Wawrzyniak
in this group.3
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(2-(1,3-Dioxolan-2-yl)phenyl)bis(3,5-di-tert-butylphenyl)phosphine (301)
A solution of 2-bromobenzaldehyde ethylene acetal 299 (0.277 mL, 1.9 mmol) in dry THF (5
mL) was cooled to -78 °C, and to this, n-butyllithium (1.25 mL, 1.6 M solution in THF, 2.0
mmol) was added slowly. The resulting mixture was stirred at this temperature for 2h. The
creamy/white suspension was then transferred portionwise via cannula to a solution of
phosphorus trichloride (1.66 mL, 19 mmol) in THF (10 mL) at -78 °C. The mixture was stirred
at -78 °C for 30 min then warmed to rt. The solvent and excess phosphorus trichloride were
removed in vacuo at 60 °C before the residue was redissolved in THF (5 mL) immediately. To
this was added a solution prepared by adding n-butyllithium (2.5 mL, 1.6 M solution in THF, 40
mmol) to a solution of 3,5-di-tert-butylbenzene (1.00 g, 37 mmol) in dry THF (10 mL), after
stirring for 2 h at -78 °C. This addition was achieved via cannula keeping all reactants at -78 °C
and the resultant mixture was stirred for a further 30 min at -78 °C. The reaction mixture was
then warmed to rt. The reaction mixture was concentrated and applied directly to a silica
column. Flash chromatography (dichloromethane:hexane 1:1) afforded the title compound as a
sticky white solid (0.435 g, 41 %), mp 102-103.5C. max/cm-1 (film) 3420 (m), 3059 (w), 2963
(s), 1589 (s), 1477 (s), 1420 (m), 1394 (m), 1363 (m), 1249 (m), 1129 (m), 1091 (s) 945 (m),
875 (m), 738 m) and 710 (m); H (CDCl3, 300 MHz) 7.66-7.56 (1H, m, CArH), 7.34-7.13 (4H,
m, CArH), 7.06-6.97 (4H, m, CArH), 6.90-6.81 (1H, m, CArH), 6.40 (1H, d, J 5, C, CH), 4.07-
3.86 (4H, m, CH2) and 1.15 (36H, s, C(CH3)3); C (CDCl3, 101 MHz) 150.4 (d, J 6, Cq), 141.8
(Cq), 137.4 (Cq), 135.9 (d, J 8, Cq), 133.8 (CArH), 128.9 (d, J 25, CArH), 128.1 (d, J 20, CArH),
126.1 (d, J 7, CArH), 122.5 (CArH), 122.3 (CArH), 101.7 (d, J 25, CH), 65.4 (CH2), 34.9
(C(CH3)3) and 31.4 (C(CH3)3); P (CDCl3, 162 MHz) -13.7; m/z (ES+) 581.03 ([M+Na]+, 100%)
and 597.03 ([M=O+Na]+, 40); HRMS (ES+) found 581.3520, C37H51O2NaP requires 581.3524.
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2-(bis(3,5-di-tert-Butylphenyl)phosphino)benzaldehyde (302)
To a solution of 301 (0.106 g, 1.90 mmol) in degassed acetone (10 mL) was added p-
toluenesulfonic acid monohydrate (0.036 g, 0.19 mmol). The reaction was stirred at rt for 4h.
The solvent was then evaporated, and the residue purified by column chromatography on silica
(dichloromethane:hexane 1:1) to furnish the pure compound as a yellow viscous liquid which
solidified upon standing (0.090 g, 92 %), mp 135-136C. max/cm-1 (film) 3441 (w), 2962 (s),
1698 (m), 1586 (m), 1477 (w), 1419 (w), 1393 (w), 1363 (m), 1249 (m), 1198 (m), 1131 (w),
875 (w), 758 (w) and 710 (m); H (CDCl3, 300 MHz) 10.63 (1H, d, J 6, CHO), 7.95-7.88 (1H,
m, CArH), 7.43-7.36 (2H, m, CArH), 7.34-7.30 (2H, m, CArH), 7.03 (2H, d, J 2, CArH), 7.00 (2H,
d, J 2, CArH), 6.94-6.88 (1H, m, CArH) and 1.15 (36H, s, C(CH3)3); C (CDCl3, 101 MHz) 191.9
(CHO), 150.9 (d, J 7, Cq), 134.9 (d, J 9, Cq), 133.6 (d, J 17, CArH), 128.8 (CArH), 128.8 (CArH),
128.7 (CArH), 128.3 (d, J 21, CArH), 123.6 (Cq), 122.9 (CArH), 34.9 (C(CH3)3) and 31.4
(C(CH3)3); P (CDCl3, 121 MHz) -11.8; m/z (ES+) 536.90 ([M+Na]+, 100%); HRMS (ES+)
found 537.3256, C35H47ONaP requires 537.3262.
5.5 Synthesis of Diamines
Ethylenediamine 267, N’,N’-dimethylethylenediamine 269, N,N’,N’-trimethylethylenediamine
271 and (R,R)-(-)-1,2-diphenyletheylenediamine 299 were purchased commercially and used as
received. (1R,2R)-Cyclohexane-1,2-diamine was either purchased commercially or prepared by
the method below.
(1R,2R)-Cyclohexane-1,2-diamine
Using a procedure adapted from the work of Zhang and Walsh,4 a mixture of cis- and trans-1,2-
diaminocyclohexane (52.6 mL, 50.0 g, 0.44 mol) was added dropwise to a solution of L-(R,R)-
(+)-tartaric acid (66.0 g, 0.44 mol) in H2O (175 mL) at 90C. Further water (up to 660 mL total)
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was added to dissolve precipitate that was formed. The solution was gradually cooled to rt and
stood overnight at 4C. The crystals formed were filtered off, washed with ice water and
methanol, and dried under vacuum to give the tartrate salt of the title ompound as a white solid.
This solid was then dissolved in a minimum amount of 10% methanolic HCl, and diethyl ether
was added dropwise until a white precipitate appeared. The precipitate was filtered and dried
under vacuum to give the hydrochloride salt. This was redissolved in a minimum amount of
saturated sodium hydroxide solution and then extracted with diethyl ether. The organic layer
was separated, filtered and concentrate in vacuo to give the title compound as a white solid
(22.11 g, 44%) in >99% diastereomeric and enantiomeric excess, mp 41-42 C (lit.5 40-43C).
[]20D -23.9 (c 5, 1M HCl), lit.6 []20D -25.0 (c 5 1M HCl); H (300 MHz, CDCl3) 2.25-2.13 (2H,
m, CHN), 1.82-1.71 (2H, m, cyclohexyl CH), 1.67-1.52 (6H, m, 2 x NH2, 2 x cyclohexyl CH)
and 1.28-0.94 (4H, m, cyclohexyl CH); Enantioselectivity determined by chiral HPLC of the
bis-m-toluoyl amide derivative.7 ChiralPak AD, 1.0 mL/min, 90:10 hexane:2-propanol.
Retention times: 6.4 min ((S,S)), 17.3 min (R,R) and 29.9 min ((S,S)+(R,R)). Data are in
agreement with the literature.7,8
5.6 Synthesis of Ligands
(1R, 2R)-N-(2-(Diphenylphosphino)benzyl)cyclohexane-1,2-diamine (307)
Prepared by modification of a literature procedure.9 A solution of 2-
(diphenylphophino)benzaldehyde 266 (0.136 g, 0.45 mmol) in absolute ethanol (13 mL) at 45C
was added over a period of 5 h to a solution of (1R,2R)-cyclohexane-1,2-diamine (0.153 g, 1.34
mmol) in absolute ethanol (23 mL) at 0C. The reaction was monitored by 1H and 31P NMR and
upon completion, sodium borohydride (0.068 g, 1.79 mmol) was added and the reaction stirred
for 12 h at rt. Once 1H and 31P NMR spectroscopy had indicated complete reduction of the
imine, the reaction was concentrated under reduced pressure. The residue was dissolved by
stirring with saturated ammonium chloride solution and dichloromethane. The aqueous phase
was then extracted with dichloromethane and the organic phases were washed with water, dried
over magnesium sulfate, filtered and concentrated to yield the product as a yellow oil (0.073 g,
40%). H (400 MHz, CDCl3) 7.47-7.34 (m, 1H, CArH), 7.31-7.14 (m, 11H, CArH), 7.12-7.06 (m,
1H, CArH), 6.83-6.78 (m, 1H, CArH), 4.04 (1H, d, AB system, JAB 14.1, CHAHBNH), 3.84 (1H,
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d, AB system, JBA 14.1, CHAHBNH), 2.29-2.17 (m, 1H, NCH), 2.06-1.92 (m, 2H, NCH, CH2),
1.84-1.76 (m, 1H, CH2), 1.64-1.52 (m, 3H, CH2), 1.24-0.94 (m, 5H, CH2, NH2, NH) and 0.90-
0.75 (1H, m, CH2); P (121 MHz, CDCl3) –16.4. Data are in agreement with the literature.9
N’-(2-(Diphenylphosphino)benzyl)ethane-1,2-diamine (268)
PPh2NH
H2N
A solution of 2-(diphenylphosphino)benzaldehyde (0.20 g, 6.9 mmol) in absolute ethanol (26
mL) at 45C was added dropwise over a period of 5 h to a solution of ethylene diamine (0.14
mL, 20.7 mmol) in absolute ethanol (46 mL). The reaction was monitored by 1H and 31P NMR
and upon completion, sodium borohydride (0.10 g, 27.6 mmol) was added portionwise and the
reaction was stirred for 12 h at rt. Once 1H NMR had shown complete reduction of the imine,
the reaction was quenched by addition of acetone and the solvent was removed under reduced
pressure. The residue was dissolved by stirring with saturated ammonium chloride solution and
dichloromethane. The organic phase was separated, washed with water, dried over magnesium
sulfate, filtered and concentrated to yield the crude product as a yellow oil. For the purposes of
purification, the hydrochloride salt of the ligand was prepared by reaction of the crude product
with concentrated hydrochloric acid solution and subsequent removal of solvent. The salt was
washed with dichloromethane, before reaction with aqueous sodium hydroxide and extraction
into dichloromethane gave the pure product as a colourless oil (0.164 g, 72 %). max/cm-1 (film)
3423, 3051, 2957, 2788, 2672, 2477, 1719, 1585, 1477, 1434 , 1261, 1180, 1118, 1093, 1026,
804, 746, 698, 547 and 507; H (CD3OD, 400 MHz) 7.54-7.48 (1H, m, CArH), 7.42-7.33 (7H, m,
CArH), 7.29-7.17 (5H, m, CArH), 6.91-6.84 (1H, m, CArH), 3.98 (2H, s, NHCH2Ar), 2.89-2.82
(2H, m, CH2CH2) and 2.78-2.71 (2H, m, CH2CH2); C (CD3OD, 75 MHz) 143.6 (d, JCP 24,
CipsoC), 136.7 (d, JCP 9, CipsoP), 136.1 (d, JCP 13, CipsoP), 134.0 (CArH), 133.7 (CArH), 129.5 (d,
JCP 5, CArH), 129.2 (CArH), 129.0 (CArH), 128.8 (d, JCP 7, CArH), 127.6 (CArH), 51.5 (d, JCP 21,
NHCH2Ar), 50.0 (CH2) and 40.3 (CH2); P (CD3OD, 162 MHz) –18.2; m/z (ES+) 335.11
((M+H)+, 100%) and 275.06 (20); HRMS (ES+) found 335.1677, [C21H24N2P]+ requires
335.1687.
Enantioselective Hydrogenation Using Ruthenium Complexes Chapter V
of Tridentate Ligands Scott Phillips
129
N-(2-(Diphenylphosphino)benzyl)-N’,N’-dimethylethane-1,2-diamine (270)
A solution of 2-(diphenylphosphino)benzaldehyde (0.150 g, 0.52 mmol) in absolute ethanol (10
mL) at 45C was added dropwise to a solution of N’,N’-dimethylethane-1,2-diamine (0.056 mL,
0.52 mol) in absolute ethanol (20 mL) at rt. The reaction was monitored by 1H and 31P NMR
and upon completion, sodium borohydride (0.079 g, 2.08 mmol) was added portionwise and the
reaction was stirred for 12 h at rt. Once 1H NMR had shown complete reduction of the imine,
the reaction was quenched by addition of acetone and the solvent was then removed under
reduced pressure. The residue was dissolved by stirring with saturated ammonium chloride
solution and dichloromethane. The organic phase was separated, washed with water, dried over
magnesium sulfate, filtered and concentrated to yield the product as a yellow oil (0.122 g, 65 %)
which was deemed sufficiently pure for complexation. max/cm-1 (film) 3437, 3052, 2940, 2817,
1457, 1434, 1264, 1182, 745 and 696; H (CDCl3, 400 MHz) 7.47-7.33 (2H, m, CArH), 7.29-7.13
(10H, m, CArH), 7.11-7.01 (1H, m, CArH), 6.86-6.74 (1H, m, CArH), 3.91 (2H, s, CH2Ar), 2.52
(2H, t, J 6.4, CH2), 2.33 (1H, br s, NH), 2.16 (3H, m, NH, CH2) and. 2.06 (6H, s, N(CH3)2); C
(CDCl3, 101 MHz) 144.5 (d, JCP 23.5, CipsoCH2), 136.8 (d, JCP 10.1, CipsoP), 135.7 (d, JCP 13.9,
CipsoP), 133.9 (d, JCP 19.7, CArH), 132.0 (d, JCP 9.7, CArH), 129.1 (d, JCP 5.4, CArH), 128.7 (d, JCP
11.1, CArH), 128.6 (CArH), 127.2 (CArH), 59.0 (CH2NMe2), 52.4 (d, JCP 23.0, ArCH2NH), 46.6
(CH2NH) and 45.5 (N(CH3)2); P (CDCl3, 121 MHz) -16.1; m/z (CI+) 363.20 ((M+H)+, 25%)
and 286.00 (100); HRMS (CI+) found 363.1995, [C23H28N2P]+ requires 363.1990.
N-(2-(Diphenylphosphino)benzyl)-N,N’,N’-trimethylethane-1,2-diamine (272)
To a solution of 2-(diphenylphosphino)benzaldehyde (0.21 g, 0.73 mmol) in dichloromethane
(20 mL) at rt was added N,N,N’-trimethylethylenediamine (0.09 mL, 0.73 mmol) followed by
sodium triacetoxyborohydride (0.23 g, 1.10 mmol). To the mixture was then added glacial
acetic acid (0.13 mL, 2.20 mmol) and the reaction stirred at room temperature for 4 h. Once 1H
NMR had shown complete reduction of the imine, the reaction was quenched by addition of
acetone and the solvent was then removed under reduced pressure. The residue was dissolved
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by stirring with saturated ammonium chloride solution and dichloromethane. The organic layer
was separated, washed with water and brine, dried over magnesium sulfate, filtered and
concentrated in vacuo. Azeotropic distillation with toluene allowed removal of residual acetic
acid. Purification by flash chromatography on silica (acetone:triethylamine 98:2) yielded the
title compound as a colourless oil (0.276 g, 95 %). max/cm-1 (KBr) 3423, 3051, 2957, 2788,
2672, 2477, 1719, 1585, 1477, 1434, 1362, 1262, 1180, 1118, 1093, 1069, 1026, 805, 746, and
698; H (CDCl3, 300 MHz)† 7.41-7.32 (1H, m, CArH), 7.31-7.22 (6H, m, CArH), 7.19-7.08 (6H,
m, CArH), 6.89 (1H, dd, J 4, 1, CArH), 3.72 (2H, s, -NMeCH2Cipso), 2.77-2.61 (4H, m, -
NMeCH2CH2NMe2), 2.52 (6H, s, N(CH3)2) and 2.08 (3H, s, -NCH3-); C (CDCl3, 101 MHz)†
144.1 (d, J 23, CipsoCH2), 137.7 (d, J 10, 2 x CipsoP), 136.5 (d, J 15, CipsoP), 134.0 (CArH), 133.9
(CArH), 133.7(CArH), 129.2 (d, J 5, CArH), 128.6 (CArH), 128.4 (CArH), 128.4 (d, J 3, CArH),
127.1 (CArH), 61.1 (d, J 19, -N(CH3)-CH2-Ar), 56.9 (CH2NMe2), 54.9 (CH2N(Me)-), 45.8
(N(CH3)2) and 41.9 (NCH3); P (CDCl3, 300 MHz) -15.7; m/z (ES+) 377.10 ((M+H)+, 100%);
HRMS (ES+) found 377.2142, [C24H30N2P]+ requires 363.2147. †Assignments supported by 1H-
13C HSQC and HMBC correlations
(1R,2R)-N1-(2-(bis(4-methoxyphenyl)phosphino)benzyl)cyclohexane-1,2-diamine (289)
Prepared using the same procedure as for ligand 307 giving (R,R)-289 as gummy solid.
Due to the sensitivity of the phosphine, this material could only be obtained in ~80% purity
(~20% ligand oxide) and was thus complexed immediately without any futher purification. H
(CDCl3, 300 MHz) 7.52-7.33 (2H, m, CArH), 7.30-7.21 (1H, m, CArH), 7.16-7.01 (4H, m, CArH),
6.96-6.87 (1H, m, CArH), 6.83-6.71 (4H, m, CArH), 4.09-3.84 (1H, m, CHAHBAr), 3.72 (6H, s, -
OCH3 x 2), 3.50 (1H, dd, J 14, 7, CHAHBAr), 2.48-2.35 (1H, m, CHN), 2.30-1.47 (5H, m, CHN,
cyclohexyl CH) and 1.25-.072 (4H, m, cyclohexyl CHN); C (101 MHz, CDCl3) 162.0 (Cipso),
160.4 (Cipso), 143.9 (Cipso), 135.2 (CArH), 133.5 (CArH), 131.4 (CArH), 129.0 (CArH), 127.7
(Cipso), 127.3 (CArH), 114.5 (Cipso), 63.4 (CH), 61.1 (CH), 55.2 (OCH3), 49.3 (d, J 21, CH2Ar),
31.5 (cyclohexyl CH2), 29.7 (cyclohexyl CH2), 25.2 (cyclohexyl CH2) and 24.5 (cyclohexyl
CH2); P (CDCl3, 121 MHz) -18.8; m/z (CI+) 449.24 ([M+H]+, 90%), 337.14 (66), 261.11 (45),
203.15 (79) and 95.05 (100); HRMS (CI+) found 449.2374, C35H47ONaP requires 449.2358.
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(1R,2R)-N1-(2-(bis(3,5-dimethylphenyl)phosphino)benzyl)cyclohexane-1,2-diamine (297)
Prepared using the same procedure as for ligand 307 giving (R,R)-297 as a pale yellow solid
(0.181 g, 67 %), mp 125-127C. max/cm-1 (IR card) 3383 (s), 3028 (w), 2859 (m), 1622 (m),
1599 (m), 1446 (s), 1379 (m), 1272 (s), 1159 (m), 1128 (s), 1038 (m), 872 (w), 851 (s), 800 (m),
760 (m), 694 (s), 579 (s), 534 (w) and 486.8 (m) ; H (CDCl3, 300 MHz)† 7.47-7.36 (1H, m
CArH), 7.27-7.19 (1H, m CArH), 7.12-7.03 (2H, m CArH), 6.87 (2H, s CArH), 6.83-6.71 (4H, m,
CArH), 4.70 (2H, br s, NH2), 4.05 (1H, d (AB system, J 12, ArCHAHBNH), 3.77 (1H, d (AB
system, J 12, ArCHAHBNH), 2.54-2.34 (1H, m, CHN), 2.19 (12H, s, Ar-CH3), 2.11-1.93 (1H,
m, CHN), 1.73-0.67 (9H, m, cyclohexyl CH and NH); C (75 MHz, CDCl3)† 143.8 (Cipso),
138.6 (Cipso), 138.2 (Cipso), 136.2 (Cipso), 134.0 (CArH), 131.8 (d, J 14, CArH), 131.5 (d, J 14,
CArH), 130.7 (CArH), 129.1 (CArH), 127.4 (CArH), 60.9 (CHN), 55.8 (CHN), 49.5 (d, J 22,
CH2Ar), 32.3 (cyclohexyl CH2), 31.1 (cyclohexyl CH2), 25.0 (cyclohexyl CH2), 24.7
(cyclohexyl CH2) and 21.4 (Ar-CH3); P (CDCl3, 121 MHz) -16.1; m/z (ES+) 445.24 ([M+H]+,
100%); HRMS (ES+) found 445.2758, [C29H38N2P]+ requires 445.2773. †Assignments
supported by 1H-13C HMBC correlations.
(1R,2R)-N1-(2-(bis(3,5-di-tert-butylphenyl)phosphino)benzyl)cyclohexane-1,2-diamine
(298)
NH2
NH P
tBu
tBu
tBu
tBu
Prepared using the same procedure as for ligand 307 giving (R,R)-298 as gummy solid. Due to
the sensitivity of the phosphine, this material could only be obtained in ~60% purity and was
thus complexed immediately without any futher purification. P (CDCl3, 121 MHz) -11.8; m/z
(ES+) 613.46 ([M+H]+, 100%); HRMS (ES+) found 613.4651, C41H62N2P requires 613.4651.
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5.7 Synthesis of Ruthenium Complexes
[RuCl2((S)-BINAP)]n was purchased commercially used as received. [RuCl2(NBD)]n 282,10
trans-[RuCl2(NBD)(pip)2] 283,11 trans-[RuCl2(NBD)(py)2] 284,11 [RuCl2((S)-BINAP)((R,R)-
DPEN)] 256,12 [RuCl2((S)-TolBINAP)((R,R)-DPEN)] 1412 and [RuCl(cymene)((S,S)-DPEN)]
15113 were prepared following literature procedures exactly. [RuCl2((S)-XylPhanePhos)((R,R)-
DPEN)] 254 and [RuCl2((R)-HEXAPHEMP) ((R,R)-DPEN)] 255 were kindly donated by Dr
Reddys (formerly Chirotech).
Complex (R,R)-174
Prepared using the general procedure outlined in section 5.3.1 giving complex (R,R)-174, after
purification by column chromatography (9:1 dichloromethane:acetone), as a brown powder
(0.048 g, 83 %), mp 169-171C (lit.14 170C). []20D + 59.1 (c 0.5, chloroform), lit.14 []20D +
60.0 (c 0.5 chloroform); H (400 MHz, CDCl3) 7.59-7.09 (14H, m, CArH), 4.41-3.91 (2H, m,
ArCH2NH), 3.64-3.74 (1H, m, NH), 3.47-3.26 (2H, m, CHNH, CHNH2), 2.99 (6H, s,
SO(CH3)2), 2.72-2.52 (1H, m, cyclohexyl CH), 2.72-2.52 (1H, m, cyclohexyl CH), 1.83-1.66
(2H, m, cyclohexyl CH), 1.55 (2H, br s, NH2) and 0.91-1.29 (4H, m, cyclohexyl CH); P (121
MHz, CDCl3) +42.5. Data are in agreement with the literature.14
Complex 263
PPh2NH
N
H2
Ru
Cl
Cl
S
O
Prepared using the general procedure outlined in section 5.3.1 giving complex 263 as a
brown/red solid (0.050 g, 86 %), m.p. 166-167.5C (decomp.). Found: C, 43.55; H, 4.24; N,
3.97%; C25H33Cl2N2OPRuS + 1 CH2Cl2 requires C, 43.06; H, 4.67; N, 4.18%; max/cm-1 (KBr
disc) 3449, 2924, 2854, 1637, 1459, 1434, 1095, 1020, 752, 724, 697, 536 and 425; H (300
MHz, CDCl3)† 7.76-7.45 (2H, m, CArH), 7.43-7.20 (11H, m, CArH), 7.08 (1H t, J 9, CArH), 4.48
(1H, app dd, J 11, 11, NHCHAHBAr), 4.02 (1H, br s, NHAHB), 3.94 (1H, app dd, J 11, 11, NH),
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3.77-3.65 (2H, m, NHCHAHBAr + NHAHB), 3.53-3.36 (1H, m, CHACHBNH2), 3.02-2.74 (6H,
m, C(HA)3SOC(HB)3 + CHACHBNH2 + CHACHBNH- + CHACHBNH-) and 2.56 (3H, s,
C(HA)3SOC(HB)3); C (75.5 MHz, CDCl3)‡ 141.3 (d, J 15, CipsoCH2), 135.9 (d, J 42, CipsoP),
135.5 (d, J 10, CArH), 134.3 (d, J 10, CArH), 133.4 (d, J 2, CArH), 132.8 (d, J 40, CipsoP), 131.8
(d, J 8, CArH), 131.0 (d, J 2, CArH), 130.8 (d, J 42, CipsoP), 130.3 (d, J 3, CArH), 130.3 (d, J 2,
CArH), 129.3 (d, J 2, CArH), 128.6 (d, J 6, CArH), 128.1 (d, J 9, CArH), 57.9 (d, J 7, NHCH2Ar),
54.2 (NHCH2CH2NH2), 47.1 (CAH3SOCBH3), 45.9 (CAH3SOCBH3) and 41.9 (NHCH2CH2NH2);
P (121 MHz, CDCl3) +44.5; HRMS (ES+) found 584.0162 ([M+]), [C23H29N2OP96RuS35Cl2]+
requires 584.0153. †Assignments supported by 1H-1H COSY and 1H-13C HSQC correlations.
‡Assignments supported by 1H-13C HSQC correlations.
Complex 264
Prepared using the general procedure outlined in section 5.3.1 giving complex 264 as a
brown/red solid (0.058 g, 95 %), m.p. 174-176C (decomp.). Found: C, 49.25; H, 5.18; N,
4.34%; C25H33Cl2N2OPRuS requires C, 49.02; H, 5.43; N, 4.57%; max/cm-1 (KBr) 3449, 2921,
1637, 1435, 1307, 1261, 1098, 1017, 923, 724, 508 and 425; H (400 MHz, CDCl3) 7.78-7.51
(2H, m, CArH), 7.48-7.10 (11H, m, CArH), 6.95-6.80 (1H, t, J 8.5 Hz, CArH), 4.67-4.54 (1H, m,
NHCHAHBAr), 4.12-3.95 (1H, m, NHCHCHDCH2NMe2), 3.70-3.60 (1H, m, NHCHAHBAr),
3.55-3.38 (1H, m, NHCH2CHEHFNMe2), 3.00 (3H, s, CAH3SOCBH3), 2.96 (7H, m, N(CH3)2,
NHCHCHDCH2NMe2), 2.77 (3H, s, CAH3SOCBH3) and 2.20-2.09 (NHCH2CHEHFNMe2); C (75
MHz, CDCl3) 139.6 (d, J 15, Cipso), 134.4 (d, J 8, CArH), 133.9 (d, J 43, Cipso), 133.5 (d, J 9,
CArH), 131.7 (d, J 2, CArH), 131.5 (d, J 42, Cipso), 129.7 (CArH), 129.6 (d, J 3, CArH), 129.1 (d, J
2, CArH), 128.8 (d, J 2, CArH), 128.6 (d, J 43, Cipso), 127.8 (d, J 7, CArH), 127.2 (d, J 9, CArH),
126.4 (d, J 9, CArH), 61.9 (CH2), 56.1 (d, J 7, NHCH2Ar), 51.3 (CH2), 49.7 (N(CAH3)(CBH3)),
49.0 (N(CAH3)(CBH3)), 47.5 (CAH3SOCBH3) and 45.5 (CAH3SOCBH3); P (121 MHz, CDCl3) +
42.5; HRMS (ES+) found 607.0577 ([M+H]+), [C25H34N2OP96RuS35Cl2]+ requires 607.0574.
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Complex 265
Prepared using the general procedure outlined in section 5.3.1 giving complex 265 as a
brown/red solid (0.040 g, 65 %), m.p. > 170C (decomp.). Found: C, 49.96; H, 5.59; N, 4.44%;
C26H35Cl2N2OPRuS requires C, 49.84; H, 5.63; N, 4.47%; max/cm-1 (KBr) 3054, 2918, 1944,
1482, 1435, 1128, 1072, 1013, 958, 840, 751, 697 and 536; H (300 MHz, CDCl3)† 7.76-7.58
(2H, m, CArH), 7.50-7.24 (6H, m, CArH), 7.23-7.08 (5H, m, CArH), 6.95 (1H, t, J 9, CArH), 5.86
(1H, d, J 14, NHCAHCBHAr), 3.38-3.11 (4H, m, -N(Me)CH2CH2NMe2), 3.01 (6H, s, N(CH3)2),
2.80 (3H, s, N(CH3)CH2Ar), 2.61 (3H, s, CAH3SOCBH3), 2.40 (3H, s, CAH3SOCBH3) and 2.22
(1H, J 14, NHCAHCBHAr); C (75 MHz, CDCl3)‡ 142.0 (d, J 14, Cipso), 137.1 (d, J 42, Cipso),
136.3 (CArH), 134.2 (d, J 9, CArH), 132.9 (d, J 9, CArH), 129.7 (d, J 39, Cipso), 129.2 (d, J 10,
CArH), 129.2 (d, J 10, CArH), 128.6 (d, J 45, Cipso), 128.6 (d, J 15, CArH), 128.6 (d, J 15, CArH),
127.0 (d, J 9, CArH), 126.3 (d, J 9, CArH), 125.3 (d, J 6, CArH), 65.4 (CH2), 63.2 (CH2), 59.2
(NMeCH2Ar), 49.4 (NCH3), 48.8 (NCH3), 48.3 (NCH3), 46.0 (CAH3SOCBH3) and 43.9
(CAH3SOCBH3); P (121 MHz, CDCl3) +49.7; m/z (EI) 628.1 ([M+H]+, 100 %), 548.1 ([M-
DMSO]+, 20) and 512.1 ([M-DMSO-HCl]+, 95). †Assignments supported by 1H-1H COSY, 1H-
13C HSQC and 1H-13C HMBC correlations. ‡Assignments supported 1H-13C HSQC and 1H-13C
HMBC correlations.
Complex (R)-285
A solution of trans-[RuCl2(NBD)(py)2] 284 (0.056 g, 0.13 mmol) and (R)-BINAP (0.083 g,
0.13 mmol) in dichloromethane was heated at 120C for 1 h in the microwave. The mixture was
concentrated in vacuo and the residue recrystallised from dichloromethane/hexane to give the
title compound as orange crystals (0.087 g, 69%). H (300 MHz, CDCl3) 8.14-8.04 (2H, m,
CArH), 7.95-7.83 (4H, m, CArH), 7.68-7.56 (6H, m, CArH), 7.46 (2H, d, J 8, CArH), 7.19-7.03
(4H, m, CArH), 6.85 (2H, app t, J 8, CArH), 6.75 (4H, app t, J 8, CArH), 6.66-6.58 (2H, m CArH)
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and 6.26 (2H, d, J 8, CArH); P (121 MHz, CDCl3) +41.0. Data are in agreement with the
literature.15
Complex (R,R)-290
Prepared using the general procedure outlined in section 5.3.1 giving Complex (R,R)-290, after
column chromatography (silica, DCM:acetone 100:0 → 50:50), as a brown/red solid (0.092 g,
85 %), m.p. 177-180 C (decomp.). Found: C, 49.75; H, 5.52; N, 3.98%; C29H39Cl2N2O3PRuS
requires C, 49.86; H, 5.63; N, 4.01%; [α]D20 +37.9 (c 0.4, CHCl3); max/cm-1 (PTFE Card) 3906
(w), 3403 (m), 2928 (m), 2855 (w), 1567 (s), 1593 (m), 1500 (m), 1440 (m), 1401 (w), 1287
(m), 1251 (m), 1183 (s), 1144 (m), 1094 (s), 1056 (w), 1024 (m), 827.8 (m), 798.0 (m), 758.5
(w), 718.9 (w), 680.8 (m), 539.8 (m), 431.3 (w) and 435.2 (w); H (300 MHz, CDCl3) 7.43-7.22
(7H, m, CArH), 7.12 (1H, app ddd, J 9,8,1, CArH), 6.78 (4H, app ddd, J 13,9,2, CArH), 4.35 (1H,
t, J 11, CH), 4.00 (1H, dd, J 12,6, CH), 3.97-3.89 (1H, m, NH), 3.74 (3H, s, OCH3), 3.71 (3H, s,
OCH3), 3.24 (1H, t, J 12, CH), 3.11 (1H, qd, J 14, 4, CH), 2.98 (3H, s, C(HA)3SOC(HB)3), 2.67-
2.58 (1H, m, NH), 2.54 (3H, s, C(HA)3SOC(HB)3), 1.78-1.62 (4H, m, NH + cyclohexyl CH),
1.38 (1H, m, cyclohexyl CH), 1.24-1.08 (3H, m, cyclohexyl CH) and 0.99 (1H, m, cyclohexyl
CH); C (300 MHz, CDCl3) 160.8 (d, J 7, Cipso), 140.8 (d, J 19, Cipso), 136.9 (d, J 13, CArH),
135.6 (d, J 11, CArH), 134.0 (d, J 38, Cipso), 132.4 (CArH), 131.0 (d, J 9, CArH), 130.5 (CArH),
128.8 (d, J 9, CArH), 126.6 (d, J 46, Cipso), 122.2 (d, J 46, Cipso), 119.1 (Cipso), 113.7 (d, J 14,
CArH), 113.2 (d, J 14, CArH), 63.7 (CHN), 57.1 (CHN), 55.2 (OCH3), 55.1 (OCH3), 52.4 (d, J 8,
CH2Ar), 46.9 (C(HA)3SOC(HB)3), 45.5 (C(HA)3SOC(HB)3), 36.0 (cyclohexyl CH2), 30.6
(cyclohexyl CH2), 24.8 (cyclohexyl CH2) and 24.4 (cyclohexyl CH2); P (121 MHz, CDCl3) +
39.6 ; m/z (ES+) 584.63 ([M-Cl-DMSO]+, 100%); HRMS (ES+) found 585.1008,
[C27H33ClN2O2PRu]+ requires 585.1012.
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Complex (R,R)-297
N
H2
NH P
Ru
Cl
Cl S
O
Me
Me
Me
Me
Prepared using the general procedure outlined in section 5.3.1 giving Complex (R,R)-297, after
column chromatography (silica, DCM:acetone 75:25), as a brown/red solid (0.141 g, 70 %),
m.p. 175-176C (decomp.). This complex showed a single peak in the 31P NMR, and the
expected spectroscopic data that confirm its structure and purity, but held onto some residual
solvents even after drying preventing good microanalysis. [α]D20 +28.2 (c 0.2, CDCl3); max/cm-1
(IR card) 2921 (m), 2857 (w), 1583 (m), 1446 (m), 1268 (m), 1194 (m), 1131 (m), 1045 (s), 999
(s), 852 (m), 758 (m), 694 (s), 574 (m) and 467 (m); H (400 MHz, C6D6) † 7.40-7.05 (6H, m,
CArH), 7.02-6.87 (4H, m, CArH), 4.32 (1H, app t, J 10, CHAHBAr), 4.10-3.95 (2H, m, NH +
CHAHBAr), 3.82-3.65 (1H, br s, NH), 3.34-3.09 (2H, m, NH + CH), 3.05 (3H, s,
C(HA)3SOC(HB)3), 2.66-2.58 (1H, m, CH), 2.43 (3H, s, C(HA)3SOC(HB)3), 2.17 (6H, 2 x Ar-
CH3), 2.14 (6H, 2 x Ar-CH3), 1.80-1.58 (3H, m, cyclohexyl CH), and 1.42-0.90 (5H, m,
cyclohexyl CH); C (101 MHz, C6D6) ‡ 139.9 (d, J 15, Cipso), 136.5 (d, J 10, Cipso-CH3), 135.7 (d,
J 10, Cipso-CH3), 134.0 (d, J 40, Cipso), 132.4 (d, J 40, Cipso), 132.0 (CArH), 131.9 (CArH), 131.6
(CArH), 130.7 (CArH), 130.5 (d, J 11, CArH), 129.8 (d, J 7, CArH), 129.5 (d, J 44, CArH), 129.4
(CArH), 127.7 (d, J 6, CArH), 62.9 (CHN), 55.9 (CHN), 51.5 (d, J 8, CH2Ar), 45.7
(C(HA)3SOC(HB)3), 43.9 (C(HA)3SOC(HB)3), 34.9 (cyclohexyl CH2), 29.6 (cyclohexyl CH2),
23.8 (cyclohexyl CH2), 23.4 (cyclohexyl CH2), 20.5 (Ar-CH3) and 20.4 (Ar-CH3); P (121 MHz,
CDCl3) +40.6; m/z (ES+) 717.11 ([M+Na]+, 100%); HRMS (ES+) found 717.1176,
[C31H43Cl2N2PRuSNa]+ requires 711.1179. †Assignments supported by 1H-1H COSY, 1H-13C
HSQC and 1H-13C HMBC correlations. ‡Assignments supported by 1H-13C HSQC and HMBC
correlations.
Complex (R,R)-298
Prepared using the general procedure outlined in section 5.3.1 giving Complex (R,R)-298, after
column chromatography (silica, DCM:acetone 80:20), as a brown/red solid (0.030 g, 50 %),
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m.p. 180-181C (decomp.). This complex showed a single peak in the 31P NMR, and the
expected spectroscopic data that confirm its structure and purity, but held onto some residual
solvents even after drying preventing good microanalysis. [α]D20 +50.0 (c 0.2, CDCl3); max/cm-1
(IR card); 3287 (br s), 2960 (m), 2140 (w), 1634 (m), 1476 (w), 1362 (w), 1263 (w), 1201 (m),
1147 (w), 1093 (w), 1015 (m), 798 (w), 752 (w), 709 (w), 637 (w), 601 (w) and 489 (w); H
(400 MHz, C6D6) 7.87-7.78 (2H, m, CArH), 7.68 (1H, app t, J 8, CArH), 7.42-7.39 (1H, m,
CArH), 7.36-7.33 (1H, m, CArH), 7.10-6.96 (4H, m, CArH), 6.80 (1H, dd, J 7, 3, CArH), 4.53 (1H,
t, J 12, CH), 4.14 (1H, br s, NH), 3.87-3.76 (1H, m, CH), 3.44 (1H, dd, J 12, 4, CH), 3.21 (3H,
s, C(HA)3SOC(HB)3), 2.94 (1H, dd, J 12, 4, CH), 2.26 (3H, s, C(HA)3SOC(HB)3, 1.76 (1H, d, J
12, cyclohexyl CH), 1.27-0.73 (9H, m, cyclohexyl CH, NH2), 1.17 (18H, s, 2 x C(CH3)2) and
1.10 (18H, s, 2 x C(CH3)2); C (300 MHz, C6D6) 150.4 (d, J 9, Cipso), 150.1 (d, J 9, Cipso), 141.8
(d, J 17, Cipso), 135.9 (d, J 40, Cipso), 134.9 (d, J 36, Cipso), 132.6 (CArH), 132.6 (CArH), 132.1 (d,
J 40, Cipso), 131.1 (CArH), 131.1 (CArH), 130.9 (CArH), 129.9 (CArH), 123.4 (CArH), 122.4
(CArH), 63.8 (CHN), 56.6 (CHN), 52. 6 (d, J 8, CH2Ar), 46.7 (C(HA)3SOC(HB)3), 44.3
(C(HA)3SOC(HB)3), 35.1 (cyclohexyl CH2), 35.1 (cyclohexyl CH2), 35.0 (cyclohexyl CH2), 34.9
(cyclohexyl CH2), 31.4 (C(CH3)3), 31.2 (C(CH3)3), 24.4 (C(CH3)3) and 24.1 (C(CH3)3); P (162
MHz, CDCl3) +45.2; m/z (ES+) 748.71 ([M-Cl-DMSO]+, 100%); HRMS (ES+) found
749.3304, [C41H61ClN2PRu]+ requires 749.3302.
Complex (R,R)-302
The DPEN-derived ligand (R,R)-301 was prepared in the same manner as ligand (R,R)-307 and
NMR analysis of the reaction mixture after treatment with sodium borohydride for 16 h showed
complete conversion to one phosphorus containing species believed to be the desired product
(δP = -7.9 ppm (C6D6)), disappearance of imine proton at 9.17 ppm in 1H NMR spectrum). Upon
work-up however, the 31P NMR spectrum showed the presence of three species at δP (C6D6) = -
9.6, -15.9 and -16.2 ppm ( ~ 3:1:1). Due to the apparent inseparability of the species and the
sensitive nature of such compounds, it was decided to use the crude mixture directly in the
complexation reaction, as described in the general procedure. This gave phosphorus containing
species at δP (CDCl3) = +42.4, -16.4 and -16.9 ppm (~3:1:1). It was believed that the species at
δP (CDCl3) = +42.4 corresponded to the desired complex and indeed following column
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chromatography on silica (DCM:acetone 80:20), analytically pure complex (R,R)-302 was
furnished as a red/orange solid (0.100 g, 62 %), m.p. 187-189C (decomp.). Found: C, 56.86; H,
4.82; N, 3.68%; C35H37Cl2N2OPRuS requires C, 57.06; H, 5.06; N, 3.80%; [α]D20 +79.3 (c 0.2,
CHCl3); max/cm-1 (IR card) 3411 (br, s), 1278 (br, s), 1179 (s), 1061 (m), 700 (m), 573 (w), 534
(w), 432 (w) and 415 (w); H (400 MHz, CDCl3) † 7.59-7.41 (4H, m, CArH), 7.37-7.22 (10H, m,
CArH), 7.18-7.03 (8H, m, CArH), 6.77-6.67 (1H, m, CArH), 4.78-4.70 (1H, m, CHN), 4.51 (1H,
br s, NH), 4.43-4.27 (3H, m, CHAHBAr +NH2), 4.13-4.06 (1H, m, CHN), and 3.54-3.44 (1H, m,
CHAHBAr); C (100 MHz, CDCl3)‡ 140.6 (d, J 16, Cipso), 139.4 (Cipso), 136.7 (Cipso), 135.6
(Cipso), 135.3 (CArH), 135.2 (CArH), 134.0 (CArH), 132.9 (Cipso), 132.7 (CArH), 132.5 (Cipso),
130.8 (CArH), 130.7 (CArH), 130.0 (CArH), 130.0 (CArH), 128.9 (CArH), 128.6 (CArH), 128.3
(CArH), 128.2 (CArH), 128.2 (CArH), 127.8 (CArH), 127.6 (CArH), 127.4 (CArH), 71.6 (CHN),
63.2 (CHN), 54.1 (d, J 7, CH2Ar), 47.0 (C(HA)3SOC(HB)3) and 45.3 (C(HA)3SOC(HB)3); P (162
MHz, CDCl3) +42.4; m/z (ES+) 623.1 ([M-Cl-DMSO]+, 100%); HRMS (ES+) found 623.0956,
[C33H31ClN2PRu]+ requires 623.0956. †Assignments supported by 1H-1H COSY, 1H-13C HSQC
and 1H-13C HMBC correlations. ‡Assignments supported by 1H-13C HSQC and HMBC
correlations.
5.8 Preparation of Substrates
Acetophenone 81, isobutyrophenone 82, trimethylacetophenone 159 and styrene 286 were
purchased commercially and used as received. 2,2-Dimethyl-1-(2-furyl)-1-propanone 210 and
1,1'-(Furan-2,5-diyl)bis(2,2-dimethylpropan-1-one) 226 were prepared in this laboratory by Jose
A. Fuentes.
2-Methyl-1,2-diphenylpropan-1-one (183)
Prepared following a literature procedure.16 To a suspension of
bis(dibenzylideneacetone)palladium (0) (53.0 mg, 0.09 mmol), 1,1’-di-tert-
butylphosphino)ferrocene (69.0 mg, 0.12 mmol) and sodium tert-butoxide (660 mg, 6.89 mmol)
in tetrahydrofuran were added bromobenzene (721 mg, 4.59 mmol) and isobutyrophenone (749
mg, 5.05 mmol). The reaction mixture was then warmed to 50C for 6 h. The mixture was
subsequently diluted with ether and washed with water and brine. The organic layer was dried
over MgSO4 and concentrated in vacuo. The residue was chromatographed on silica gel (95:5
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hexane:diethyl ether) to give the pure product as a colourless solid (0.55 g, 49 %), m.p. 45-
46C (lit.17 46-47C). H (300 MHz, CDCl3) 7.46-7.37 (2H, m, CArH), 7.33-7.23 (5H, m, CArH),
7.22-7.08 (3H, m, CArH) and 1.53 (6H, s, C(CH3)2; C (75 MHz CDCl3) 202.7 (C=O), 144.2
(COCipso), 135.2 (C(CH3)2Cipso), 130.6 (CArH), 128.8 (CArH), 128.0 (CArH), 126.9 (CArH), 125.7
(CArH), 124.7 (CArH), 50.4 (C(CH3)2) and 26.8 (C(CH3)2); m/z (ES+) 247.08 ((M+Na)+, 100 %).
Data are in agreement with the literature.16
2-Ethyl-1,2-diphenylbutan-1-one (184)
To a suspension of sodium hydride (0.37 g, 15.29 mmol) in tetrahydrofuran (40 mL) at 0C was
added a solution of deoxybenzoin (1.00 g, 5.10 mmol) in tetrahydrofuran (10 mL), dropwise via
cannula. The mixture was allowed to warm to rt and stirred for one hour before recooling to
0C. Iodoethane (1.22 mL, 15.29 mmol) was then added dropwise and the mixture allowed to
warm to rt over 16 h with stirring. Excess sodium hydride was then quenched with cautious
addition of ethyl acetate and followed by water. The reaction mixture was partitioned between
water and diethyl ether and the organic fractions collected. Subsequent drying of the organic
phase over magnesium sulfate, filtration and concentration of the filtrate yielded the product.
NMR examination of the product showed it to be a mixture of the mono- and di-alkylated
ketone. This crude material was then resubjected to the initial reaction conditions, first by
dropwise addition to a suspension of sodium hydride (0.37 g, 15.29 mmol) in tetrahydrofuran
(40 mL) at 0C, then after a period of stirring between 0C and rt, addition of iodoethane (1.22
mL, 15.29 mmol) and continuation of stirring for 16 h. Quenching of the reaction followed by
work-up as described previously furnished the dialkylated ketone exclusively. Purification by
short-path distillation yielded the ketone (0.86 g, 67 %) as a colourless oil. H (400 MHz,
CDCl3) 7.34-7.25 (5H, m, CArH), 7.23-7.17 (3H, m, CArH), 7.15-7.09 (2H, m, CArH), 2.14-1.98
(4H, m, C(CH2CH3)2 and 0.57 (6H, t, J 7.5, C(CH2CH3)2); C (75 MHz CDCl3) 215.9 (C=O),
143.0 (COCipso), 137.4 (Cipso), 131.5 (CArH), 129.3 (CArH), 128.8 (CArH), 127.9 (CArH), 127.0
(CArH), 126.8 (CArH), 58.6 (C(CH2CH3)2), 26.4 (C(CH2CH3)2) and 7.8 (C(CH2CH3)2); m/z
(ES+) 275.18 ((M+Na)+, 100 %). Data are in agreement with the literature.18
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1-(4-Methoxyphenyl)-2,2-dimethylpropan-1-one (197)
Prepared by modification of literature procedures.19,20 To a suspension of copper bromide
dimethyl sulfide complex (1.33 g, 6.49 mmol) in tetrahydrofuran (20 mL) at -78C was added a
1.7 M solution of tert-butyllithium in pentane (4.33 mL, 6.49 mmol). After stirring for 30 min, a
solution of 4-methoxybenzoyl chloride (1.00 g, 5.86 mmol) in tetrahydrofuran (5 mL) was
added slowly via cannula. After stirring for 4 h, the reaction was quenched by addition of
saturated ammonium chloride solution and the organic layer separated. The aqueous layer was
extracted with diethyl ether and the organic fractions combined, dried over magnesium sulfate,
filtered and concentrated in vacuo. The residue was purified by short-path distillation to yield
the product as a colourless oil (0.73 g, 65 %). H (300 MHz, CDCl3) 7.81-7.74 (2H, d, J 9,
CArH), 6.85-6.79 (2H, d, J 9, CArH), 3.78 (3H, s, OCH3) and 1.30 (9H, s, C(CH3)3; C (75 MHz
CDCl3) 206.3 (C=O), 162.0 (COCipso), 131.0 (CArH), 130.1 (CipsoOMe), 113.2 (CArH), 55.4
(OCH3), 43.9 (C(CH3)3) and 28.4 (C(CH3)3); m/z (CI+) 193.1 ((M+H)+, 100 %), 135.1, 109.1
and 85.1. Data are in agreement with the literature.21
1-(4-Chlorophenyl)-2,2-dimethylpropan-1-one (198)
Prepared by same method as for compound 197 giving the product as a colourless oil (0.75 g, 67
%). H (300 MHz, CDCl3) 7.62-7.56 (2H, m, CArH), 7.32-7.26 (2H, m, CArH) and 1.26 (9H, s,
C(CH3)3); C (75 MHz CDCl3) 207.7 (C=O), 137.2 (Cipso), 136.5 (Cipso), 129.6 (CArH), 128.4
(CArH), 44.2 (C(CH3)3) and 28.0 (C(CH3)3); m/z (ES+) 219.02 ((M+H)+, 100 %). Data are in
agreement with the literature.22
1-(4-Trifluoromethyl)-2,2-dimethylpropan-1-one (199)
Prepared by same method as for compound 197 giving the product as a colourless oil (0.83 g, 49
%). H (400 MHz, CDCl3) 7.66-7.61 (2H, m, CArH), 7.59-7.55 (2H, m, CArH) and 1.24 (9H, s,
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C(CH3)3); C (101 MHz, CDCl3) 208.9 (C=O), 142.1 (COCipso), 127.8 (q, 2JCF 32.9, CipsoCF3),
125.1 (q, 3JCF 3.6, CArHCCF3), 123.7 (q, 1JCF 272.6, CF3), 44.4 (C(CH3)3) and 27.7 (C(CH3)3); F
(376 MHz, CDCl3) - 63.5; m/z (CI+) 231.10 (M+H+, 100 %). Data are in agreement with the
literature.21
1-(2-Methoxyphenyl)-2,2-dimethylpropan-1-one (200)
Prepared by same method as for compound 197 giving the product as a colourless oil (1.62 g, 70
%). H (300 MHz, CDCl3) 7.28-7.20 (1H, m, CArH), 6.98-6.90 (1H, m, CArH), 6.89-6.78 (2H,
m, CArH), 3.71 (3H, s, OCH3) and 1.14 (9H, s, C(CH3)3; C (101 MHz CDCl3) 213.9 (C=O),
155.3 (COCipso), 129.9 (CipsoOMe), 126.3 (CArH), 120.2 (CArH), 110.9 (CArH), 55.3 (OCH3), and
26.8 (C(CH3)3); m/z (ES+) 215.11 ((M+Na)+, 100 %). Data are in agreement with the
literature.23
2,2-Dimethyl-1-(pyridin-4-yl)propan-1-one (209)
To a suspension of sodium hydride (1.72 g, 71.75 mmol) in tetrahydrofuran (120 mL) at 0C
was added a solution of 4-acetylpyridine (0.91 mL, 8.21 mmol) in tetrahydrofuran (10 mL)
dropwise via cannula. The mixture was allowed to warm to rt and stirred for one hour before
recooling to 0 ºC. Iodomethane (4.48 mL, 72.00 mmol) was then added dropwise and the
mixture stirred between 0 ºC and rt for 16 h. Excess sodium hydride was then quenched with
cautious addition of ethyl acetate followed by water. The reaction mixture was partitioned
between water and diethyl ether and the organic fractions collected. Subsequent drying of the
organic phase over magnesium sulfate, filtration and concentration of the filtrate yielded the
product. NMR examination of the product showed it to be a mixture of the tri- and di-alkylated
ketone. This crude material was then resubjected to the initial reaction conditions, first by
dropwise addition to a suspension of sodium hydride (1.72 g, 71.75 mmol) in tetrahydrofuran
(120 mL) at 0C, then after a period of stirring between 0C and rt, addition of iodomethane
(4.48 mL, 72.00 mmol) and continuation of stirring for 16 h. Quenching of the reaction
followed by work-up as described previously, furnished the trialkylated ketone exclusively.
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Purification by short-path distillation yielded the ketone (1.35 g, 57 %) as a colourless oil. H
(300 MHz, CDCl3) 8.65-8.58 (2H, m, CArH), 7.33-7.29 (2H, m, CArH) and 1.23 (9H, s,
C(CH3)3); C (75 MHz CDCl3) 209.1 (C=O), 150.3 (CArH), 146.4 (Cipso), 121.4 (CArH), 44.8
(C(CH3)3) and 27.6 (C(CH3)3); m/z (CI+) 164.11 ((M+H)+, 100 %). Data are in agreement with
the literature.24
1-(Thien-2-yl)-2,2-dimethylpropan-1-one (211)
O
S
To a solution of thiophene (3.20 mL, 40 mmol) and pivaloyl chloride (4.92 mL, 40 mmol)
in toluene (40 mL) at 0C was added a solution of stannic chloride (10.5 g, 40 mmol)
dropwise over a period of 15 min. The reaction mixture was stirred for a further 1 h at rt. It
was then diluted with diethyl ether and added to 2M hydrochloric acid solution (30 mL).
The organic layer was separated and washed thoroughly with water, dried with magnesium
sulfate, filtered and concentrated in vacuo. Purification by short-path distillation furnished
the pure product as a colourless oil (5.04 g, 75 %). H (CDCl3, 400 MHz) 7.71 (1H, dd, J 4,
1, CArH), 7.49 (1H, dd, J 5, 1, CArH), 7.04 (1H, dd, J 5, 4, CArH) ands, C(CH3)3);
C (CDCl3, 75 MHz) 199.0 (C=O) 142.6 (Cipso), 132.4 (CArH), 131.9 (CArH), 127.8 (CArH),
43.9 C(CH3)3) andC(CH3)3); m/z (ES+) 190.96 ([M+Na]+, 100%) and 358.97
([M+Na]+, 50). Data are in agreement with the literature.25
N-Hydroxy-4-methoxybenzimidoyl chloride (217)
Prepared by modification of literature procedures.26,27 To a mixture of 4-methoxybenzaldehyde
215 (6.09 mL, 50.00 mmol) in water (12.5 mL), absolute ethanol (12.5 mL) and ice (ca. 10 mL)
was added hydroxylamine hydrochloride (3.82 g, 55.00 mmol). To this was added 50 % sodium
hydroxide solution (125.00 mmol) and the mixture was stirred for 1 h whilst maintaining the
temperature between 25-30C by the addition of further ice. The mixture was then extracted
with diethyl ether, acidified with concentrated hydrochloric acid then further extracted with
diethyl ether (x2). The latter two extracts were combined, dried with magnesium sulfate, filtered
and concentrated to give solid oxime (5.35 g, 71 %). H (400 MHz, CDCl3) 8.68 (1H, br s,
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NOH), 8.14 (1H, s, N=CHAr), 7.57-7.53 (2H, m, CArH), 6.97-6.91 (2H, m, CArH) and 3.86 (3H,
s, OCH3). The oxime 216 (5.35 g, 40.00 mmol) was dissolved in N,N-dimethylformamide (50
mL) and to this was added N-chlorosuccinimide (5.35 g, 40.00 mmol) portionwise, allowing for
an initial induction period and avoiding vigorous reaction by cooling using a dry ice bath.
Completion of the reacton was indicated by the cessation of the exotherm and the reaction
mixture was then poured into four volumes of ice water. The mixture was extracted twice with
diethyl ether, washed with water, dried over magnesium sulfate, filtered and concentrated to
yield the product 217 as a yellow solid (4.83 g, 65 %), mp 106-108C (lit.27 112-112.5C. H
(400 MHz, CDCl3) 9.35 (1H, br s, NOH), 7.84-7.76 (2H, m, CArH), 6.97-6.89 (2H, m, CArH)
and 3.86 (3H, s, OCH3). Data are in agreement with the literature.26
[5-n-Butyl-3-(4-methoxyphenyl)isoxazol-4-yl](4-methoxyphenyl)methanone (212)
Prepared following a literature procedure.28 To a solution of
bis(triphenylphosphine)palladium(II) dichloride (0.022 g, 0.03 mmol) and copper (I) iodide
(0.012 g, 0.06 mmol) in degassed tetrahydrofuran (4 mL) in a microwave vial under nitrogen
was added 4-methoxybenzoyl chloride 218 (0.21 mL, 1.53 mmol), hex-1-yne 219 (0.18 mL,
1.53 mmol) and triethylamine (0.22 mL, 1.60 mmol). The mixture was stirred for 1 h before N-
hydroxy-4-methoxybenzimidoyl chloride 217 (0.28 g, 1.53 mmol) and triethylamine (0.23 mL,
1.68 mmol) were added. The mixture was then heated under microwave conditions at 90C for
30 min. After cooling to room temperature, the solvent was removed in vacuo and the crude
product was purified by flash column chromatography (hexane:diethyl ether, 3:1) to yield the
pure product as a viscous colourless oil (0.117 g, 21 %). H (400 MHz, CDCl3) 7.67-7.62 (2H,
m, CArH), 7.39-7.34 (2H, m, CArH), 6.77-6.69 (4H, m, CArH), 3.75 (3H, s, OCH3), 3.69 (3H, s,
OCH3), 2.72 (2H, t, J 7.5, -CH2CH2CH2CH3), 1.68-1.55 (2H, m, -CH2CH2CH2CH3), 1.25 (2H,
sext, J 8, -CH2CH2CH2CH3) and 0.80 (3H, t, J 7, -CH2CH2CH2CH3); C (101 MHz, CDCl3)
188.0 (Cquat), 174.1 (Cquat), 162.9 (Cquat), 160.0 (Cquat), 159.6 (Cquat), 131.0 (CArH), 129.3 (Cquat),
128.8 (CArH), 119.7 (Cquat), 114.0 (Cquat), 113.0 (CArH), 112.8 (CArH), 54.5 (OCH3), 54.2
(OCH3), 28.6 (-CH2CH2CH2CH3), 25.3 (-CH2CH2CH2CH3), 21.2 (-CH2CH2CH2CH3) and 12.5
(-CH2CH2CH2CH3); m/z (ES+) 388.15 ((M+Na)+, 100 %). Data are in agreement with the
literature.28
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3-(Benzyloxy)-2,2-dimethylpropan-1-ol (241)
Following the literature procedure of Onomura,31 neopentyl glycol (0.277 g, 2.7 mmol) and
potassium carbonate (0.55 g, 4.0 mmol) were added to a solution of p-fluorophenylboronic acid
(0.038 g, 0.27 mmol) and benzyl bromide (0.48 mL, 4.0 mmol) in DMF (10 mL) and the
reaction stirred at rt for 36 h. After this time, the mixture was poured into water and extracted
with ethyl acetate. The organic component was dried over magnesium sulfate, filtered and
concentrated in vacuo to give the crude product as colourless oil (0.420 g, 80%), which was
deemed sufficiently pure for the next step. H (CDCl3, 300 MHz) 7.31-7.17 (5H, m, CArH), 4.44
(2H, s, CH2Ph), 3.38 (2H, s, CH2), 3.25 (2H, s, CH2), 2.56 (1H, br s, OH) and 0.86 (6H, s,
C(CH3)2). Data are in agreement with the literature.32
3-(Benzyloxy)-2,2-dimethylpropanal (242)
To a solution of oxalyl chloride (0.30 mL, 3.50 mmol) in dichloromethane (6 mL) at -78C was
added dimethylsulfoxide (0.50 mL, 7.00 mmol) and the mixture stirred for 5 min. To this, 3-
(benzyloxy)-2,2-dimethylpropan-1-ol 241 (0.340 g, 1.75 mmol) was added and the reaction
stirred for a further 30 min at -78C, before addition of triethylamine (0.93 mL, 7.00 mmol) and
stirring again for 45 min. After this period, the mixture was warmed to rt and 2M HCl (3 mL)
was added. The mixture was extracted with dichloromethane, washed with brine, dried over
magnesium sulfate, filtered and concentrate in vacuo. Flash chromatography on silica (19:1
hexane:ethyl acetate) gave the title compound as a colourless oil (0.272 g, 81%). H (CDCl3, 300
MHz) 9.46 (1H, s, CHO), 7.29-7.13 (5H, m, CArH), 4.40 (2H, s, CH2Ph), 3.36 (2H, s, CH2) and
0.99 (6H, s, C(CH3)2). Data are in agreement with the literature.32#
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3-(Benzyloxy)-2,2-dimethyl-1-phenylpropan-1-ol (231)
To a solution of 3-(benzyloxy)-2,2-dimethylpropanal 242 (0.105 g, 0.55 mmol) in diethyl ether
at -78C was added phenylmagnesium bromide (0.219 mL, 3M solution in Et2O, 0.66 mmol)
and stirred for 1 h. The reaction was allowed to warm to rt and stirred for 16 h. After this time,
the reaction was quenched with water, then extracted with diethyl ether. The organic component
was dried over magnesium sulfate, filtered and concentrated in vacuo to give the product as a
colourless oil which was used directly in the next step. H (CDCl3, 300 MHz) 7.31-7.14 (10H,
m, CArH), 4.53 (1H, s, CHOH) 4.49 (2H, s, CH2Ph), 3.87 (1H, br s, CHOH), 3.31 (1H, d, AB
system, J 9, CHAHB), 3.23 (1H, d, AB system, J 9, CHAHB), 0.82 (3H, s, C((CAH3)(CBH3))) and
0.81 (3H, s, C((CAH3)(CBH3))); C (CDCl3, 300 MHz) 139.9 (Cipso), 138.5 (Cipso), 128.5 (CArH),
128.3 (CArH), 127.7 (CArH), 127.7 (CArH), 127.6 (CArH), 127.2 (CArH), 81.5 (CHOH), 79.7
(CH2), 74.0 (CH2), 33.1 (C(CH3)2, 23.3 C(CAH3)(CBH3) and 20.1 C(CAH3)(CBH3); m/z (ES+)
293.07 ([M+Na]+, 100%) and 563.16 ([2M+Na]+, 100); HRMS (ES+) found 293.1518,
C18H22O2Na requires 293.1517.
3-(Benzyloxy)-2,2-dimethyl-1-phenylpropan-1-one (239)
To a solution of oxalyl chloride (0.094 mL, 1.09 mmol) in dichloromethane (6 mL) at -78C
was added dimethylsulfoxide (0.170 mL, 2.18 mmol) and the mixture stirred for 5 min. To this,
3-(benzyloxy)-2,2-dimethyl-1-phenylpropan-1-ol 231 (0.148 g, 0.55 mmol) was added and the
reaction stirred for a further 30 min at -78C, before addition of triethylamine (0.304 mL, 2.18
mmol) and stirring again for 45 min. After this period, the mixture was warmed to rt and 2M
HCl (3 mL) was added. The mixture was extracted with dichloromethane, washed with brine,
dried over magnesium sulfate, filtered and concentrate in vacuo. Flash chromatography on silica
(19:1 hexane:ethyl acetate) gave the title compound as a colourless oil (0.102 g, 69%). H
(CDCl3, 300 MHz) 7.56-7.49 (2H, m, CArH), 7.40-7.14 (8H, m, CArH), 4.39 (2H, s, CH2Ph),
3.54 (2H, s, CH2) and 1.27 (6H, s, C(CH3)2); C (CDCl3, 75 MHz) 208.9 (C=O), 139.5 (Cipso),
138.2 (Cipso), 130.5 (CArH), 128.3 (CArH), 128.0 (CArH), 127.5 (CArH), 127.5 (CArH), 127.2
(CArH), 73.5 (CH2), 48.9 (CH2), 25.4 (C(CH3)2) and 23.4 (C(CH3)2).
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4,4-Dimethyl-5-oxo-5-phenylpentanenitrile (237)
In a similar procedure to that reported by Campbell,29 acrylonitrile (2.62 mL, 0.04 mol) was
added dropwise with stirring to a solution of isobutyrophenone (6.00 mL, 0.04 mol) in dioxane
(10 mL) containing 30 % solution of potassium hydroxide in methanol (0.5 mL). This solution
was heated at 50 oC for 24 h. After this time, the mixture was poured into water and the oil
separated. Column chromatography of this oil on silica (Hexane:EtOAc 9:1) yielded the title
compound as a colourless oil (1.71 g, 21 %). H (CDCl3, 300 MHz) 7.72-7.65 (2H, m, CArH),
7.55-7.40 (3H, m, CArH), 2.39-2.30 (2H, m, CH2), 2.18-2.10, (2H, m, CH2) and 1.42 (6H, s,
C(CH3)2; C (CDCl3, 75 MHz) 207.0 (C=O), 137.9 (Cipso), 131.6 (CArH), 128.4 (CArH), 127.8
(CArH), 119.8 (CN), 47.0 (C(CH3)2), 36.4 (CH2), 25.8 (C(CH3)2) and 13.1 (CH2); m/z (ES+)
224.01 ([M+Na]+, 100 %) and 425.03 ([2M+Na]+, 25). Data are in agreement with the
literature.30
2-(1H-Imidazol-1-yl)-2-methyl-1-phenylpropan-1-one (244)
Prepared by modification of a literature procedure.33 A solution of imidazole (3.40 g, 49.90
mmol) and 2-bromo-2-methylpropiophenone (4.00 mL, 23.80 mmol) in absolute ethanol (40
mL) was refluxed for 3 days. The mixture was then partitioned between diethyl ether and water
and the organic phase collected, dried with magnesium sulfate, filtered and concentrated to yield
a yellow sticky solid. Recrystallisation from dichloromethane/hexane (1:2) afforded the desired
ketone (3.14 g, 62 %) as a yellow solid. mp 118-119C (lit. 117-119C) H (300 MHz, CDCl3)
7.63 (1H, br s, CArH), 7.43-7.35 (1H, m, CArH), 7.26-7.21 (4H, m, CArH), 7.08 (1H, br s, CArH),
6.90 (1H, br s, CArH) and 1.79 (6H, s, C(CH3)2); C (75 MHz CDCl3) 198.5 (C=O), 134.8
(CArH), 134.5 (Cipso), 132.9 (CArH), 130.3 (CArH), 128.6 (CArH), 128.5 (CArH), 117.4 (CArH),
64.9 (C(CH3)2) and 27.2 (C(CH3)2); m/z (CI+) 215.12 ((M+H)+, 100 %). Data are in agreement
with the literature.33
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Ethyl 2-cyano-5-oxo-5-phenylpentanoate (251)
Prepared following the procedure of Wessig.34 To a solution of 1-phenylprop-2-ene-1-one 249
(0.841 g, 6.40 mmol) and ethyl cyanoacetate 250 (0.677 mL, 6.40 mmol) in tetrahydrofuran
wass added potassium carbonate (0.089 g, 6.50 mmol) and 18-crown-6 (0.142 mL, 0.66 mmol)
and the mixture stirred for 2 h. After this period, water was added and the mixture diluted with
diethyl ether. The organic component was separated, washed with further water, dried over
magnesium sulfate, filtered, and concentrated in vacuo giving product that was deemed pure
enough for direct use in the next step. H (400 MHz, CDCl3) 8.00-7.94 (2H, m, CArH), 7.62-7.56
(1H, m, CArH), 7.50-7.44 (2H, m, CArH), 4.26 (2H, q, J 7, CH2CH3), 3.82 (1H, dd, J 10, 7, CH),
3.25 (2H, t, J 7, COCH2), 2.56-2.24 (2H, m, COCH2CH2) and 1.32 (3H, t, CH2CH3). Data are in
agreement with the literature.34
5-Oxo-5-phenylpentanenitrile (252)
Following the procedure of Wessig,34 the ester 251 (0.90 g, 3.7 mmol), sodium chloride (0.20 g,
3.8 mmol) and water (2 mL) in dimethylsulfoxide (20 mL) were refluxed for 24 h. After this
time, the mixture was diluted with further water and extracted with diethyl ether. The organic
component was dried over magnesium sulfate, filtered and the solvent removed in vacuo. Flash
chromatography on silica (10:2 petroleum ether:ethyl acetate) furnished the product as a
colourless oil (0.320 g, 50%); H (300 MHz, CDCl3) 7.99 (2H, d, J 7, CArH), 7.66-7.55 (1H, m,
CArH), 7.55-7.44 (2H, m, CArH), 3.20 (2H, t, J 7, CH2), 2.54 (2H, t, J 7, CH2) and 2.13 (2H, app
pent, J 7, CH2); C (75 MHz, CDCl3) 198.3 (C=O), 136.5 (Cipso), 133.6 (CArH), 128.8 (CArH),
128.1 (CArH), 119.6 (CN), 36.5 (CH2), 19.9 (CH2) and 16.6 (CH2). m/z (ES+) 196.07 ((M+Na)+,
100%); HRMS (ES+) found 196.0743, [C11H11NONa]+ requires 196.0738. Data are in
agreement with the literature.34
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5.9 Data for Hydrogenation Products
1-Phenylethanol (12)
[α] D
20 -32.0 (60% e.e., c 2.5, CHCl3) (lit.51 [α]D25 -45.0 (S, 99% e.e., c 5.0, methanol)); H (400
MHz, CDCl3) 7.18-7.33 (5H, m, CArH), 4.84 (1H, q, J 6, CHOH), 1.63 (1H, br s, -OH) and 1.43
(3H, d, J 6, CH3). Enantioselectivity determined by HPLC, ChiralPak OD-H, 0.5 mL/min, 95:5
hexane:2-propanol. Retention times: 17.4 min ((R)-(+)-enantiomer) and 21.2 min ((S)-(–)-
enantiomer). Data are in agreement with the literature.50
2-Methyl-1-phenylpropan-1-ol (83)
[α] D
20 -30.1 (48% e.e., c 1, acetone) (lit.14 [α]D25 -28.6 (S, 48 % e.e., c 0.16, acetone)); H (300
MHz, CDCl3) 7.24-7.11 (5H, m, ArCH); 4.18 (1H, d, J 6.8, CHOH), 2.23 (br s, 1H, CHOH),
1.82 (1H, m, CH(CH3)2), 0.87 (3H, d, J 6.8, CH(CAH3)(CBH3)) and 0.67 (3H, d, J 6.8,
CH(CAH3)(CBH3)). Enantioselectivity determined by HPLC. ChiralPak OD-H, 0.5 ml/min,
90:10 hexane:2-propanol. Retention times: 10.8 min (S, major enantiomer) and 11.8 min (R,
minor enantiomer). Data are in agreement with the literature.48
2-Methyl-1,2-diphenylpropan-1-ol (187)
[]20D -34.0 (84% e.e., c 0.1, chloroform); H (300 MHz, CDCl3) 7.36-7.21 (4H, m, CArH),
7.20-7.14 (4H, m, CArH), 7.09-7.03 (2H, m, CArH), 4.69 (1H, s, CHOH), 1.63 (1H, br s,
CHOH), 1.25 (3H, s, C(CAH3CBH3)) and 1.21 (3H, s, C(CAH3CBH3)); C (75 MHz CDCl3)
145.3 (Cipso), 139.8 (Cipso), 127.1 (CArH), 126.8 (CArH), 126.3 (CArH), 126.3 (CArH), 125.9
(CArH), 125.3 (CArH), 81.0 (CHOH), 42.1 (C(CH3)2), 24.7 (C(CAH3CBH3)) and 21.4
(C(CAH3CBH3)); m/z (ES+) 249.09 ((M+Na)+, 100 %). Enantioselectivity determined by chiral
HPLC. ChiralPak AD, 1.0 mL/min, 95:5 hexane:2-propanol. Retention times: 9.5 min (major
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enantiomer) and 11.1 min (minor enantiomer). Data are in agreement with the literature for the
racemic compound that has been reported before.35
2-Ethyl-1,2-diphenylbutan-1-ol (188)
[]20D -28.1 (75% e.e, c 0.2, chloroform); H (400 MHz, CDCl3) 7.21-7.14 (3H, m, CArH), 7.11-
7.02 (5H, m, CArH), 6.64-6.59 (2H, m, CArH), 4.68 (1H, s, CHOH), 2.13 (1H, dq, ABX system,
JAB 15.2, JAX 7.4, C(CHAHB)(CHCHD)), 1.94 (1H, dq, ABX system, JBA 15.2, JBX 7.4,
C(CHAHB)(CHCHD)), 1.70 (1H, br s, CHOH), 1.69-1.53 (2H, m, C(CHAHB)(CHCHD)), 0.84
(3H, t, J 7.4, C(CAH3CBH3)) and 0.77 (3H, t, J 7.4, C(CAH3CBH3)); C (101 MHz CDCl3) 140.6
(Cipso), 140.4 (Cipso), 127.8 (CArH), 126.7 (CArH), 126.4 (CArH), 126.3 (CArH), 126.1 (CArH),
125.1 (CArH), 78.0 (CHOH), 47.9 (C(CH2CH3)2), 23.9 (C(CAH2CBH3)(CCH2CDH3)), 23.1
(C(CAH2CBH3)(CCH2CDH3)) 7.30 (C(CAH2CBH3)(CCH2CDH3)) and 7.2
(C(CAH2CBH3)(CCH2CDH3)). Enantioselectivity determined by chiral HPLC. ChiralPak AD, 1.0
mL/min, 98:2 hexane:2-propanol. Retention times: 12.8 min (major enantiomer) and 13.7 min
(minor enantiomer).
1-(4-Methoxyphenyl)-2,2-dimethylpropan-1-one (201)
OH
MeO
[]20D -16.3 (77% e.e., c 4.24, toluene) (lit36 (S, 99% e.e.) [α]20D -21.6 (c 4.24, benzene)); H
(400 MHz, CDCl3) 7.14-7.09 (2H, m, CArH), 6.77-6.72 (2H, m, CArH), 4.23 (1H, s, CHOH),
3.70 (s, 3H, OCH3), 1.92 (1H, br s, CHOH) and 0.81 (9H, s, C(CH3)3); C (75 MHz, CDCl3)
158.8 (Cipso), 134.5 (Cipso), 128.7 (CArH), 112.9 (CArH), 82.0 (CHOH), 55.2 (OCH3), 35.7
(C(CH3)3), and 25.9 (C(CH3)3); m/z (CI+) 195.1 ((M-H2O), 100 %) and 177.1 ((M+H)+, 33 %).
Enantioselectivity determined by chiral HPLC. Chiralpak AD, 1.0 mL/min, 98:2 hexane:2-
propanol. Retention times: 16.8 min (minor enantiomer) and 18.0 min (major enantiomer). Data
are in agreement with the literature.37
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1-(4-Chlorophenyl)-2,2-dimethylpropan-1-ol (202)
[]20D -22.9 (80% e.e, c 1.0, chloroform); H (300 MHz, CDCl3) 7.25-7.14 (4H, m, CArH), 4.30
(1H, s, CHOH), 1.73 (1H, br s, CHOH) and 0.84 (9H, s, C(CH3)3); C (75.5 MHz CDCl3) 140.58
(Cipso), 133.1 (Cipso), 129.0 (CArH), 127.7 (CArH), 81.7 (CHOH), 35.7 (C(CH3)3), and 25.8
(C(CH3)3); m/z (CI+) 181.1 ((M-H2O), 100 %) and 199.9 ((M+H)+, 7 %). Enantioselectivity
determined by chiral HPLC. Chiralcel OD, 1.0 mL/min, 98:2 hexane:2-propanol. Retention
times: 10.3 min (major enantiomer) and 12.4 min (minor enantiomer). Data are in agreement
with the literature for the racemic compound that has been reported before.38
1-(4-(Trifluoromethyl)phenyl)-2,2-dimethylpropan-1-ol (203)
[]20D -11.3 (76% e.e., c 0.50, chloroform); H (300 MHz, CDCl3) 7.45-7.40 (2H, m, CArH),
7.32-7.26 (2H, m, CArH), 4.31 (1H, s, CHOH), 1.76 (1H, br s, CHOH) and 0.78 (9H, s,
C(CH3)3); C (75.5 MHz, CDCl3) 146.5 (Cipso), 129.1 (q, 2JCF 34.3, CipsoCF), 127.9 (CArH), 124.5
(q, 3JCF 3.8, CArHCCF3), 123.7 (q, 1JCF 271.1, CF3), 81.7 (CHOH), 35.7 (C(CH3)3) and 25.8
(C(CH3)3); F (376 MHz, CDCl3) –62.4; m/z (ES-) 231.1 (M-H+, 100 %). Enantioselectivity
determined by chiral HPLC. Chiralcel OD, 1.0 mL/min, 98:2 hexane:2-propanol. Retention
times: 9.5 min (major enantiomer) and 11.0 min (minor enantiomer). Data are in agreement with
the literature.37
1-(2-Methoxyphenyl)-2,2-dimethylpropan-1-ol (204)
OHOMe
 [α] D
20 -24.3 (69% e.e., c 0.1, CHCl3); H (400 MHz, CDCl3) 7.24-7.20 (1H, m, CArH), 7.19-
7.13 (1H, m, CArH), 6.90-6.85 (1H, m, CArH), 6.81-6.78 (1H, m, CArH), 4.66 (1H, d, J 6.0,
CHOH), 3.74 (s, 3H, OCH3), 2.57 (1H, br s, CHOH) and 0.86 (9H, s, C(CH3)3); C (101 MHz,
CDCl3) 157.0 (Cipso), 130.0 (Cipso), 129.4 (CArH), 128.1 (CArH), 120.2 (CArH), 110.5 (CArH),
77.9 (CHOH), 55.1 (-OCH3), 36.7 (C(CH3)3) and 26.0 (C(CH3)3); m/z (ES+) 217.15 ((M+Na)+,
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100 %). Enantioselectivity determined by chiral HPLC. Chiralpak AD, 1.0 mL/min, 98:2
hexane:2-propanol. Retention times: 17.2 min (major enantiomer) and 25.5 min (minor
enantiomer). Data are in agreement with the literature.39
2,2-Dimethyl-1-(pyridin-4-yl)propan-1-ol (222)
[]20D –8.9 (69% e.e., c 1.0, CHCl3); H (400 MHz, CDCl3) 8.39-8.35 (2H, m, CArH), 7.17-7.13
(2H, m, CArH), 4.29 (1H, s, CHOH), 3.15 (1H, br s, CHOH) and 0.85 (9H, s, C(CH3)3); C (101
MHz CDCl3) 151.4 (Cipso), 148.8 (CArH), 122.9 (CArH), 80.9 (CHOH), 35.6 (C(CH3)3), and 25.8
(C(CH3)3); m/z (ES-) 164.1 ((M-H)-, 100 %). Enantioselectivity determined by chiral HPLC.
Chiralpak AS, 1.0 mL/min, 98:2 hexane:2-propanol. Retention times: 13.8 min (minor
enantiomer) and 17.9 min (minor enantiomer). Data are in agreement with the literature.40
1-(Furan-2-yl)-2,2-dimethylpropan-1-ol (223)
OH
O
[α] D
20 -13.5 (74% e.e., c 2.0, toluene) (lit.25 [α] D25 +19.7 (R, 98 % e.e., c 2.2, benzene); H
(300 MHz, CDCl3) 7.34-7.26 (1H, dd, J 2, 1, CArH), 6.31-6.24 (1H, dd, J 3, 2, CArH), 6.18-
6.11 (1H, d, J 3, CArH), 4.31 (1H, s, CHOH), 1.85 (1H, br s, CHOH) and 0.89 (9H, s,
C(CH3)3); C (101 MHz CDCl3) 155.7 (Cipso), 141.4 (CArH), 110.0 (CArH), 107.0 (CArH),
76.5 (CHOH), 35.8 (C(CH3)3), and 25.8 (C(CH3)3); m/z (ES+) 177.0 ([M+Na]+, 100 %).
Enantioselectivity determined by chiral HPLC. Chiralcel OD-H, 0.5 miL/min, 98:2
hexane:2-propanol. Retention times 13.4 min (major enantiomer), 14.8 min (minor
enantiomer). Data are in agreement with the literature.41
2,2-Dimethyl-1-(thiophen-2-yl)propan-1-ol (224)
H (CDCl3, 300 MHz) 7.23 (1H, dd, J 5, 1, CArH); 6.99-6.93 (2H, m, CArH), 4.66 (1H, s,
CHOH), 2.00 (1H, s, CHOH), 0.99 (9H, s, C(CH3)3); C (CDCl3, 75 MHz) 146.2 (Cipso), 126.5
(CArH), 125.6 (CArH), 124.6 (CArH), 79.4 (CHOH), 36.1 (C(CH3)3) and 26.3 (C(CH3)3); m/z
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(ES+) 193.00 ([M+Na]+, 100%). Enantioselectivity determined by chiral HPLC. Chiralcel OD-
H, 0.5 mL/min, 98:2 hexane:2-propanol. Retention times 20.9 min (major enantiomer), 29.5 min
(minor enantiomer). Data are in agreement with the literature.41
(5-n-Butyl-3-(4-methoxyphenyl)isoxazol-4-yl)(4-methoxyphenyl)methanol (225)
[α] D
18 -38.1 (67% e.e, c 0.1, CHCl3); max /cm-1 (film) 3367, 2960, 2932, 1611, 1510, 1459,
1435, 1296, 1255, 1175, 1110, 1033 and 834; H (400 MHz, CDCl3) 7.43-7.38 (2H, m, CArH),
7.18-7.13 (2H, m, CArH), 6.85-6.81 (2H, m, CArH), 6.80-6.76 (2H, m, CArH), 5.78 (1H, s,
CHOH), 3.75 (3H, s, OCH3), 3.73 (3H, s, OCH3), 2.63-2.50 (2H, m, -CH2CH2CH2CH3), 2.08
(1H, br s, CHOH), 1.62-1.42 (2H, m, -CH2CH2CH2CH3), 1.29-1.12 (2H, m, -CH2CH2CH2CH3)
and 0.80 (3H, t, J 7.3, -CH2CH2CH2CH3); C (101 MHz, CDCl3) 170.7 (Cquat), 161.0 (Cquat),
159.5 (Cquat), 158.0 (Cquat), 133.1 (Cquat), 129.1 (CArH), 126.3 (CArH), 120.5 (Cquat), 114.4 (Cquat),
113.0 (CArH), 112.8 (CArH), 76.3 (CHOH), 65.7 (-OCH3), 54.3 (-OCH3), 28.8 (-
CH2CH2CH2CH3), 25.2 (-CH2CH2CH2CH3), 21.4 (-CH2CH2CH2CH3) and 12.7 (-
CH2CH2CH2CH3); m/z (ES+) 390.23 ((M+Na)+, 100 %); HRMS (ES+) found 390.1678,
C22H25NNaO4 requires 390.1681. Enantioselectivity determined by chiral HPLC. Chiralcel AD,
1.0 mL/min, 85:15 hexane:2-propanol. Retention times: 16.7 min (major enantiomer) and 27.1
min (minor enantiomer).
1,1'-(Furan-2,5-diyl)bis(2,2-dimethylpropan-1-ol) (227)
H (400 MHz, CDCl3) 6.07 (2H, s, CArH), 4.23 (2H, s, CHOH), 2.40 (2H, s, OH), and 0.87
(18H, s, CH3); [Meso: H (400 MHz, CDCl3) 6.03 (2H, s, CArH), 4.20 (2H, s, CHOH), 2.80
(2H, s, OH) and 0.87 (18H, s, CH3); Enantioselectivity determined by chiral HPLC.
ChiralPak AD, 1.0 miL/min, 93:7 hexane:2-propanol. Retention times 10.4 min (major
enantiomer (-)), 14.8 min (meso), 21.4 min (minor enantiomer (+)). Data are in agreement
with the literature for the racemic compound that has been reported before.42
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5-Hydroxy-4,4-dimethyl-5-phenylpentanenitrile (230)
[α]D
20 -3.6 (74% ee, c 1.7, CHCl3); H (CDCl3, 400 MHz) 7.32-7.17 (5H, m, CArH), 4.35
(1H, s, CHOH), 2.33 (1H, app dd, J 7, 2, C(HA)(HB)CN), 2.31 (1H, app dd, J 7, 1,
C(HA)(HB)CN), 1.92 (1H, br s, CHOH), 1.84-1.75 (1H, m, C(HA)(HB)CH2CN), 1.64-1.54
(1H, m, C(HA)(HB)CH2CN), 0.82 (3H, s, C(CAH3)(CBH3)) and 0.81 (3H, s, C(CAH3)(CBH3));
C (CDCl3, 101 MHz) 141.3 (Cipso), 127.9 (CArH), 127.8 (CArH), 127.6 (CArH), 120.8 (CN),
80.9 (CHOH), 37.9 (C(CH3)2), 34.4 (CH2), 23.4 C(CAH3)(CBH3), 22.3 C(CAH3)(CBH3) and
12.6 (CH2); m/z (ES+) 226.12 ([M+Na]+, 100 %). Enantioselectivity determined by chiral
HPLC. Chiralpak AD, 1 mL/min, 90:10 hexane:2-propanol. Retention times 12.2 min
(minor enantiomer), 15.2 min (major enantiomer). Data are in agreement with the literature
for the racemic compound that has been prepared previously.43
3-(Benzyloxy)-2,2-dimethyl-1-phenylpropan-1-ol (231)
[α]D
20 -20.6 (50% ee, c 0.06, CHCl3); H (CDCl3, 300 MHz) 7.31-7.14 (10H, m, CArH), 4.53
(1H, s, CHOH) 4.49 (2H, s, CH2Ph), 3.87 (1H, br s, CHOH), 3.31 (1H, d, AB system, J 9,
CHAHB), 3.23 (1H, d, AB system, J 9, CHAHB), 0.82 (3H, s, C((CAH3)(CBH3))) and 0.81 (3H, s,
C((CAH3)(CBH3))); C (CDCl3, 300 MHz) 139.9 (Cipso), 138.5 (Cipso), 128.5 (CArH), 128.3
(CArH), 127.7 (CArH), 127.7 (CArH), 127.6 (CArH), 127.2 (CArH), 81.5 (CHOH), 79.7 (CH2),
74.0 (CH2), 33.1 (C(CH3)2, 23.3 C(CAH3)(CBH3) and 20.1 C(CAH3)(CBH3); m/z (ES+) 293.07
([M+Na]+, 100%) and 563.16 ([2M+Na]+, 100); HRMS (ES+) found 293.1518, C18H22O2Na
requires 293.1517. Enantioselectivity determined by chiral HPLC. Chiralpak AD, 0.5 mL/min,
98:2 hexane:2-propanol. Retention times 33.6 min (major enantiomer), 39.8 min (minor
enantiomer).
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2-(1H-Imidazol-1-yl)-2-methyl-1-phenylpropan-1-ol (236)
m.p. 166-168 ºC (lit.44 167-168 ºC); []20D – 20.0 (53% e.e., c 2.9, CHCl3); H (300 MHz,
CDCl3) 7.31 (1H, br s, NCHN), 7.24-7.13 (4H, m, CArH), 6.97-6.83 (4H, m, CArH), 4.60 (1H, s,
CHOH), 2.42 (1H, br s, CHOH), 1.49 (3H, s, C(CAH3)(CBH3)) and 1.46 (3H, s,
C(CAH3)(CBH3)); C (101 MHz, CDCl3) 140.0 (Cipso), 135.6 (N=C-N), 128.0 (CArH), 127.9
(CArH), 127.7 (CH=CH), 127.3 (CArH), 118.0 (CH=CH), 80.2 (CHOH), 60.9 (C(CH3)2), 25.0
(C(CAH3CBH3)) and 24.2 (C(CAH3CBH3)); m/z (ES+) 217.2 ((M+H)+, 100 %); HRMS (ES+)
found 217.1346 (± 0.9 ppm), C13H17N2O requires 217.1341. Enantioselectivity determined by
chiral HPLC. Chiralcel OD, 1.0 mL/min, 93:7 hexane:2-propanol. Retention times: 35.6 min
(minor enantiomer) and 40.9 min (minor enantiomer). Data are in agreement with the
literature.44
5,5-Dimethyl-6-phenyltetrahydro-2H-pyran-2-one (248)
m.p. 103-104 ºC (lit.30 102-103 ºC);  [α]D20 -17.2 (74% ee, c 0.5, CHCl3); H (CDCl3, 400 MHz)
7.29-7.22 (2H, m, CArH), 7.21-7.14 (3H, m, CArH), 5.00 (1H, s, >CHO-), 2.65-2.60 (2H, m,
CH2CO), 1.86-1.75 (1H, m, C(HA)(HB)CH2CO), 1.70 (1H, m, C(HA)(HB)CH2CO), 0.87 (3H, s,
C(CAH3)(CBH3)) and 0.77 (3H, s, C(CAH3)(CBH3)); C (CDCl3, 75 MHz) 171.6 (C=O), 136.3
(Cipso), 128.2 (CArH), 127.8 (CArH), 127.5 (CArH), 89.1 (1H, s, >CHO-), 34.2 (CH2), 33.3
(C(CH3)2), 27.5 (CH2), 26.8 (C(CAH3)(CBH3)) and 19.4 (C(CAH3)(CBH3)); m/z (CI+) 205.12
([M+H]+, 68%), 187.11 (100), 145.10 (80), 127.08 (39), 105.07 (30) and 91.05 (15); HRMS
(CI+) 205.1237 ([M+H]+), [C13H18O]+ requires 205.1229. Enantioselectivity determined by
chiral HPLC. Chiralpak AD, 1 mL/min, 95:5 hexane:2-propanol. Retention times 19.9 min
(minor enantiomer), 28.0 min (major enantiomer). Data are in agreement with the literature for
the racemic compound that has been reported before.30
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5-Hydroxy-5-phenylpentanenitrile (252)
[α]D
20 -20.4 (49% ee, c 4.5, CHCl3); H (CDCl3, 300 MHz) 7.40-7.18 (5H, m, CArH), 4.69-4.63
(1H, s, CHOH), 2.34-2.28 (2H, m, CH2CN), 2.00 (1H, br s, CHOH) and 1.90-1.67 (4H, m,
CH2CH2); C (CDCl3, 75 MHz) 144.0 (Cipso), 128.8 (CArH), 128.0 (CArH), 125.8 (CArH), 119.7
(CN), 73.7 (CHOH), 37.7 (CH2), 21.9 (CH2) and 17.2 (CH2); m/z (ES+) 198.09 ([M+Na]+, 100
%); HRMS (ES+) 198.0894 ([M+Na]+), [C11H13NONa]+ requires 198.0895. Enantioselectivity
determined by chiral HPLC. Chiralcel OD-H, 1 mL/min, 90:10 hexane:2-propanol. Retention
times 20.2 min (major enantiomer), 22.1 min (minor enantiomer). Data are in agreement with
the literature for the racemic compound that has been reported before.45
6-Phenyltetrahydro-2H-pyran-2-one (258)
[α] D
20 -16.6 (48 % e.e., c 0.1, CHCl3) (lit.46 [α] D25 +38.5 (R, 98 % e.e., c 1.0, CHCl3); H
(CDCl3, 400 MHz) 7.45-7.24 (5H, m, CArH), 5.30 (1H, dd, J 11,3, CHO), 2.80-2.46 (2H, m,
CH2), 2.20-2.10 (1H, m, CHAHB), 2.00-1.81 (3H, m, CHAHB + CH2); Enantioselectivity
determined by chiral HPLC. Chiralcel OD-H, 1 mL/min, 90:10 hexane:2-propanol. Retention
times 28.7 min (minor enantiomer) and 32.8 min (major enantiomer). Data are in agreement
with the literature.47
2,2-Dimethyl-1-phenylpropan-1-ol (273)
m.p. 45 ºC (lit.48 45 ºC); [α] D20 -19.3 (74% e.e., c 0.3, acetone) (lit.49 [α]D25 -30.3 (S, >99% e.e.,
c 0.36, acetone); H (300 MHz, CDCl3) 7.25-7.19 (5H, m, CArH), 4.31 (s, 1H, CHOH), 1.97
(1H, br s, CHOH) and 0.85 (9H, s, C(CH3)3); Enantioselectivity determined by chiral HPLC.
Chiralpak OD-H, 1 mL/min, 98:2 hexane:2-propanol. Retention times: 10.5 min (S, major
enantiomer) and 15.0 (R, minor enantiomer). Data are in agreement with the literature.50
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Appendix A
Other Active [RuCl2(P^N^X)L] catalysts
A number of other ruthenium complexes of P^N^X (X=N,O) were prepared in this work and
shown to be active catalysts but fall outwith the scope of the work discussed so far. These shall
be outlined in the following addendum.
A.1 Alternative Precatalysts -Imine Complexes as Precursors to the Active Catalyst
Preliminary attempts by Diaz and Clarke, using uncharacterised and unpurified complex,
suggests that the imine variant of the original catalyst gives similar results to the amine catalysts
in terms of productivity and enantioselectivity in the hydrogenation of ,,-
trimethylacetophenone. This is likely due to in situ hydrogenation of the imine bond to give
equivalent active species. If this is the case, it is desirable to be able to use the imine variant in
such cases where it is impossible to prepare the amine ligand. In order to verify this, the imine
variant of the original catalyst (R,R)-174 was first prepared and its performance in catalysis
analysed.
Ligand (R,R)-307 was prepared as a mixture with the difunctionalised diamine (R,R)-308 (3:1
monofunctionalised:difunctionalised species) by reacting equimolar amounts of 2-
(diphenylphosphino)benzaldehyde 266 and (R,R)-diaminocyclohexane in dichloromethane for 5
hours (Scheme A1-1).   Conversion to imine was shown by the presence of signals at δH
(CDCl3) = 8.72 ppm (d, J 4, monofunctionalised species) and 8.55 ppm (d, J 4, difunctionalised
species) corresponding to the CH=N proton, and signals at -12.7 ppm and -13.8 ppm in the 31P
NMR, corresponding to the monofunctionalised and difunctionalised species respectively. The
solvent was removed and the crude mixture immediately reacted with [RuCl2(DMSO)4] in the
usual complexation protocol to furnish two complexes: the known [RuCl2(N^P^P^N)] complex
(R,R)-310 (δP (CDCl3) = +47.3 ppm),1 and the desired [RuCl2(P^N^N)L] complex (R,R)-309 (δP
(CDCl3) = +51.5 ppm). These complexes were easily separated by column chromatography. It is
worthwhile noting that the chemical shift in the 31P NMR spectrum of these imine variants are
typically downfield of those associated with complexes of the original amine ligands (δP
(CDCl3) = +43.6 ppm).2 The identity of complex (R,R)-309 was supported by x-ray diffraction
studies of the crystal structure and is represented in Figure A1-1. This shows the tridentate
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ligand bound at three of the four meridional sites with DMSO occupying the final site, as in
catalyst (R,R)-174. The final two coordination sites are occupied by trans-chloride ligands.
Scheme A1-1 The synthesis of complex (R,R)-309, the imine variant of complex (R,R)-174.
Reaction conditions: 2-(diphenylphosphino)benzaldehyde 266 (1 eq.), (R,R)-
diaminocyclohexane (1 eq.), DCM, rt, 5 h; (ii) 307 and 308 (1 eq.), [RuCl2(DMSO)4] (1 eq.),
THF, μw, 120C, 20 min.
Figure A1-1 Representation of the molecular structure of (R,R)-309, from x-ray diffraction
studies, supporting the expected coordination mode of the ligands.
Hydrogenation with catalyst (R,R)-309 was shown to give very similar results to the original
catalyst (R,R)-174 with reactions typically complete within an hour and with equivalent or
enhanced enantioselectivities (Table A1-1).
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Entry Ketone R= X= Catalyst Conversion(yield) [%] ee [%]
1 81 Me H (R,R)-174 >99 0
2 81 Me H (R,R)-309 >99 0
3a 82 iPr H (R,R)-174 93 48 (S)
4 82 iPr H (R,R)-309 >99 77 (S)
5 198 tBu 4-Cl (R,R)-174 >99 80 (S)
6 198 tBu 4-Cl (R,R)-309 >99 81 (S)
Table A1-1 Comparison of the hydrogenation of ketones 81, 82 and 198 with catalyst
(R,R)-174 and its imine derivative (R,R)-309. General conditions: ketone (~1 mmol),
catalyst (R,R)-174 or (R,R)-309 (0.5 mol%), potassium tert-butoxide (1 mol%),
isopropanol (3 mL), molecular H2 (50 bar), 50C, 16 h. a From reference 2
Since the enantioselectivity obtained using the imine derivative (R,R)-309 was on par with, if
not better than, that obtained with catalyst (R,R)-174, using such derivatives in hydrogenation,
in situations when it was impossible to make the amine variant, seemed feesible. The enhanced
selectivity obtained for the hydrogenation of ketone 82 was mysterious if the stereoinduction
step is equivalent. We felt it necessary to examine further whether the imine function is indeed
reduced during hydrogeation, forming the same active species in solution.
In order to do this, stoichiometric amounts of complex (R,R)-309 were reacted with potassium
tert-butoxide in isopropanol in the presence of 70 bar hydrogen at 70C for 16 hours. NMR
analysis of the resulting material showed one main species in the 31P NMR spectrum (CDCl3) at
+42.3 ppm, shifted upfield from +51.5 ppm. The signal in the 1H NMR (CDCl3) of the imine
complex at 8.53 ppm disappeared from the spectrum after this treatment, while signals
corresponding to the other ligand protons remained. This suggests that the imine component is
being hydrogenated to reform the original amine species, thus why similar activities and
enantioselectivities are observed. Mass spectrometry studies of the mixture failed to identify
molecular ions corresponding to species (R,R)-309 or its reduced form. However, a signal with a
molecular weight corresponding to the potassium adduct of the reduced ligand was the
predominant species in positive electrospray studies, suggesting the ligand is indeed reduced in
the process.
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It was concluded that in the cases where it was impossible to prepare the amine variety of the
desired catalyst, the imine variant may be used to give clues as to whether the ligand in question
is useful in catalysis.
A.2 Further Modification of Diamine Component
It was felt that by altering the bite angle of the diamine component in the [RuCl2(P^N^N)L]
system, one could not only tune the orientation of the N-H bond to maximise interaction with
the incoming substrate, the enantioselectivity of the reaction could be enhanced as the spacial
proximity of the phosphine substituents to the mechanistically important N-H group is
consequently modified. It was envisaged that the bite angle of the diamine component could be
varied by adjustment of the ring size and the conformational constraints in the diamine. In the
first instance, attempts were made to widen the bite angle of the diamine component by
increasing the dihedral angle between the vicinal amine groups. Basic computational
calculations (Table A1-2), based on the MM2 force field, showed that reducing the ring size of
the diamine component, increases the dihedral angle between the vicinal amine groups (312 cf
311 cf 310).† Constraining the ring in bicyclic system (313) also increases the dihedral angle.
Our immediate targets were the ligands shown in Scheme A1-2; (R,R)-314 with five-membered
cyclic backbone and (S,S)-315 with a fused bicyclic backbone: both expected to have larger bite
angles than present in the original catalyst once complexed.
Table A1-2 Comparison of theoretical bite angles for
unbound diamines based on MM2 calculations.
† The nature of the metal centre, as well as the ligand dihedral angle, has a significant impact on the bite
angle once the ligand is bound. This analysis allows for a rough appreciation of the relative bite angles of
each of the diamines.
Scheme A1-2 Target ligands to explore
the effect of increased bite angle upon
performance of [RuCl2(P^N^N)L]
catalysts in hydrogenation
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The five-membered cyclic backbone of ligand (R,R)-314 was chosen in preference to 1,2-
diaminocylopentane 311 due to the significant instability of 311, which rapidly reacts with
carbon dioxide in the atmosphere to give the carbamate ester. A secondary advantage of (R,R)-
314 is that the tertiary amine is a handle which can potentially be exploited to attach the
ligand/catalyst to a solid support to aid catalyst recovery. It was envisaged that (R,R)-314 could
be prepared in an analgous manner to the original ligand by the condensation of diamine (R,R)-
222 with 2-(diphenylphosphino)benzaldehyde 266.
The enantiopure diamine (R,R)-322 was first prepared in a number of steps from L-
(R,R)-(+)-tartaric acid 317 (Scheme A1-3). The pyrrolidindione 318 was obtained on multigram
scale by reacting (R,R)-317 with benzylamine 316 in xylene at reflux, making use of the
procedures of Skarzevski and Gupka.3 Reduction of the amide proved to be tricky and all
attempts using diborane, generated in situ from sodium borohydride and iodine, 3 proved futile.
The reduced product was obtained however, albeit in poor yield, by addition of 318 to a large
excess (6-10 equivalents) of lithium hydride in THF and the reaction stirred overnight. Research
published while this work was ongoing,4 combined with personal correspondence with the
authors,5 led to increased yields for this reaction. Maximum yields were accomplished by the
portion-wise addition of 318 to a dilute solution of lithium aluminium hydride (three-fold
excess) in THF.
Scheme A1-3 Preparation of diol (S,S)-319. Reaction conditions: (i)
benzylamine 316 (1 eq.), L-(R,R)-(+)-tartaric acid (R,R)-317 (1 eq.),
xylene, Δ, 6 h; (ii) (R,R)-318 (1 eq.), LiAlH4 (3-10 eq.), THF, 0C→ Δ, 16 
h.
It is reported in the literature that the diol (R,R)-319 can be transformed into the corresponding
diamine by Mitsunobu reaction followed by hydrogenation with palladium on carbon.6
However, Fuentes reports that this method is unreliable7 and instead employed a two step
procedure to access the diazido compound (R,R)-321 as described for the preparation of 1,2-
diazidocyclopentane, 6 which was successfully employed here (Scheme A1-4). The hydroxyl
groups of (S,S)-319 were first activated by reaction with methanesulfonyl chloride in the
presence of triethylamine to give the bis-mesylate (S,S)-320. Subsequent treatment of (S,S)-320
with sodium azide furnished the diazido compound (R,R)-321 with inversion of configuration at
each stereocentre. Reduction of this compound was accomplished easily by hydrogenation with
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palladium on carbon and 1 bar hydrogen pressure, and monitoring of the reaction by thin layer
chromatography indicated that the reaction was complete within 16 hours.
Scheme A1-4 Preparation of diamine (R,R)-322. Reaction conditions: (i)
(S,S)-319 (1 eq.), methanesulfonyl chloride (3 eq.), triethylamine (3 eq.),
dichloromethane, 0C→rt, 5 h; (ii) (S,S)-320 (1 eq.), sodium azide (4 eq.),
DMF, 100C, 4 h then rt, 24 h; (iii) (R,R)-321 (1 eq.), 10% Pd/C (0.1 eq.), H2
(1 bar), EtOH, rt, 16 h.
Attempts to prepare the P^N^N ligand (R,R)-314 from diamine (R,R)-322 were unsuccessful
(Scheme A1-5). Condensation of the diamine (R,R)-322 with 2-
(diphenylphosphino)benzaldehyde 266 in ethanol, using a three-fold excess of the amine to
avoid difunctionalisation, furnished the imine (R,R)-323, indicated by the appearance of a signal
in the 1H NMR spectrum at δH (C6D6) = 9.41 (d, J 5), corresponsing to the CH=N proton, and a
signal at δP (C6D6) = -11.2 in the 31P NMR spectrum. However, attempts at the reduction of this
species resulted in the formation of a significant amount of a phosphine oxide species (δP (C6D6)
= +34.6) as well as the desired phosphine ligand (δP (C6D6) = -15.8), despite rigorous exclusion
of air from the system. Aqueous work-up in an inert environment, necessary to remove the
excess diamine, resulted in almost complete conversion of the desired phosphine to the
phosphine oxide species. Multiple attempts at this procedure failed to yield significant amounts
of the desired phosphine ligand for complexation, as did attempts at reduction of the phosphine
oxide.
Scheme A1-5 Attempted preparation of ligand (R,R)-314. Reaction conditions: (i) 2-
(diphenylphosphino)benzaldehyde 266 (1 eq.), (R,R)-322 (3 eq.), EtOH, rt, 3 h; (ii) (R,R)-323
(1 eq.), NaBH4 (4 eq.), EtOH, rt, 16 h.
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Since the problematic oxidation of the phosphine appeared to occur after the reduction of the
imine species, it was decided to prepare the ruthenium complex of the imine species itself. It has
been shown that complexes of such are likely reduced under the hydrogenation conditions to
give similar active species to those obtained from the corresponding amine species (See
previous section). Ligand (R,R)-324 was prepared by the slow, dropwise addition of a solution
of 2-(diphenylphosphino)benzaldehyde 266 in dichloromethane over a period of 16 hours to a
dilute solution of diamine (R,R)-322 in dichloromethane. The monofunctionalised diamine was
formed almost exclusively, with identical signals as previously (Scheme A1-6). Once the
solvent was removed the ligand was complexed immediately using the standard complexation
protocol and, after silica flash chromatography (1:1 DCM:acetone), pure complex (R,R)-324
was obtained. The identity of the complex was supported by the appearance of a single peak at
δP (CDCl3) = +53.7 in the 31P NMR spectrum, in the characteristic region for such complexes,
and two signals in the 1H NMR for the inequivalent protons of the remaining bound DMSO
ligand. Although microanalysis data could not obtained due to residual solvent molecules, the
complex was deemed pure from NMR data, and accurate mass analysis identified the moecular
ion corresponding to the structure presented.
Scheme A1-6 Preparation of complex (R,R)-324,. Reaction conditions:
(i) 2-(diphenylphosphino)benzaldehyde 266 (1 eq.), (R,R)-322 (1 eq.),
EtOH, rt, 16 h; (ii) (R,R)-323 (1 eq.), [RuCl2(DMSO)4] (1 eq.), THF,
μw, 120C, 20 min.
Complex (R,R)-324 was found to hydrogenate ,,-trimethylacetophenone quantitatively
within 16 hours at 50C and 50 bar hydrogen pressure (Scheme A1-7). Unfortunately, an
erosion of enantioselectivity was observed, with the (S)-alcohol produced in just 40% e.e.
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Scheme A1-7 Hydrogenation with catalyst (R,R)-324 . Reaction
conditions: ketone 159, catalyst (R,R)-324 (0.5 mol%), potassium tert-
butoxide (1 mol%), isopropanol (3 mL), molecular H2 (50 bar), 50C,
16 h.
We next turned our attention to catalysts derived from 11,12-diamino-9,10-dihydro-9,10-
ethanoanthracene. It was predicted that ligand (S,S)-315 could be prepared in a similar manner
to the original ligand (R,R)-174 from the diamine (S,S)-331. Racemic diacid 327 was first
prepared by heating fumaric acid 326 and anthracene 325 in dioxane at reflux over a period of
three days using the methods of Bachman and Scott8 (Scheme A1-8). Resolution by formation
of the diastereomeric salts of the diacid with the alkaloid brucine 328, and subsequent fractional
recrystallisation, yielded the desired (S,S)-diastereomer (S,S)-327 in 34% yield upon
decomposition of the salt with sodium hydroxide.9,10 The optical purity of the diacid was
analysed by HPLC analysis of its isopropyl ether derivative, and was shown to be greater than
99% enantiomerically and diasteromerically pure.
(S,S)-327
34%
>99% e.e.
>99% d.e.
HO2C
CO2H
HO2C CO2H
+
HO2C
CO2H
(±)-327
61%
325
326
(i) (ii)
N
O
O
H
H
N
H
O
O H
H
brucine, 328
Scheme A1-8 Synthesis of (11S,12S)-(-)-9,10-dihydro-9,10-ethanoanthracene-
11,12-dicarboxylic acid (S,S)-327. Reaction conditions: (i) anthracene 325 (3 eq.),
fumaric acid 326 (1 eq.), dioxane, Δ, 3 d then 2.5 M NaHCO3, dioxane, 2 h; (ii)
(±)-327 (1 eq.), brucine 328 (1 eq.), 35% EtOH in H2O, rt →90C then 4C, 24 h
then 2M NaOH, 30 min.
The diacid (S,S)-327 was converted to the diamine (S,S)-331 by first conversion to the
corresponding bis-azide via the bis-acid chloride, then subsequent Curtius Rearrangment,
following the methods of Trost11 and modifications made by Fuentes (Scheme A1-9).7 Curtius
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rearrangement yielded the hydrochloride salt of diamine (S,S)-331, and the free amine was
liberated by treatment with sodium hydroxide and extraction into dichloromethane.‡
Scheme A1-9 Synetheis of diamine (S,S)-331. Reaction conditions: (i) (S,S)-327 (1
eq.), thionyl chloride (3 eq.), toluene, 60C, 16 h; (ii) (S,S)-329 (1 eq.), sodium
azide (3.5 eq.), toluene, 0C →rt, 4 h; (iii) (S,S)-330, toluene, 80C, 1 h then 6M
HCl, 80C, 4 h then NaOH, DCM, 2 h.
Under strictly inert conditions,§ condensation of (S,S)-331 (a three-fold excess in ethanol) with
2-(diphenylphosphino)benzaldehyde 266 furnished the imine species (S,S)-332, indicated by the
appearance of a signal at δP (C6D6) = -11.6 ppm in the 31P NMR spectrum and a signal at at δH
(C6D6) = 9.46 ppm (d, J 5), corresponding to the CH=N proton, in the 1H NMR spectrum
(Scheme A1-10). Reduction of the imine species was achieved by addition of sodium
borohydride to the reaction mixture and stirring for 4 h. Complete reduction was indicated by
disappearance of signals in the 1H and 31P NMR spectra corresponding to the imine species and
appearance of a new signal at δP (C6D6) = -15.9 ppm in the 31P NMR spectrum. However,
aqueous work-up failed to remove the excess diamine from the reaction mixture. Purification
procedures resulted in the complete oxidation of the phosphine (δP (CDCl3) = +34.8 ppm). It
was decided to subject the reaction mixture to the complexation protocol, and purify the
resultant complex. This appeared to yield the desired complex (S,S)-333, with the appearance of
the principal signal at δP (CDCl3) = +45.3 ppm in the 31P NMR spectrum. However, column
chromatography to remove the organic impurities, resulted in the apparent degradation of the
complex, with the appearance of a second signal at δP (CDCl3) = +54.2. This unknown species
could not be removed and has hampered full characterisation of complex (S,S)-333.
‡ Enantiomerically and diastereomerically pure (R,R)-331 could also be prepared by first preparing
racemic 331, using identical procedures as shown in Scheme A1-9, from racemic diacid 327, then
resolving the diamine by diastereomeric salt formation with (S)-mandelic acid, and subsequent base
hydrolysis. Both the the (S,S) and the (R,R) forms were employed in attempts to prepare P^N^N ligands.
§ Initial attempts at this transformation encountered significant problems with phosphine oxidation,
particularly in the condensation step. This was overcome to a great extent by meticulous exclusion of air
from the system and minimising reaction times, i.e. the time components spent in solution.
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Scheme A1-10 Synetheis of complex (S,S)-333. Reaction conditions: (i) 2-
(diphenylphosphino)benzaldehyde 266 (1 eq.), (S,S)-331 (3 eq.), EtOH, 45C → rt, 2 
h; (ii) 332, NaBH4 (3 eq.), EtOH, rt, 4 h; (iii) (S,S)-315 (1 eq.), [RuCl2(DMSO)4] (1
eq.), THF, μw, 120C, 20 min.
It was decided to employ the mixture of what appeared to be complex (S,S)-323, based on the
characteristic chemical shift of the species in the 31P NMR, and the unknown complex (5:1
mixture), in the hydrogenation of ,,-trimethylacetophenone 159. Pleasingly full conversion
was obtained at 50C and 50 bar hydrogen pressure (Table A1-3). However, the reaction
yielded racemic alcohol 273. Due to the absense of full characterisation of complex (S,S)-333 to
confirm its identity, and the presence of an unknown complex in the reaction mixture, limited
conclusions can be drawn from this result.
Due to the problems encountered with formation of the ruthenium complex of ligand
(S,S)-315, it was decided to prepare the borane-protected form of the ligand and employ it in the
in situ hydrogenation protocol described in section 4.1, and compare the results with that of the
impure precatalyst. We had the (R,R)-diastereomer of diamine 331 to hand and decided to use
this to first prepare the amide (R,R)-335 (Scheme A1-11). This was accomplished using an
amide coupling protocol described by Santos and coworkers.12 N-[2-
(Diphenylphosphanyl)benzoyloxy]succinimide 33413 was added dropwise to a solution of
diamine (R,R)-331 in dichloromethane to give the amide (R,R)-335, which was air stable and
could be purified by column chromatography. Treatment of (R,R)-335 with 5 equivalents of
borane tetrahydrofuran complex yielded the borane adduct of the P^N^N ligand (R,R)-336, δP
(CDCl3) = +18.9 ppm (br s). Reduction of the amide was indicated by disappearance of the
signal at δH (CDCl3) = 5.71 ppm (d, J 8) corresponding to the amide NHCO.
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Scheme A1-11 Synthesis of borane-protected ligand (R,R)-336. Reaction conditions:
(i) N-[2-(diphenylphosphanyl)benzoyloxy]succinimide 334 (1 eq.), (R,R)-331 (2 eq.),
DCM, rt, 3 h; (ii) (R,R)-336 (1 eq.), BH3.THF (5 eq.), rt, 16 h.
Borane-protected ligand (R,R)-336 was used in the in situ hydrogenation protocol in
combination with [RuCl2(DMSO)4], and successfully reduced ,,-trimethylacetophenone 159
cleanly in 16 hours at 50C and 50 bar hydrogen pressure (Table A1-3). Again, however, no
enantioselectivity was observed in the product alcohols.
Entry Catalyst Ketone R= Conversion(yield) [%] ee [%]
1 (S,S)-333 159 tBu >99 0
2 [RuCl2(DMSO)4]/(R,R)-336 81 Me >99 0
3 [RuCl2(DMSO)4]/(R,R)-336 82 iPr >99 0
4 [RuCl2(DMSO)4]/(R,R)-336 159 tBu >99 0
Table A1-3 Hydrogenation employing wide-bite angle ligands. General conditions: ketone
81, 82 or 159, catalyst (S,S)-333 (0.5 mol%) or [RuCl2(DMSO)4] (0.5 mol%)/Ligand (R,R)-
336, potassium tert-butoxide (1 mol%), isopropanol (3 mL), molecular H2 (50 bar), 50C, 16
h.
It is worth noting that whilst poor for the enantioselective hydrogenation of ,,-
trimethylacetophenone, and other simple ketones, it is conceivable that these catalysts may have
niche application in the hydrogenation of other substrates. To date this remains a relatively
unstudied, but worthwile area of research. These results, in combination with catalysis using
complex (R,R)-324, might suggest that widening the ligand bite angle has a negative effect upon
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enantioselectivity. However, these are different catalyst structures and it is important to interpret
these findings with some caution.
A.3 Further Attempted Tuning of Catalyst Structure
Although highly efficient catalysts exist for the hydrogenation of acetophenone 81 and
derivatives, and the preparation of further catalysts was not our aim, the results shown in section
4.2.2 demonstrated that the catalyst scaffold can be tuned for particular substrates. A significant
increase in enantioselectivity was observed from 0% e.e. when using the original catalyst to
60% e.e. when the bulky derviative (R,R)-298 was employed. We decided to explore the
tunability of the catalyst structure this further by preparing the bulky derivative of catalyst
(R,S)-337, which was shown in work by Fuentes and Clarke, to give 51% e.e. in the
hydrogenation of acetophenone (Scheme A1-12).14 If a similar increase in enantioselectivity
was brought about by the incorporation of bulk on the phosphine substituents, then industrially
viable levels of selectivity may be approached for such substrates.
Scheme A1-12 Hydrogenation of acetophenone with complex (R,S)-337
(work carried out by Fuentes and Clarke). Reaction conditions:
acetophenone, complex (R,S)-3337 (0.5 mol%), potassium tert-butoxide
(5 mol%), iPrOH, H2 (50 bar), 50C, 16 h.
The bulky derivative of complex (R,S)-337 was prepared by condensation of equimolar amounts
of (1R,2S)-(+)-cis-1-amino-2-indanol 338 and 2-(bis(3,5-di-tert-
butylphenyl)phosphino)benzaldehyde 302 in degassed ethanol of a period of 3 hours (Scheme
A1-13). Formation of the imine species was indicated by the disappearance of the signal
corresponding to the aldehyde species in the 31P NMR spectrum (δP (C6D6) = -10.2 ppm) and the
appearance of a signals at δH (C6D6) = 9.75 ppm (d, J 5) and at δP (C6D6) = -7.9 ppm in the 1H
and 31P NMR spectra repectively. Treatment with sodium borohydride resulted in the
disappearance of these signals and a new signal in the 31P NMR spectrum at δP (C6D6) = -14.0
ppm. Due to the sensitivity of the ligand, full characterisation was not possible. The molecular
ion of the phosphine oxide was observed however after positive electrospray mass spectrometry.
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Scheme A1-13 The synthesis of [RuCl2(P^N^O)L] complex 341. Reaction conditions: 2-(bis(3,5-di-
tert-butylphenyl)phosphino)benzaldehyde 302 (1 eq.), (R,S)-1-amino-2-indanol 338 (1 eq.), EtOH,
rt, 3 h; (ii) (R,S)-339 (1 eq.), NaBH4 (4 eq.), EtOH, rt, 12 h; (iii) (R,S)-340 (1 eq.), [RuCl2(DMSO)4]
(1 eq.), THF, μw, 120C, 20 min.
The ligand was thus complexed immediately with [RuCl2(DMSO)4], making use of the standard
microwave assisted protocol, and purified by column chromatography. Complexation was
verified by the downfield shift of the signal corresponding to the phosphorus nuclei to δP (C6D6)
= +58.6 ppm in the 31P NMR spectrum. This appears further downfield than typical shifts for
[RuCl2(P^N^N)L] complexes but matched well with data for previously prepared
[RuCl2(P^N^O)L] complexes, with signals typically in the range 57-60 ppm.14 Like the
analogous [RuCl2(P^N^N)L] complexes, signals for CHX (X = N, O) protons were shifted
downfield by complexation, and previously equivalent dimethylmethoxide protons again
became inequivalent, giving two distinct singlets at δH (CDCl3) = 2.85 and 2.65 ppm.
Coordination of the hydroxyl group was supported by the broad singlet at δH (CDCl3) = 5.96
ppm corresponding to the –OH proton: the unbound signal appears downfield at 6.29 ppm. X-
ray diffraction studies on similar [RuCl2(P^N^O)L] complexes prepared by Fuentes and Clarke,
also indicates that the oxygen atom in such ligands does indeed coordinate to the ruthenium
centre.14
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(R,S)-341
R
O
R
OH
81, R = Me
159, R = tBu
Ru Cat
KOtBu, iPrOH
H2
16h
O
H
NH P
Ru
Cl
Cl S
O
tBu
tBu
tBu
tBu
12, R = Me
273, R = tBu
Entry Ketone R= Conversion(yield) [%] ee [%]
1 81 Me 43 0
2a 81 Me 72 0
3a 159 tBu <5 -
Table A1-4 Hydrogenation with the [RuCl2(P^N^O)L]
catalyst (R,S)-341 . General conditions: ketone 81 or 159,
catalyst (R,S)-341 (0.5 mol%), potassium tert-butoxide (1
mol%), isopropanol (3 mL), molecular H2 (50 bar), 70C,
16 h. a 5 mol% KOtBu.
Like the complex (R,R)-298, also with bulky substituents upon phosphorus, catalyst (R,S)-341
was also found to be less active than its non-bulky parent catalyst. Temperatures of 70C and
increased base loading were required to get above 70% conversion in the hydrogenation of
acetophenone 81 (Table A1-4). The bulky substrate ,,-trimethylacetophenone 159 was
practically inactive to hydrogenation with catalyst (R,S)-341. Disappointlingly, only racemic
material was obtained on reduction of acetophenone. The results suggest, since
enantioselectivity is completely eroded, and activity is significantly diminished, that this
catalyst may operate by a different mechanism, i.e. the bulky substituents may block the
mechanistically important secondary NH, and hydrogenation may occur via pathways more akin
to non-NH complexes. Our rationale that bulky substituents near the ‘active site’ may still hold
true, but up to a point where they hinder the approach of the ketone substrate.
A.4 Experimental
Complex (R,R)-309
(1R,2R)-Cyclohexane-1,2-diamine (0.105 g, 0.91 mmol) and 2-
(diphenylphosphino)benzaldehyde 266 0.267 g, 0.91 mmol) were dissolved in ethanol and the
mixture stirred for 5 h. The solvent was removed and the resultant residue was redissolved in
tetrahydrofuran (3 mL) and to this [RuCl2(DMSO)4] (0.441 g, 0.91 mmol) was added. The
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mixture was heated at 120C for 20 min in the microwave and the solvent was then removed.
Flash chromatography of the residue (8:2 dichloromethane:acetone) isolated the desired
complex (R,R)-309 as a red solid (0.110 g, 19%), m.p. > 230 C. Recrystallisation from
CHCl3/tetrahydrofuran gave small microcrystals which were used in x-ray diffraction studies.
[]D20 = + 140 (c = 0.1, CHCl3); Found: C, 44.98; H, 4.59; N, 3.77%; C27H33Cl2N2OPRuS + 1
CHCl3 requires C, 44.43; H, 4.66; N, 3.70%; max/cm-1 (KBr) 3578 (br), 3058 (w), 2923 (s),
2855 (m), 1631 (w), 1481 (m), 1434 (s), 1301 (m), 1089 (s), 1018 (s), 699 (s), 534 (s) and 488
(m); H (400 MHz, CDCl3) 8.53 (1H, s, -N=CH), 7.66-7.56 (3H, m, CArH), 7.52 (1H, t, J 8,
CArH), 7.42 (1H, t, J 7, CArH), 7.38-7.31 (1H, m, CArH), 7.30-7.15 (7H, m, CArH), 7.11 (1H, t, J
9, CArH), 4.20 (1H, br s, NHAHB), 4.07 (1H, app t, J 11, CHN), 3.99-3.87 (1H, m, NHAHB), 2.94
(3H, s, CAH3SOCBH3), 2.65-2.51 (1H, m, CHN), 2.46 (3H, s, CAH3SOCBH3), 2.36-2.25 (2H, m,
cyclohexyl CH), 1.91-1.72 (2H, m, cyclohexyl CH) and 1.70-1.41 (4H, m, cyclohexyl CH); C
(75 MHz, CDCl3) 162.1 (d, J 5, CArH), 135.7 (d, J 10, CArH), 135.2 (Cipso) 133.6 (CArH), 133.1
(d, J 10, CArH), 132.4 (d, J 10, CArH), 131.6 (Cipso), 130.8 (d, J 9, CArH), 129.7 (d, J 6, CArH),
129.0 (d, J 2, CArH), 128.7 (d, J 2, CArH) 127.3 (d, J 9, CArH), 126.7 (Cipso), 126.7 (d, J 9, CArH),
116.4 (Cipso), 72.7 (CHN), 54.0 (CHN), 43.6 (CAH3SOCBH3), 41.7 (CAH3SOCBH3), 35.2
(cyclohexyl CH2), 29.6 (cyclohexyl CH2), 24.1 (cyclohexyl CH2) and 23.0 (cyclohexyl CH2); P
(121 MHz, CDCl3) + 51.5; m/z (EI) 637.2 ([M+H]+, 20 %), 558.1 ([M-DMSO]+, 100), 523.1
([M-Cl]+, 20) and 486.2 ([M-DMSO-2HCl]+, 80); HRMS (ESI) found 637.0538 ([M]+),
[C27H34N2OP96RuS35Cl2]+ requires 637.0545.
(3R,4R)-1-Benzyl-3,4-dihydroxypyrrolidine-2,5-dione ((R,R)-318)
Prepared according to the procedure of Skarzewski and Gupka6 and modifications made by
Fuentes.7 A mixture of benzylamine (10.72 g, 0.1 mol) and L-(R,R)-(+)-tartaric acid 317 (15.01
g, 0.1 mol) in xylene (60 mL) was refluxed using Dean-Stark apparatus for 6 h and was
subsequently left to cool to rt for 16 h. The crystalline product was filtered off and washed with
acetone to give compound (R,R)-318 as white solid (15.51 g, 70%), mp 196-197C (lit.6 197-
198C). H (300 MHz, d6-DMSO) 7.38-7.21 (5H, m, CArH), 6.33 (2H, br s, 2 x OH), 4.56 (2H,
d, J 5, 2 x CHOH) and 4.40 (2H, s, CH2Ph); C (101 MHz, CDCl3) 179.8 (C=O), 141.2 (Cipso),
133.7 (CArH), 132.7 (CArH), 132.7 (CArH), 79.7 (CHOH), 46.4 (CH2Ph). Data are in agreement
with the literature.6,7
(3S,4S)-1-Benzylpyrrolidine-3,4-diol ((S,S)-319)
Prepared following the procedure of Cardona.4 Compound (R,R)-318 was added portionwise to
a suspension of lithium aluminium hydride (1.02 g, 0.027 mol) in tetrahydrofuran (100 mL) at
rt. The mixture was then heated at reflux for 16 h. This was then cooled to 0C and a saturated
solution of sodium sulfate was added until no more gas was evolved. The mixture was filtered
through Celite, washing with ethyl acetate, and was then concentrated in vacuo to give
compound (S,S)-319, after recrystallisation, as a white solid (0.855 g, 49%), mp 72-73C (lit.6
70-71.5); H (300 MHz, CDCl3) 7.27-7.14 (5H, m, CArH), 4.03-3.97 (2H, m, 2 x CHOH), 3.55
(2H, d, J 5, CH2Ph), 3.02 (2H, br s, 2 x OH), 2.87 (2H, dd, J 10, 6, 2 x CHAHB) and 2.37 (2H,
dd, J 10, 6, 2 x CHAHB); C (101 MHz, CDCl3) 132.6 (Cipso), 123.7 (CArH), 123.1 (CArH), 122.0
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(CArH), 73.2 (CHOH), 54.9 (CH2) and 54.8 (CH2Ph). Data are in agreement with the
literature.6,7
(3R,4R)-3,4-Di(methanesulfonyloxy)-1-benzylpyrrolidine ((S,S)-320)
Following the procedure of Fuentes,7 triethylamine (2.68 mL, 19.2 mmol) was added dropwise
to a solution of (S,S)-319 (1.23 g, 6.4 mmol) in DCM at 0C and the reaction mixture stirred for
10 min. To this, methanesulfonyl chloride (1.49 g, 19.2 mmol) was added dropwise over 5 min.
The reaction was stirred at 0C for 4 h and then was allowed to warm to rt over 1 h. The mixture
was filtered and the filtrate was washed with water, before being dried over magnesium sulfate,
filtered and concentrated in vacuo, to afford the bis-mesylate (S,S)-320 as a white solid (1.46 g,
65%), mp 56-58C (lit.15 56C). H (400 MHz, CDCl3) 7.28-7.15 (5H, m, CArH), 5.06-5.00 (2H,
m, 2 x CHOMs), 3.55 (2H, app d, J 2, CH2Ph), 3.01 (2H, app dd, J 11, 6, 2 x CHAHB), 2.98 (6H,
s, 2 x SO2CH3) and 2.67 (2H, dd, J 11, 4, 2 x CHAHB); C (101 MHz, CDCl3) 137.0 (Cipso),
128.8 (CArH), 128.5 (CArH), 127.6 (CArH), 82.6 (CHOMs), 59.1 (CH2Ph), 57.9 (CH2) and 38.3
(SO2CH3). Data are in agreement with the literature.16
(3R,4R)-3,4-Diazido-1-benzylpyrrolidine ((R,R)-321)
Following the procedure of Fuentes,7 the bis-mesylate (S,S)-320 (0.186 g, 0.53 mmol) was
dissolved in DMF (10 mL) and to this, sodium azide (0.138 g, 0.53 mmol) was added, and the
mixture heated to 100C for 4 h. The reaction mixture was then stirred for a further 16 h at rt,
before dichloromethane was added. The organic component was washed with water, dried over
magnesium sulfate, filtered and concentrated in vacuo to give the crude product. Flash
chromatography (100% dichloromethane) gave the bis-amide as a colourless liquid (0.039 g,
30%). H (400 MHz, CDCl3) 7.26-7.16 (5H, m, CArH), 3.81-3.76 (2H, m, 2 x CHN3), 3.57 (2H,
d, J 13, CH2Ph), 2.90 (2H, dd, J 10, 6, 2 x CHAHB) and 2.52 (2H, dd, J 10, 5, 2 x CHAHB). Data
are in agreement with the literature.7
(3R,4R)-1-Benzylpyrrolidine-3,4-diamine ((R,R)-322)
Following the procedure of Skareski and Gupta,6 10% Pd on carbon (0.040 g) was added to a
solution of (R,R)-321 (0.357 g, 15 mmol) in absolute ethanol (10 mL) and the mixture was
stirred at rt for 16 h under a hydrogen atmosphere (1 bar). The mixture was subsequently
filtered through Celite, washing with ethyl acetate, and concentrated in vacuo to give the title
compound as a sticky solid (0.230 g, 82%). []20D -15.5 (c 1.0, MeOH), lit.6 []20D -15.0 (c 1.0,
MeOH); H (400 MHz, CDCl3) 7.28-7.13 (5H, m, CArH), 3.62-3.45 (2H, m, CH2Ph), 3.05-2.93
(2H, m, 2 x CHAHB), 2.91-2.79 (2H, m, 2 x CHAHB), 2.30-2.18 (2H, m, 2 x CHNH2) and 1.71
(4H, br s, J 10, 5, 2 x NH2). m/z (ES+) 192.07 ([M+H]+, 100%); HRMS (ES+) found 192.1502,
[C11H18N3]+ requires 192.1501. Data are in agreement with the literature.6
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Complex (R,R)-324
A solution of 2-(diphenylphosphino)benzaldehyde 266 (0.082 g, 0.28 mmol) in ethanol at 45C
was added dropwise to a solution of (3R,4R)-1-benzylpyrrolidine-3,4-diamine (R,R)-322 (0.054
g, 0.28 mmol) in the same solvent over a period of 16 h. The solvent was then removed and the
residue complexed immediately following the protocol described in section 5.2.1. After column
chromatography (1:1 DCM:acetone), the title complex was obtained as a brown powder (0.122
g , 61%), mp 180-187C (decomp.). H (400 MHz, CDCl3) 8.18 (1H, s, N=CH), 7.70-7.04 (19H,
m, CArH), 5.07 (1H, br s, NHAHB), 3.86-3.66 (4H, NCH2Ar† + CHNH2† + NHAHB), 3.19-3.08
(1H, m, pyrrolidine CXHAHB)†, 3.07-2.99 (2H, m, pyrrolidine CXHAHB + pyrrolidine CYHAHB)†,
2.98-2.87 (2H, m, pyrrolidine CYHAHB + CHN=CH)†, 2.56 (3H, s, C(HA)3SOC(HB)3) and 2.51
(3H, s, C(HA)3SOC(HB)3); C (400 MHz, CDCl3) 163.3 (N=CH), 137.1 (Cipso), 136.2 (d, J 9,
CArH), 135.8 (Cipso), 134.9 (CArH), 134.1 (d, J 10, CArH), 133.6 (d, J 10, CArH), 132.1 (d, J 7,
CArH), 131.8 (d, J 11, Cipso), 130.9 (CArH), 130.2 (CArH), 129.8 (CArH), 128.5 (CArH), 128.5
(CArH), 127.7 (d, J 10, CArH), 127.2 (Cipso), 116.0 (Cipso), 61.3 (NCH2Ph)†, 58.5 (CHNH2)†, 54.5
(pyrrolidine CxH2)†, 50.8 (pyrrolidine CYH2)†, 44.7 (CHN=CH)†, 43.0 (CAH3SOCBH3) and 41.1
(CAH3SOCBH3); P (121 MHz, CDCl3) +53.7; HRMS (ES+) found 708.0845,
[C32H37Cl2N3OP96RuS]+ requires 708.0842. †Observed from 1H-13C HSQC correlations.
(±)-trans-9,10-Dihydro-9,10-ethanoanthracene-11,12-dicarboxylic acid ((±)-327)
HO2C
CO2H
Following the procedure of Bachmann and Scott,8 a solution of anthracene (24.0 g, 130 mmol)
and fumaric acid (5.2 g, 44.80 mmol) in dioxane (250 mL) was refluxed for 3 days. The solvent
was then evaporated in vacuo and the residue stirred with 2.5 M sodium bicarbonate solution for
2 h. The mixture was filtered and concentrated hydrochloric acid was added to the filtrate until
it reached pH 7 and extracted with toluene (2 x 100 mL). The aqueous layer was acidified with
concentrated hydrochloric acid causing the product to precipitate. The mixture was filtered and
the precipitate was with chloroform to leave compound (±)-327 as a white solid (23.16 g, 61 %).
mp 248 - 250C (lit.10 253 -254C). H (400 MHz, d6 DMSO) 12.54 (2H, br s, OH), 7.41-7.36
(2H, m, CArH), 7.27-7.23 (2H, m, CArH), 7.13-7.03 (4H, m, CArH), 4.71 (2H, s, 2 x CHCO2H)
and 3.10 (2H, s, 2 x CH); C (75 MHz, d6 DMSO) 45.9 (CH), 47.3 (CH), 123.5 (CArH), 124.6
(CArH), 125.8 (CArH), 126.0 (CArH), 140.5 (CAr), 142.7 (CAr) and 173.3 (CO2H); m/z (CI+)
294.09 ([M]+, 10 %), 207.12 ([M-(2 x (CO2H))]+, 10) and 179.07 ([M-(HO2CCH2CH2CO2H)]+,
100). Data are in agreement with the literature.7
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(-)-9,10-Dihydro-9,10-ethanoanthracene-11(S),12(S)-dicarboxylic acid ((S,S)-327)
Following a procedure introduced by Brienne and Jaques9 and later modified by Allenmark,10
(±)-trans-9,10-dihydro-9,10-ethanoanthracene-11,12-dicarboxylic acid 327 (10.48 g, 35.60
mmol) and brucine (28.01 g, 71.20 mmol) were stired in a 35 % solution of absolute ethanol in
water (v/v) (300 mL). The resulting mixture was warmed until all the solids dissolved. The
solution was then allowed to cool to room temperature and was kept at 4C for 24 h. The white
precipitate was collected by suction filtration and the same procedure was repeated again, this
time using 200 mL of a 35 % solution of absolute ethanol in water. The solution was allowed to
stand for 4 h at 4C and the precipitate collected by suction filtration, washed with cold 35 %
solution of absolute ethanol in water (2 x 20 mL) and dried via suction filtration to leave the
brucine salt as a white crystalline solid. []D20 -14.9 (c 1, dioxane), (Lit.10 []D20 -15.3 (c 2,
dioxane). The brucine salt was stirred with 1M NaOH (100 mL) for 30 min before the free
brucine was filtered off. The filtrate was acidified to pH < 2 by addition of concentrated
hydrochloric acid and the resulting precipitate was filtered, washed with chloroform, and dried
in vacuo to leave the desired product as a white powder (3.56 g, 34 %). Characterisation data
matched that of the racemate.
(-)-9,10-Dihydro-9,10-ethanoanthracene-11(S),12(S)-diacid chloride ((S,S)-329)
ClOC
COCl
By adaption of the procedure of Allenmark,10 thionyl chloride (0.79 mL, 10.80 mmol) was
added dropwise to a stirred slurry of (-)-9,10-dihydro-9,10-ethanoanthracene-11(S),12(S)-
dicarboxylic acid (S,S-327) (1.06 g, 36.00 mmol) in anhydrous toluene (8 mL). The mixture was
heated at reflux until the entire solid had disappeared and then for 16 h at 60C. The solution
was allowed to cool to room temperature and the solvent and thionyl chloride were removed
under reduced pressure to afford the bis-acid chloride (S,S)-329 as a sticky clear solid (0.94 g,
79 %), of >99% enantiomeric excess. H (400 MHz, CDCl3) 7.36-7.26 (4H, m, CArH), 7.15-7.10
(4H, m, CArH), 4.88 (2H, s, 2 x CH) and 3.75-3.74 (2H, m, 2 x CH). Enantioselectivity
determined by chiral HPLC of the isopropyl ester derivative of (S,S)-338. ChiralPak AD, 1.0
mL/min, 98:2 hexane:2-propanol. Retention times: 6.0 min (R,R) and 9.7 min (S,S). Data are in
agreement with the literature.11
(+)-(11S,12S)-11,12-Diamino-9,10-dihydro-9,10-ethanoanthracene ((S,S)-331)
By modification of the procedures of Trost11 and Fuentes,7 a solution of (+)-(11S,12S)-11,12-
Diamino-9,10-dihydro-9,10-ethanoanthracene diacid chloride (S,S-329) (1.10 g, 3.32 mmol) in
toluene (15 mL) was added dropwise to a solution of sodium azide (0.76 g, 11.60 mmol) in
water (15 mL) cooled to 0C. The mixture was stirred 4 h while warming up from 0C to rt. The
organic layer was separated and washed with dilute sodium hydrogen carbonate (15 mL) and
water (2 x 10 mL), dried over anhydrous magnesium sulfate and filtered to give a solution of the
corresponding bis-azide. The solution was diluted further with toluene and heated to 80C for 1
h then cooled to rt to give a solution of the bis-isocyanate. To this solution was added 6M
hydrochloric acid (6 mL) and the mixture heated to 80C for 3 h and then stirred at rt for 16 h.
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The two layers were separated and the aqueous phase washed with toluene then concentrated to
give the diamine hydrochloride as a brownish solid. This was dissolved in water and sodium
hydroxide was added until the solution became milky (~ pH 14). The solution was extracted
with dichloromethane and the organic solution was washed with water then brine before being
separated, dried over magnesium sulfate and concentrated to give the title compound as a beige
solid (0.157 g, 20 %), which was used without further purification, mp 151-153C (lit.11 153-
156C). []20D + 19.9 (c 2.0, MeOH), lit.11 []20D + 21.2 (c 2.3, MeOH); H (400 MHz, CDCl3)
7.23-7.09 (4H, m, CArH), 7.05-6.92 (4H, m, CArH), 3.86 (2H, s, 2 x CH), 2.45 (2H, s, 2 x CH)
and 1.12 (4H, br s , 2 x NH2); m/z (ES+) 237.08 ([M+H]+, 5 %) and 220.06 ([M-NH2]+, 100).
Data are in agreement with the literature.11
N-[2-Diphenylphosphanyl)benzoyloxy]succinimide (334)
Following the procedure of Santos and coworkers,12 2-(diphenylphospanyl)benzoic acid (0.984
g, 3.2 mmol) and N-hydroxysuccinimide (0.737 g, 6.4 mmol) were dissolved in
dichloromethane (20 mL) at rt, and a solution of dicyclohexylcarbodiimide (1.32 g, 6.4 mmol)
was added dropwise. After 3 h, the mixture was filtered through Celite, washing with further
dichloromethane, and concentrated in vacuo. Column chromatography (4:1 ethyl
acetate:hexane) afforded the pure material as a yellowish solid (1.16 g, 90%). mp 142-144C. H
(300 MHz, CDCl3) 8.27-8.20 (1H, m, CArH), 7.44-7.34 (3H, m, CArH), 7.27-7.10 (9H, m, CArH),
6.95-6.88 (1H, m, CArH) and 2.68 (4H, s, 2 x CH2); P (121 MHz, CDCl3) -4.7. Data are in
agreement with the literature.12
[(11R,12R)-N-(12-Amino-9,10-dihydro-9,10-ethanoanthracen-11-yl)]-2-
(diphenylphosphino) benzamide (335)
By modification of a literature procedure of Santos and coworkers,12 N-[2-
(diphenylphosphanyl)benzoyloxy]succinimide 334 (0.100 g, 0.42 mmol), dissolved in
dichloromethane (10 mL), was added dropwise to a solution of (+)-(11S,12S)-11,12-diamino-
9,10-dihydro-9,10-ethanoanthracene (R,R)-331 in the same solvent (25 mL). After 4 h, the
mixture was washed with water and the organic phase separated. The aqueous phase was
extracted with further dichloromethane. The combined organic fractions were dried over
magnesium sulfate, filtered and concentrated in vacuo. Flash chromatography on silica
(95:5→9:1 DCM:MeOH) and subsquent recrystallisation furnished the product as yellowish 
crystals (0.137 g, 75%), mp 129-130C. H (CDCl3, 300 MHz) 7.37 (1H, ddd, J 8, 4, 2, CArH),
7.30-7.08 (16H, m, CArH), 7.07-6.94 (4H, m, CArH), 6.79 (1H, ddd, J 8, 4, 1, CArH), 5.71 (1H, d,
J 8, NHCO), 4.08 (1H, d, J 3, CH), 4.00 (1H, d, J 3, CH), 3.66-3.59 (1H, m , CH), 2.43 (1H, t, J
3, CH) and 1.53 (2H, br s, NH2); C (CDCl3, 400 MHz) 169.2 (C=O) 142.4 (Cipso), 140.9 (d, J
26, Cipso), 140.3 (Cipso), 139.2 (Cipso), 138.5 (Cipso), 136.8 (Cipso), 136.7 (Cipso), 135.8 (d, J 21,
Cipso), 134.1 (CArH), 134.0 (CArH), 133.9 (CArH), 133.9 (CArH), 133.7 (CArH), 130.3 (CArH),
129.0 (d, J 6, CArH), 128.8 (app d, J 6, CArH), 128.7 (app d, J 6, CArH), 128.6 (CArH), 127.9 (d, J
5, CArH), 126.7 (CArH), 126.6 (d, J 5, CArH), 126.3 (CArH), 126.2 (CArH), 125.4 (CArH), 124.5
(d, J 9, CArH), 60.7 (CHN), 60.3 (CHN), 51.5 (CH) and 48.6 (CH); P (CDCl3, 121 MHz) –10.1;
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m/z (ES+) 524.92 ((M+H)+, 100%); HRMS (ES+) found 525.2089, [C35H30N2OP]+ requires
525.2096. †Assignments supported by 1H-1H COSY and 1H-13C HSQC correlations.
‡Assignments supported by 1H-13C HSQC correlations.
Complex (S,S)-333
A solution of 2-(diphenylphosphino)benzaldehyde 266 (0.099 g, 0.34 mmol) in ethanol at 45C
was added dropwise to a solution of (+)-(11S,12S)-11,12-diamino-9,10-dihydro-9,10-
ethanoanthracene (S,S)-331 (0.250 g, 1.03 mmol) in the same solvent over a period of 2 h at rt.
To this, sodium borohydride (0.051 g, 1.36 mmol) was added and the solution stirred for a
further four hours at rt. The solvent was removed and the ligand complexed immediately using
the protocol described in section 5.2.1. Attempts at purification of the crude product by flash
chromatography on silica (100:0 to 50:50 DCM:acetone) only furnished the product as an 80:20
mixture with an unidentified species. Product: P (121 MHz, CDCl3) +45.3; Unidentified side
product P (121 MHz, CDCl3) +54.2. We therefore have only made tentative conclusions
regarding the performance of this complex.
(11S,12S)-N11-(2-(Diphenylphosphino)benzyl)-9,10-dihydro-9,10-ethanoanthracene-
11,12-diamine borane adduct (336)
(R,R)-331 and borane tetrahydrofuran complex were stirred together under nitrogen for 16 h.
Evaporation of the solvent and recrystallisation from dichloromethane yielded the title
compound (0.067 g, 59%) in around 90% purity by NMR. H 7.70-7.14 (22H, m, CArH), 4.60
(2H, br s, NH2), 4.44-4.40 (1H, m, NH or CH), 4.36-4.32 (2H, m, NH or CHN), 4.23-4.17 (2H,
m, 2 x NH or CHN), 3.16-3.15 (CH) and 2.83-2.80 (CH); P (CDCl3, 300 MHz) +18.9; B
(MeOD, 400 MHz) = -1.3.
(1R,2S)-1-((2-(bis(3,5-di-tert-butylphenyl)phosphino)benzyl)amino)-2,3-dihydro-1H-inden-
2-ol (340)
(1R,2S)-(+)-cis-1-amino-2-indanol 338 (0.022 g, 0.195 mmol) and 2-(bis(3,5-di-tert-
butylphenyl)phosphino)benzaldehyde 302 (0.100 g, 0.195 mmol) were dissolved in ethanol (20
mL) and stirred at rt for 3 h. After this period, sodium borohydride (0.030 g, 0.780 mmol) was
added and the mixture stirred for a further 16 h. The solvent was then removed under reduced
pressure. The residue was dissolved by stirring with saturated ammonium chloride solution and
dichloromethane. The organic layer was separated, washed with water and brine, dried over
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magnesium sulfate, filtered and concentrated in vacuo to give the crude product as a sticky
colourless solid. Due to the sensitivity of the phosphine to air, full characterisation was not
possible and the ligand complexed immediately. H (CDCl3, 300 MHz) 7.71-6.75 (14H, m,
CArH), 6.29 (1H, d, J 7, OH), 4.39-4.32 (1H, m, CHO or CHN), 4.18-4.11 (2H, m, CH2CHOH),
3.97-3.90 (1H, m, CHO or CHN), 2.96-2.83 (3H, m, CH2Ar + NH) and 1.13 (36H, s, 4 x
C(CH3)3; C (CDCl3, 75 MHz) 149.9 (d, J 7, Cipso), 149.8 (d, J 7, Cipso), 142.6 (d, J 20, Cipso),
140.9 (Cipso), 140.0 (Cipso), 136.1 (d, J 12, Cipso), 134.9 (d, J 9, Cipso), 134.4 (d, J 10, Cipso), 132.8
(CArH), 129.0 (CArH), 127.9 (CArH), 127.2 (CArH), 126.9 (CArH), 126.6 (CArH), 126.5 (CArH),
125.4 (CArH), 124.3 (CArH), 122.5 (CArH), 121.7 (CArH), 121.6 (CArH), 69.3 (CHN or CHO),
64.1 (CHN or CHO), 50.2 (d, J 18, NHCH2Ar), 38.6 (CH2CHOH). 33.9 (C(CH3)3) and 30.3
(C(CH3)3); P (CDCl3, 121 MHz) –14.2; m/z (ES+) 664.26 ((M=O+H)+, 100%).
Complex (R,S)-341
Prepared using the general procedure outlined in section 5.3.1 giving complex (R,S)-341 as a
brown solid (0.138 g, 79 %), m.p. > 187C (decomp.). Micronalysis was not possible as the
complex held on to some solvent even after exhaustive drying preventing good microanalysis.
H (300 MHz, CDCl3) 7.46-7.40 (1H, m, CArH), 7.31-7.04 (13H, m, CArH), 5.96 (1H, br 2,
OH)†, 5.08 (1H, br s, NH)†, 4.89 (1H, dd, J 11, 6, CHN)†, 4.68-4.52 (1H, m ,CHAHBCHOH)†,
4.34-4.23 (1H, m, CHAHBCHOH)†, 4.15 (1H, t, J 11, CHO)†, 3.64-3.47 (1H, m, CHAHBNH)†,
3.11-2.96 (1H,m, CHAHBNH)†, 2.85 (3H, s, CAH3SOCBH3), 2.65 (3H, s, CAH3SOCBH3), 1.18
(18H, s, 2 x C(CH3)3) and 1.10 (18H, s, 2 x C(CH3)3); C (75 MHz, CDCl3) 149.9 (d, J 14, Cipso),
140.9 (Cipso), 139.0 (Cipso), 134.1 (Cipso), 133.3 (d, J 11, Cipso), 133.1 (CArH), 132.7 (Cipso), 132.0
(CArH), 131.8 (CArH), 131.0 (CArH), 130.3 (CArH), 129.4 (Cipso), 128.8 (Cipso), 128.4 (CArH),
128.3 (CArH), 127.5 (CArH), 126.5 (CArH), 126.0 (CArH), 124.0 (CArH), 123.4 (CArH), 68.7
(CHN)‡, 64.8 (CHO)‡, 54.6 (d, J 7, NHCH2Ar)‡, 45.9 (CAH3SOCBH3), 45.4 (CAH3SOCBH3),
37.0 (CH2CHOH)‡, 31.8 (C(CH3)3), 31.8 (C(CH3)3) and 31.6 (C(CH3)3); P (121 MHz, CDCl3)
+58.6; HRMS (ES+) found 898.2889, [C46H64Cl2NOPRuS]+ requires 898.2894. †Observed from
1H-1H COSY correlations. ‡ Observed from 1H-13C HSQC and HMBC correlations.
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Appendix B
Mass Spectrometry Isotope Profiles for Ru Complexes
Complex 264
Complex (R,R)-297
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Complex (R,R)-309
Complex (R,R)-324
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Complex (R,S)- 341
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Appendix C
X-ray Crystallographic Data
X-ray crystallographic data were collected at 93 K using a Rigaku MM007 High Brilliance
RA generator and Mercury/Saturn CCD systems using Mo Kα radiation. Intensities were
corrected for Lorentz-polarisation and for absorption. The structures were solved by direct
methods. All hydrogen atoms were refined as idealised riding geometries and structural
refinements were obtained with full-matrix least squares based on F2 by using the program
SHELXTL. Full crystallographic data in CIF format are available on the CD attachment.
B.1 Crystal data and structure refinement for Complex 264.2CHCl3 (Shown in Figure
III.1 (a))
Empirical formula C27 H35 Cl8 N2 O P Ru S
Formula weight 851.27
Temperature 93(2) K
Wavelength 0.71073 Å
Crystal system Triclinic
Space group P-1
Unit cell dimensions a = 10.2097(11) Å = 89.317(7)°.
b = 10.9133(11) Å = 84.379(7)°.
c = 15.9236(16) Å  = 83.876(7)°.
Volume 1755.6(3) Å3
Z 2
Density (calculated) 1.610 Mg/m3
Absorption coefficient 1.186 mm-1
F(000) 860
Crystal size 0.100 x 0.100 x 0.100 mm3
Theta range for data collection 1.28 to 25.35°.
Index ranges -12<=h<=11, -13<=k<=13, -19<=l<=16
Reflections collected 16641
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Independent reflections 6257 [R(int) = 0.1380]
Completeness to theta = 25.00° 98.6 %
Absorption correction Multiscan
Max. and min. transmission 1.0000 and 0.71446
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 6257 / 72 / 371
Goodness-of-fit on F2 1.122
Final R indices [I>2sigma(I)] R1 = 0.1944, wR2 = 0.4185
R indices (all data) R1 = 0.2028, wR2 = 0.4257
Extinction coefficient 0.021(3)
Largest diff. peak and hole 3.453 and -1.995 e.Å-3
B.2 Crystal data and structure refinement for complex formed upon attempted
crystallisation of Complex 264 from MeCN (Shown in Figure III.1 (b))
Empirical formula C25 H30 Cl2 N3 P Ru
Formula weight 575.46
Temperature 93(2) K
Wavelength 0.71073 Å
Crystal system Triclinic
Space group P-1
Unit cell dimensions a = 12.409(5) Å = 90.79(4)°.
b = 15.030(5) Å = 100.49(4)°.
c = 15.379(5) Å  = 114.17(5)°.
Volume 2560.8(16) Å3
Z 4
Density (calculated) 1.493 Mg/m3
Absorption coefficient 0.901 mm-1
F(000) 1176
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Crystal size 0.1200 x 0.1200 x 0.0800 mm3
Theta range for data collection 1.35 to 25.31°.
Index ranges -14<=h<=14, -17<=k<=18, -18<=l<=18
Reflections collected 24631
Independent reflections 9190 [R(int) = 0.0894]
Completeness to theta = 25.00° 99.0 %
Absorption correction Multiscan
Max. and min. transmission 1.0000 and 0.5235
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 9190 / 0 / 579
Goodness-of-fit on F2 1.070
Final R indices [I>2sigma(I)] R1 = 0.1004, wR2 = 0.2730
R indices (all data) R1 = 0.1206, wR2 = 0.2985
Largest diff. peak and hole 2.063 and -2.013 e.Å-3
B.3 Crystal data and structure refinement for Complex (R,R)-309
Empirical formula C27 H33 Cl2 N2 O P Ru S
Formula weight 636.55
Temperature 93(2) K
Wavelength 0.71073 Å
Crystal system Monoclinic
Space group P2(1)
Unit cell dimensions a = 8.981(4) Å = 90°.
b = 11.235(4) Å = 102.690(17)°.
c = 13.362(5) Å  = 90°.
Volume 1315.2(9) Å3
Z 2
Density (calculated) 1.607 Mg/m3
Absorption coefficient 0.964 mm-1
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F(000) 652
Crystal size 0.100 x 0.030 x 0.010 mm3
Theta range for data collection 4.66 to 25.35°.
Index ranges -10<=h<=10, -13<=k<=12, -15<=l<=9
Reflections collected 6595
Independent reflections 4339 [R(int) = 0.1879]
Completeness to theta = 25.00° 97.5 %
Absorption correction Multiscan
Max. and min. transmission 1.0000 and 0.9182
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 4339 / 7 / 316
Goodness-of-fit on F2 1.069
Final R indices [I>2sigma(I)] R1 = 0.1087, wR2 = 0.2398
R indices (all data) R1 = 0.1657, wR2 = 0.2722
Absolute structure parameter 0.07(15)
Largest diff. peak and hole 0.818 and -0.838 e.Å-3
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